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ABSTRACT 
 
This work stems from an increased effort to improve cancer survival rates through 
earlier diagnosis, which itself may be achieved through prompt medical help-seeking for 
symptoms. This thesis focuses on responses to symptoms potentially indicative of a 
gynaecological cancer; a group of cancers that pose a significant threat to women, and 
yet are under-represented in the literature. 
 
Four studies were conducted. Studies One and Two (n=1392 and n=1000, respectively) 
were population-based surveys of women, measuring awareness of cervical and ovarian 
cancer risk factors and symptoms, respectively. Study two also measured hypothetical 
help-seeking. Study three was a survey of a nationally-representative sample of women 
(n=911), which explored responses to real symptoms that were potentially indicative of a 
gynaecological cancer. Building on study three, study four explored responses to 
symptoms at a deeper level, through in-depth, one-to-one interviews with women who 
had recently, or were currently, experiencing a symptom potentially indicative of a 
gynaecological cancer. 
 
Awareness of symptom and risk factors for cervical and ovarian cancer was low overall. 
Women anticipated seeking help promptly for symptoms of ovarian cancer, however, 
when faced with real symptoms, outside of the context of cancer, help might not be 
sought as promptly. I found that women with symptoms respond in many different ways. 
Mapping my findings onto the Model of Pathways to Treatment, I identified a number of 
different influences which may be more important at the appraisal stage, including what 
can be expected as part of being a woman and those which may be more important at 
the help-seeking stage, such as feeling justified in seeking help. 
 
More education is needed about the symptoms and risk factors for gynaecological 
cancers. Further, campaigns encouraging women to seek help for symptoms should 
include messages which target those variables that may lead women to wait longer 
before seeking help, such as misattribution of symptoms. 
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CHAPTER ONE – GYNAECOLOGICAL CANCERS IN THE UNITED KINGDOM 
 
1.1 Overview 
Recent European and global publications have demonstrated that one-year survival 
rates for many cancers, including some gynaecological cancers (a group of cancers 
consisting of ovarian, cervical, uterine, vaginal and vulval cancers) are lower in the 
United Kingdom (UK) than they are in comparable countries (Coleman et al., 2011; De 
Angelis et al., 2014). One-year survival rates are a proxy for stage at diagnosis as lower 
one-year survival rates suggest that the disease has been growing for some time before 
being diagnosed, and higher one-year survival rates suggest that the disease was 
detected earlier in its progression. As such, early diagnosis of cancer is thought to play a 
key role in survival rates, and consequently in the reduction of mortality rates. A major 
part of the remit of global and national government policies on cancer (discussed below) 
is to improve survival rates through earlier diagnosis, and it is thought this may, in part, 
be achieved through education about the risk factors and symptoms of cancer and 
through encouraging prompt help-seeking in symptomatic individuals. 
 
Throughout this thesis, I have aimed to answer the following questions: 
1. How much do women in the United Kingdom currently know about gynaecological 
cancer symptoms and risk factors? 
2. What variables predict time to hypothetical help-seeking for symptoms of ovarian 
cancer? 
3. How do women respond both behaviourally and emotionally to symptoms which 
may indicate a gynaecological cancer? 
4. What factors explain the different behavioural and emotional responses women may 
have to an experienced symptom of a gynaecological cancer? 
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1.2 Definition of early diagnosis 
This thesis is concerned with encouraging prompt help-seeking, which may increase 
earlier diagnosis and, in turn, improve UK survival rates for gynaecological cancers. 
Throughout this thesis, I have used the term, ‘earlier diagnosis’. This term is 
polysemous, potentially meaning that a cancer is diagnosed soon after patient 
presentation, or that the cancer is diagnosed earlier in its clinical progression. In the 
medical literature this term usually means the latter, and it is this definition that I have 
used in my thesis. I have also referred to the term, ‘help-seeking’ within this thesis, 
which refers to seeking medical attention (usually from a GP) following detection of a 
symptom or a bodily change, which may be indicative of a gynaecological cancer, as 
opposed to non-symptomatic help-seeking (for example, attending screening for pre-
cancerous cells or early cancers). 
 
1.3 The importance of the early diagnosis of cancer 
The latest available UK statistics (covering the period from 2008 to 2010) reveal an 
average of over 320,000 registrations of newly diagnosed cases of cancer per annum in 
the UK, of which just under 160,000 were in women. Over the same period, there was 
an average of just under 75,000 cancer deaths in women (156,244 in total) (Office for 
National Statistics, 2012a). 
 
A number of studies in the past few years have shown that survival rates in the UK are 
falling behind those observed in countries with similar spending and similar cancer plans 
for many cancers, including some gynaecological cancers (Coleman et al., 2011; De 
Angelis et al., 2014). It has been argued that, if Britain equalled the mean European 
survival rate for cancer during the period 1985 to 1999, up to 7000 deaths a year that 
occurred within five years of diagnosis could have been avoided; if we matched the 
highest European survival rates, this figure could have been 13,000 in the period from 
1985 to 1994 and 11,500 in the period from 1995 to 1999 (Abdel-Rahman, Stockton, 
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Rachet, Hakulinen, & Coleman, 2009). Although the authors of the report that made this 
estimate did not differentiate between the proportion of avoidable deaths attributable to 
different stages of the diagnostic and treatment pathway (such as time to diagnosis or 
delays in treatment), it is likely that earlier diagnosis of a number of cancers could 
considerably increase survival rates in the UK. 
 
Currently screening only exists at national levels for breast, cervical and bowel cancer 
(Public Health England, 2013), although feasibility trials are currently being carried out 
for stratified ovarian cancer screening, which are discussed in more detail below. The 
bowel screening programme aims to detect asymptomatic early stage cancers and 
bowel polyps, which may develop into cancers. The breast screening programme aims 
to detect a cancer that has already begun, albeit in the early stages, whereas the 
cervical screening programme aims to prevent abnormal cells from developing into 
cervical cancer, rather than detecting existing cancers. However, for the many other 
types of cancer for which there is no screening programme (including (currently) 
ovarian, vaginal, vulval and uterine cancers), early diagnosis achieved through prompt 
patient help-seeking and diagnosis is key. Again, this is discussed further below. 
 
1.4 Cancer policies and NAEDI 
Reducing cancer incidence and mortality and improving outcomes in cancer patients (for 
example through increasing patient quality of life) is a global issue, and guidance for, as 
well as publications on, international cancer policies are directed and coordinated by 
The World Health Organisation1 (WHO) (within the United Nations system). These 
policies and guidance are informed by findings from global research on cancer via the 
WHO’s specialised cancer agency, the International Agency for Research on Cancer2 
                                                          
1
 http://www.who.int/about/en/ 
2
 http://www.iarc.fr/en/about/index.php 
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(IARC), who are responsible for promoting international collaboration in cancer 
research. 
 
WHO recommends that each nation should have a cancer plan that sets goals to 
improve cancer outcomes through reducing incidence and mortality and increasing 
quality of life in cancer patients (World Health Organization, Geneva, 2002). These 
cancer plans may vary between nations, due to different needs, resources and health 
systems, although WHO advises that, for all cancer plans, the aim should be to lower 
cancer incidence and improve the lives of cancer patients, irrespective of resource 
constraints within any given nation (World Health Organization, 2014). To support 
nations (and in particular lower and middle income countries), between 2006 and 2008, 
WHO published a series of six modules offering advice on the implementation of cancer 
control programmes, including a guide for early detection, which states that the two 
strategies for such are early diagnosis and screening (World Health Organization, 2007). 
 
In keeping with the above recommendations, all four of the constituent countries of the 
UK have their own cancer plans. The most recent cancer plan in England is the 
‘Improving Outcomes: A strategy for cancer’ (Department of Health, 2011b) document. 
In Wales, the most recent plan is the document, ‘Together for Health – Cancer Delivery 
Plan’ (Welsh Government, 2012), in Northern Ireland it is ‘A Cancer Control Programme 
for Northern Ireland’ (Northern Ireland Cancer Network, 2008) and in Scotland it is, 
‘Better Cancer Care, An Action Plan’ (NHS Scotland, 2008). 
 
Each of these plans explicitly mentions the importance of earlier diagnosis of cancer, for 
example, in the document, ‘Improving Outcomes: A strategy for cancer’ (Department of 
Health, 2011b), it is stated that,  
“later diagnosis in England is a major explanation for poorer survival rates 
and, if patients were diagnosed at the same earlier stage as they are in other 
countries, up to 10,000 deaths could be avoided every year. We know that 
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95% of patients present with symptoms and that nearly a quarter of all 
cancers are diagnosed through an emergency route. The scale of the 
challenge is clear” (p. 42). 
 
Moreover, each of these plans sets out specific targets for increasing the number of 
earlier diagnoses, and in turn reducing mortality. For example, the latest ‘Improving 
Outcomes: A strategy for cancer’ progress report (NHS England, 2013) revealed 
promising improvements in early diagnosis, partly through the ‘Be Clear on Cancer’ 
programmes run both nationally and regionally (NHS Choices, 2013a). 
 
Some of these cancer plans have led to, or have been informed by, initiatives and 
strategies to promote earlier diagnosis. For example, as part of the prioritisation of 
diagnosing more cancers earlier, the Cancer Reform Strategy in England (Department 
of Health, 2007), which precedes the current plan, announced the establishment of the 
National Awareness and Early Diagnosis Initiative (NAEDI) (Cancer Research UK, 
2013g). 
 
In 2008 NAEDI was formally launched as a partnership between the Department of 
Health (DoH), the National Cancer Action Team (NCAT) and Cancer Research UK 
(CRUK). The aim of the initiative is to support research that seeks to increase earlier 
diagnoses of cancer in England. Within NAEDI there are four work streams, namely: 
‘Achieving early presentation by public and patients’, ‘Optimising clinical practice and 
systems’, ‘Improving GP (General Practitioner) access to diagnostics’, and ‘Research, 
evaluation and monitoring’. Work stream 1 (‘Achieving early presentation by public and 
patients’) is concerned with achieving prompt patient presentation with symptoms to 
primary care, which includes increasing awareness of the symptoms of cancer. The full 
NAEDI pathway can be seen in Figure 1.1, below. 
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Figure 1.1. The NAEDI pathway (source: Richards, 2009) 
 
As part of work stream 1, the Cancer Awareness Measure (CAM) (Stubbings et al., 
2009) was developed. This tool measures cancer awareness (including warning signs 
and symptoms and risk factors) and can be used in research to help identify 
relationships between awareness and barriers to help-seeking and intention to seek 
help. Since the introduction of the CAM, several site-specific CAMs have been 
developed and implemented in research on awareness in various cancers (for example, 
Power, Simon, Juszczyk, Hiom, & Wardle, 2011; Simon, Wardle, et al., 2012). Two of 
these site-specific measures were used to collect data in two of the studies presented in 
this thesis (studies one and two), and can be seen in Appendices 1 and 2. 
 
1.5 The importance of a focus on early diagnosis of gynaecological cancers 
The importance of early diagnosis of cancer has been demonstrated above. In my thesis 
I have attempted to identify factors that may influence the early diagnosis of this group 
of cancers, with a particular focus on patient help-seeking for symptoms that may 
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indicate a gynaecological cancer. Below I have discussed why increasing earlier 
diagnosis of gynaecological cancers is a worthy research topic. 
 
1.6 Gynaecological cancer incidence in the United Kingdom 
Gynaecological cancers (uterine, vaginal, cervical, ovarian and vulval cancers) as a 
group are a considerable burden in the UK, accounting for around 12% of new female 
cancer diagnoses annually (Cancer Research UK, 2013e, 2013f; Office for National 
Statistics, 2012a). Put in context, gynaecological cancers are equal in incidence to lung 
cancer and are second only to breast cancer (which accounts for 31% of new female 
cancer diagnoses (Office for National Statistics, 2012a)). Gynaecological cancers are 
also responsible for 9% of female cancer deaths, making them the fourth most lethal 
malignancy in UK women after lung (21%), breast (16%) and colorectal cancers (10%) 
(Cancer Research UK, 2013e, 2013f; Office for National Statistics, 2012a). 
 
1.6.1 Trends in incidence 
The most recent data available for vaginal cancer in UK women shows an incidence 
level of 0.6 per 100,0000 women in 2011, a figure that has remained unchanged since 
2004 (Cancer Research UK, 2014b). Incidence of vulval cancer has marginally (but 
steadily) increased over the last few years, from 2.3 to 2.6 per 100,0000 women over 
the same period (Cancer Research UK, 2014c).  
 
Latest available data on incidence in the UK (Office for National Statistics, 2007, 2012a) 
show an increase in incidence of cervical cancer from 8.5 per 100,000 in 2001-2003 9.3 
in 2008-2010. However, these figures are presented as three yearly averages (to reduce 
the effects of random variation in small numbers over time), and the 2008-2009 period 
covers the period during the well-publicised cervical cancer diagnosis and subsequent 
death of a young reality television star, Jade Goody in 2009, which led to an increase in 
screening, follow-up and colposcopy attendances (known as ‘the Jade Goody effect’), 
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and likely resulted in an increased number of diagnoses in that year (Lancucki, Sasieni, 
Patnick, Day, & Vessey, 2012).  
 
Data from Cancer Research UK supports this explanation for the overall increase in 
incidence during 2008-2009. For example, in 2008 incidence was 8.8 per 100,000, in 
2009 it was 10.3 and in 2010 it dropped again to 8.4 (Cancer Research UK, 2014a). 
However, there is evidence that in some UK populations, incidence has increased, 
independently of the rise attributable to ‘the Jade Goody effect’, and independent of a 
possible effect of the increase in the age at first cervical screening from 20 to 25 years in 
2003 (National Health Service Cervical Screening Programme, 2003) (which could have 
potentially led to more incident cases of cervical cancer). For example, Patel et al. 
(2012) found evidence of an increase in incidence of cervical cancer in women aged 20-
29 in the North-East of England (NE) after excluding cases from 2009 (the period during 
which ‘the Jade Goody effect’ was most evident). Moreover, data from Wales (where the 
age of first screen has not increased, and remains at 20 years), showed a significant 
and similar increase in incidence to the data from the NE, suggesting that the increase 
in incidence observed in the latter may not have been a result of the increase in age at 
first screen. This finding is further supported by analyses carried out by Sasieni, 
Castanon, and Cuzick (2009), which showed that screening women aged 20-24 has little 
to no impact on invasive cervical cancer rates in women under 30 years old. Patel et al. 
(2012) conclude that the rise in incidence in the NE may be the result of an increase in 
exposure to background risk factors, such as the Human Papillomavirus (HPV), leading 
to an increase in high grade cervical intraepithelial neoplasia. There is evidence then, 
that in some UK populations, incidence of cervical cancer may be increasing. However, 
in the UK as a whole, it seems that incidence is reducing.   
 
Incidence of uterine cancer has increased in recent years, from 15.4 per 100,000 
women in 2001-2003 to 19.1 in 2008-2010 (Office for National Statistics, 2007, 2012a). 
This increase may largely be down to an increase in obesity in British women. In 2007, 
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Reeves et al. explored cancer incidence in relation to body mass index (BMI) in a 
sample of over one million women, as part of the Million Women Study3. They found that 
the relative risk (RR) for endometrial cancer (the most common type of uterine cancer 
(American Cancer Society, 2013)) increased almost three fold for each 10 point increase 
in BMI after adjusting for other potentially influential factors such as age, geographical 
region, socioeconomic status (SES), age at first birth, parity, smoking status, alcohol 
intake, physical activity, and, where appropriate, time since menopause and use of 
Hormone Replacement Therapy (HRT). Given that the proportion of obese women in 
England rose from 16.4% in 1993 to 25.9% in 2011 and the proportion of overweight 
women rose from 48.6% to 58.4% in the same period (Health and Social Care 
Information Centre, 2013), this explanation of the increase in incidence of uterine cancer 
seems likely. 
 
Conversely, ovarian cancer incidence has actually reduced steadily (although 
marginally), from 18 cases per 100,000 UK women in 2001-2003 to 16.6 cases in 2008-
2010 (Office for National Statistics, 2007, 2012a). One possible reason for this decrease 
in incidence is an increase in contraceptive pill use. Behaviours that interrupt the 
ovulation process, such as oral contraceptive use, have been shown to have a long 
lasting protective effect for ovarian cancer. For example, in their 2008 study, the 
Collaborative Group on Epidemiological Studies of Ovarian Cancer obtained and 
reanalysed original data exploring oral contraceptive use and ovarian cancer risk from 
45 epidemiological studies carried out in 21 countries. The reanalysis included data from 
23,257 women diagnosed with ovarian cancer and 87,303 women without. The authors 
found that the overall relative risk of ovarian cancer decreased by a fifth (20%) for every 
five years of oral contraceptive use, and that the protective effects can last for decades. 
Furthermore, there is evidence that just under 20% of incident ovarian cancers in the UK 
are attributable to reproductive factors (Parkin, Boyd, & Walker, 2011). 
                                                          
3
 www.millionwomenstudy.org 
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It should be noted, however, that the drop in ovarian cancer incidence in recent years 
amounts to only one case in every 100,000 women and it remains that almost 7,000 
women a year are diagnosed with this malignancy. Given the overall burden of 
gynaecological cancers, and the increase in incidence for some of them, it is important 
to strengthen efforts to reduce incidence and increase survival rates. The most recent 
available incidence data for all of the gynaecological cancers can be seen in Table 1.1. 
 
Table 1.1 Latest available statistics on incidence of gynaecological cancers in the 
UK 
Cancer type Incidence rate per 100,000 Dates covered 
Uterine cancer 19.1* 2008-2010 
Ovarian cancer 16.6* 2008-2010 
Cervical cancer 8.4 2010 
Vulval cancer 2.6 2011 
Vaginal cancer 0.6 2011 
*Three yearly average, per annum 
 
 
1.7 Gynaecological cancer survival rates and stage at diagnosis 
1.7.1 One-year survival rates in the UK and comparison with other countries 
The most recent available data for the UK (2004–2007) show that the net one-year 
survival rate for ovarian cancer is 68.6% (Maringe et al., 2012). For cervical cancer it is 
87%, for uterine cancer it is 91%, for vulval cancer it is 85% and for vaginal cancer, it is 
70% (Elleray, 2013b). These rates can be seen in Table 1.2. 
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Table 1.2 Latest available statistics on one-year survival rates for gynaecological 
cancers in the UK 
Cancer type Survival rate Dates covered 
Uterine cancer 90.7% 2005-2009* 
Cervical cancer 87% 2005-2009* 
Vulval cancer 85% 2005-2009* 
Vaginal cancer 70% 2005-2009* 
Ovarian cancer 68.6% 2004-2007 
* Followed up to 2010 
 
 
Logically, any survival rate below 100% would suggest that more could be achieved. 
However, it is unlikely that any cancer will reach 100% survival at one year in the near 
future. A better way of determining whether or not there is a realistic probability of 
improving survival rates for any given cancer in the UK is to compare survival rates to 
other countries with similar cancer plans. If the UK falls short, this indicates that there 
may indeed be room for improvement. In 2009, Sant et al. published the results of such 
a comparison. They reported survival rates across European countries and compared 
these with the European average one-year survival rates for each cancer in patients 
diagnosed in 1995 to 1999. The authors found that one-year survival rates across UK 
countries for ovarian cancer were considerably lower than the European rate (60%-61% 
versus 67% respectively). This finding was also reflected in more recent data from the 
International Cancer Benchmarking Partnership, which also reported lower one-year 
survival rates for ovarian cancer in the UK compared to other countries with similar 
cancer plans (Coleman et al., 2011). 
 
The cervical cancer one-year survival rate was also lower than the European average 
(78%-81% versus 84%). For vaginal and vulval cancers (77%-83% versus 79%) and 
uterine cancers (86%-92% versus 90%), there were no real differences (Sant et al. 
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2009). However, more recent data have shown that one-year uterine cancer survival 
rates in England (60%) are significantly lower than the European average (67%). This 
data also confirmed that one-year survival rates for both cervical (81%) and ovarian 
cancer (60%) were significantly lower than the European average (84% and 67% 
respectively) (Thomson & Forman, 2009). Although there appears to be no real 
difference in survival rates between UK countries and Europe for vaginal and vulval 
cancers, reported survival rates are still noticeably lower than the highest rates observed 
in Europe at that time (95% in Iceland) (Sant et al. 2009). These data suggest that better 
survival rates could be achieved for gynaecological cancers in the UK. Earlier, I 
demonstrated the importance of earlier diagnosis of cancers in terms of achieving 
improved survival rates, and below I have discussed how we might improve survival 
through earlier diagnoses of gynaecological cancers. 
 
1.7.2 Survival by FIGO stage and stage distribution at diagnosis 
At diagnosis, gynaecological cancers are categorised by FIGO (International 
Federation of Gynecology and Obstetrics) stage. Staging enables clinicians to determine 
how advanced the cancer is and what treatment would be most appropriate. It is also 
used to provide an indication of the likelihood of survival overall and at one-year or five-
years. Earlier stage diagnoses (stages I or II) are generally associated with better 
prognoses than later stage diagnoses (stages III and IV). Consequently, increasing the 
proportion of earlier stage diagnoses of cancer is frequently posited as a way of 
increasing survival rates. For example, ovarian cancers diagnosed at FIGO stage I have 
a survival rate of 92% compared to those diagnosed at stage IV, which have a survival 
rate of just 6% (Cancer Research UK, 2013c). It follows that countries with poorer 
survival rates may have a higher proportion of cancers diagnosed at later stages than 
comparable countries with better survival rates. 
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Data on stage distribution (the proportion of cancers diagnosed at each FIGO stage) 
could confirm the hypothesis that countries with poorer one-year survival rates have 
higher rates of later stage diagnoses than countries with better survival rates. However, 
in the UK there is an acknowledged lack of national cancer staging data for many 
different cancers (House of Commons Committee of Public Accounts, 2011; Welsh 
Government, 2012), with national staging information only available for around 40% of 
diagnosed cancers in 2010 (Department of Health, 2011a) (although at least in some 
areas this is improving (for example, London Cancer Alliance, 2012; NHS Wales, 
2013)). 
 
UK gynaecological cancer incidence by stage data could only be found for ovarian 
cancer (Maringe et al., 2012). For cervical cancer, I could only locate these data 
individually for Northern Ireland (Donnelly, 2013), Wales (White, 2013), and England 
(NHS Cancer Screening Programmes, 2012).  For uterine cancer, stage distribution data 
is only available for parts of England covered by the Eastern Cancer Registration & 
Information Centre (Norfolk, Suffolk, Cambridgeshire, Essex, Bedfordshire and 
Hertfordshire) (The National Cancer Registration Service (NRCS) Eastern Office, 2013), 
Wales (White, 2013) and Northern Ireland (Donnelly, 2013). No stage distribution data 
exist for vulval and vaginal cancers, which is likely to be the result of the rarity of these 
cancers (Elleray, 2013a). All available data can be seen in Table 1.3 below. 
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Table 1.3 Proportion of diagnoses by stage in the UK (and by country) 
    Ovarian cancer Cervical cancer Uterine cancer 
    %† Year* %† Year* %† Year* 
        
England‡ Stage I 33.6 
2009 
73.4 
2010-2011 
71.7 
2009 
  Stage II 3.3 14.5 9.1 
  Stage III 42.7 5.6 8.1 
  Stage IV 10.7 4.7 5.5 
                
Northern 
Ireland 
  
Stage I 21.1 
2007-2010 
56.4 
2007-2010 
55.6 
2007-2010 
Stage II 6.6 10.1 9.8 
  Stage III 35.3 18.4 9.5 
  Stage IV 16.9 7.1 4.2 
                
Wales Stage I - 
- 
51.9 
2011 
63.6 
2011 
  Stage II - 13.5 8.3 
  Stage III - 13.5 9.9 
  Stage IV - 12.8 4.1 
                
Scotland Stage I - 
- 
- 
- 
- 
- 
  Stage II - - - 
  Stage III - - - 
  Stage IV - - - 
                
United 
Kingdom 
  
  
Stage I 30.5 
1995-2007 
- 
- 
- 
- 
Stage II 5.6 - - 
Stage III 37.8 - - 
  Stage IV 26.1 - - 
Note: stage distribution data are not available for some cancers either in England or 
in the UK. Available data are shown. 
*Most recent data available, †Some missing data, where stage was not known or not 
recorded 
‡Data shown for England for ovarian and uterine cancers relate to data from the parts 
of England covered by the Eastern Cancer Registration & Information Centre 
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In the UK, 64% of ovarian cancers are diagnosed at stages III or IV (Maringe et al., 
2012), where five-year survival rates are 22% and 6% respectively (Cancer Research 
UK, 2013c). In England, over 10% of cervical cancer diagnoses in 2010/2011 were 
made at stages III and IV (NHS Cancer Screening Programmes, 2012). In Wales and 
Northern Ireland, this figure was 26% (Donnelly, 2013; White, 2013). At these later 
stages, five-year survival rates are between 30-50% for stage III and 20% for stage IV 
(Cancer Research UK, 2012b). However, it should be noted that there are some cases 
of cervical cancer that were not staged (around 8% in Wales and Northern Ireland 
(Donnelly, 2013; White, 2013) and 14% in England (NHS Cancer Screening 
Programmes, 2012)). This could be a result of the cancers being very early stage, which 
were not recorded, or it could be a result of very late stage cancers that were 
immediately treated in palliative care and were consequently not a priority for staging (as 
it would not have informed the patients’ care at this stage). Alternatively, missing stage 
information may be due to procedure within regional registries; some regions complete 
their audit process before all of the staging data have become available for that period, 
whilst others may wait until all of these data are available, and consequently delay the 
audit process (NHS Cancer Screening Programmes, 2012). 
 
In the areas covered by the Eastern Cancer Registration & Information Centre, Wales 
and Northern Ireland, 14% of uterine cancer cases were diagnosed at stages III and IV 
(Donnelly, 2013; The National Cancer Registration Service, Eastern Office, 2009; White, 
2013), where five-year survival rates are around 45% for stage III and 25% for stage IV 
(Amant et al., 2005). However as with cervical, there were some unstaged cases (14% 
in Wales, 21% in Northern Ireland and 6% in Eastern England (Donnelly, 2013; The 
National Cancer Registration Service, Eastern Office, 2009; White, 2013)), which may 
possibly have increased the proportion of later stage diagnoses. Moreover, with wide 
differences in survival from early stage (stage I: around 85%) to late stage (stage IV: 
around 25%)  (Amant et al., 2005), any improvements in the number of women 
diagnosed in the early stages of uterine cancer could be beneficial.  
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The higher rate of earlier stage diagnoses for uterine cancer compared to the other 
gynaecological cancers may be a result of the appearance of easily recognisable 
symptoms (i.e. post-menopausal bleeding) early in disease progression (Amant et al., 
2005)). For example, Barak et al. (2013) found that of 220 women diagnosed with 
endometrial cancer in their study, 81% had reported bleeding symptoms, of whom 86% 
were diagnosed at stage I and 14% were diagnosed at stage II or IV. As mentioned 
above, there is a possibility that these unstaged cases may increase the proportion of 
later stage diagnoses if they were to be staged. It should also be noted that data on 
survival rates come from areas that are relatively affluent when compared to the rest of 
the UK, and survival rates are known to be adversely affected by deprivation (Rachet et 
al., 2010). Consequently the rates reported here may actually be higher than those in 
the UK overall. Irrespective, given the differences in survival rates between early and 
late stage uterine cancer, any increase in earlier stage diagnoses is likely to improve 
outcomes. 
 
As discussed, staging data are not available in the UK for many diagnosed cancers 
(House of Commons Committee of Public Accounts, 2011), including vaginal and vulval 
cancers. The lack of staging data for these cancers in particular may be due to their 
relative rarity compared to other cancers (in 2010 there were 281 cases of vaginal 
cancer in the UK (Cancer Research UK, 2013e) and 1,157 cases of vulval cancer 
(Cancer Research UK, 2013f)), which results in a lower demand for this information. For 
vaginal cancer in particular, lack of accurate staging data may also be affected by the 
complexity of the processes involved in diagnosing these cancers as ‘true’ vaginal 
cancers and not an extension of an undetected cervical cancer (Greenberg, 2013). 
Moreover, historically, UK cancer registries have not been mandated to collect data on 
stage for gynaecological cancers (other than for cervical cancer), although data capture 
is improving (Elleray, 2013a). 
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Where stage distribution data are not available, one-year survival rates can be used as 
a proxy for later stage diagnoses, as mentioned above (National Cancer Intelligence 
Network, 2010). Given that there are no data available for vaginal and vulval cancers, 
we are reliant on these one-year survival rates to provide an indication of whether these 
cancers are mostly being diagnosed at the later or earlier stages. 
 
As I detailed earlier, the most recent data available show that the one-year UK survival 
rates for vaginal cancer and vulval cancer are 70% and 85%, respectively (Elleray, 
2013b). This would appear to suggest that vaginal and vulval cancers are mostly 
diagnosed in the earlier stages. However, as this is only an indication, it is not possible 
to definitively say that the majority of these cancers are diagnosed at the earlier FIGO 
stages (I and II). For example, data from non-UK countries (including the USA, Canada, 
Germany, France, Sweden and Australia) suggest that the majority of vulval (55%) and 
vaginal (67%) cancers are diagnosed at FIGO stages II+, where one-year survival 
ranges from 39.5% to 87.8% (Beller et al., 2003b) and 44.4% to 82.1% (Beller et al., 
2003a) respectively. These data may provide some indication of the stage distribution 
for these cancers in the UK. In this context, despite the lack of staging data for vaginal 
and vulval cancers, it may be wise to err on the side of caution and aim to look at ways 
of encouraging earlier stage diagnoses; particularly given that the difference in survival 
rate between earlier and later stage cancers is wide (85% for Stage 1 and 25% for 
Stage IV (Cancer Research UK, 2013d)), and any increase in earlier diagnoses could 
save lives. 
 
The evidence discussed above shows that the UK has poorer one-year survival rates 
when contrasted with other, comparable European countries for uterine, cervical and 
ovarian cancers (Coleman et al., 2011; Sant et al., 2009; Thomson & Forman, 2009), 
and that this may be the result of an unfavourable stage distribution in the UK for these 
cancers. Rebalancing the stage distribution in the UK may lead to better outcomes for 
most of the gynaecological cancers.  
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For ovarian cancer, however, there has been a strong argument against this conclusion. 
Recent data show that despite poorer one–year survival rates, the proportion of early 
stage diagnoses in the UK is comparable to other countries, meaning that differences in 
survival rates between countries cannot be explained by an unfavourable stage 
distribution in the UK. In their 2012 study, Maringe et al. looked at cancer registration 
data collected by the International Cancer Benchmarking Partnership (ICBP4) from 
Australia, Canada, Denmark, Norway and the UK. Just over 20,000 women with a 
diagnosis of ovarian cancer were included in the study. Age standardised one-year net 
survival was lowest for UK women (69%) and higher in Denmark (73%), Canada (74%), 
Norway (74%) and Australia (75%). However, 31% of women in the UK were diagnosed 
at stage I (after imputation for missing data), compared to 22% in Norway and Canada, 
and 20% in Denmark. FIGO stage data were not presented for Australia, although 
SEER5 summary staging data (Young, Roffers, Ries, Fritz, & Hurlbut, 2001) for all 
countries was presented. These data showed that 23% of diagnoses in Australia, 14% in 
Canada, 12% in Denmark and Norway and 22% in the UK were localised disease 
(limited to the organ of origin (National Cancer Institute, 2013)), which is generally 
equivalent to FIGO stage I (confined to the organ of origin, Odicino, Pecorelli, Zigliani, 
and Creasman, 2008). Although fewer women were diagnosed as having SEER defined 
localised disease than were diagnosed as having FIGO stage I ovarian cancer, the 
pattern remained broadly the same, with the UK having a higher proportion of earlier 
stage diagnoses. The disparity in the proportions of early diagnoses between stage I 
and localised disease is surprising, given the almost identical definitions for both stages. 
This disparity does not seem to be a result of missing data, as the same amount were 
missing for both SEER and FIGO staging for all countries (expect Norway, where 9% of 
FIGO stage data were missing compared to 4% of SEER data). The differences in the 
                                                          
4
 The ICBP is a global partnership of clinicians, academics and policymakers across the UK, Canada, 
Australia, Denmark, Norway and Sweden, founded to determine why and how cancer survival rates differ 
between countries or jurisdictions. See http://www.cancerresearchuk.org/cancer-info/spotcancerearly/ICBP/ 
5
 The Surveillance, Epidemiology, and End Results program of the National Cancer Institute in the United 
States, which groups cancer sites into localised, regional and distant stage, as opposed to the FIGO staging 
(stages I, II, III, IV) system for gynaecological cancers. 
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proportions of women diagnosed at stage I and those diagnosed as having localised 
disease are therefore likely to be due to differences in classification processes between 
the FIGO and SEER systems (for example, the FIGO system broadly has four stages, 
whereas the SEER system has three). 
 
These findings suggest that the lower one-year survival observed in the UK for ovarian 
cancer when compared to the other countries in this study is not attributable to a lower 
proportion of women being diagnosed with early stage disease; rather, it may be a result 
of poorer management of the women diagnosed at more advanced stages. However, 
there were a substantial amount of missing data in this study, which was most evident in 
the UK registry data (32% of FIGO staging data were missing, compared to 25% in 
Canada, 23% in Denmark and 9% in Norway). The large amount of missing data in the 
UK is unsurprising, given the acknowledged deficiency in stage recording in the UK 
described above (Department of Health, 2011a). 
 
The authors used multiple imputation by chained equations to deal with the missing 
data, which reduced the proportion of stage I diagnoses in the UK from 33% to 31%, 
although the proportion was still considerably higher than the proportion of earlier stage 
diagnoses in the other countries. Although it could be argued that such a large 
proportion of missing data in the UK may well have led to an overestimation of the 
proportion of earlier stage diagnoses in that country, even if we were to assume that all 
of the missing cases were later stage diagnoses, the UK still would have a favourable 
stage distribution compared to the remaining countries (for example, if all missing cases 
were stage IV, this would still mean that 26% of cases were stage I, which is still higher 
than the proportion found in the remaining countries). 
 
Nevertheless earlier diagnosis could still improve outcomes for ovarian cancer. For 
example, the majority of high-grade serous ovarian cancers (HGSCs) (which are 
included in Type II epithelial ovarian cancers; responsible for the majority of all ovarian 
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cancer mortality (Brown & Palmer, 2009)) originate outside the ovaries (possibly in the 
fallopian tubes (Hunn and Rodriguez, 2012)), spreading to the ovaries as they progress 
(Gilbert et al., 2012). This results in these tumours becoming advanced-stage earlier in 
their development (Cho & Shih, 2009). For Type II ovarian cancers, prognosis is 
influenced by tumour volume, not stage (Kurman et al., 2008), and moving the focus of 
early diagnosis for ovarian cancer from earlier stage to detection of low volume disease 
in Type II cancers, or earlier diagnosis of HGSCs, could substantially improve outcomes 
(Gilbert et al., 2012). 
 
1.8 Increasing earlier stage diagnoses 
In light of the evidence that it may be possible to increase the proportion of earlier stage 
diagnoses (or in the case of ovarian cancer, lower volume disease diagnoses in Type II 
cancer) for some gynaecological cancers in the UK, which would ultimately improve 
outcomes, it is necessary to determine how such an improvement might be undertaken. 
 
1.8.1 Screening programmes 
In 1988, the NHS introduced the national cervical cancer screening programme, a call-
recall programme designed to detect potentially cancerous or pre-cancerous 
abnormalities in the cervix, which led to a considerable drop in cervical cancer incidence 
(Peto, Gilham, Fletcher, & Matthews, 2004). In 2008, in a further bid to reduce incidence 
of cervical cancer, the NHS introduced the HPV vaccination programme, designed to 
protect women against infection with HPV types 16 and 18, which are known to jointly 
cause up to 71% of cervical cancer cases  (Muñoz et al., 2004). The vaccine is offered 
to girls aged 12-13 in a bid to protect against HPV infection before they engage in 
sexual activity, whereby they might contract the virus, although it was also offered to 
girls aged up to 18 as a catch-up programme (NHS Cervical Screening Programme, 
2013).  
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However, even with the existence of a highly effective screening programme, there were 
still an average of 951 deaths attributable to cervical cancer annually in the UK during 
2008-2010 (Office for National Statistics, 2012a). One possible reason for this is the 
failure of the programme to reach full coverage; the most recent available statistics show 
that 27% of women aged 30-34 and 24% of women aged 35-39 (the highest incidence 
age groups (Cancer Research UK, 2013b)) are not up-to-date with screening (Health & 
Social Care Information Centre, 2012). 
 
Further, attendance in these age groups has started to show a slight downward trend in 
recent years, from 72.8% in 2010 and 2011 to 72.7% for women aged 30-34, and from 
76.9% in 2010 and 76.5% in 2011 to 76.1% in 2012 for women aged 35-39 (Health & 
Social Care Information Centre, 2012). Recent data show that the majority of 
unscreened women who were diagnosed with a cervical cancer in the age groups 20-34 
and 35-49 were diagnosed at later stage of cervical cancer (FIGO stage IB+) (NHS 
Cancer Screening Programmes, 2012). In never-screened women aged 20-29, 80% of 
those diagnosed with cervical cancer were diagnosed at stage 1B+, including 32% 
diagnosed at stage II+ (Castanon, Leung, Landy, Lim, & Sasieni, 2013). Although the 
data show that the stage distribution is favourable for cervical cancer, with most cases 
diagnosed in the earlier stages, there is still opportunity for improvement in the number 
of earlier diagnoses in women who do not attend screening. 
 
Moreover, although the HPV vaccination programme will likely reduce incidence further, 
including in unscreened women, the effects of this vaccine will not be seen until the first 
vaccinated cohort in England reaches the age group at which cervical cancer begins to 
peak in incidence (i.e. age 30-39 years (NHS Cancer Screening Programmes, 2011)). 
The HPV vaccination programme aimed to protect all girls born on or after 1990 (NHS 
Cervical Screening Programme, 2013). Consequently, a reduction in incidence will not 
be seen until around 2025, although we should start to see a drop in abnormal cytology 
earlier than this date. 
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Currently there are no national gynaecological cancer screening programmes except for 
cervical, although trials exploring the feasibility of introducing a screening programme for 
post-menopausal women and for women with a significant family history are underway. 
These are the UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) (UCL 
and UCLH NHS Foundation Trust, 2008) and UK FOCSS (UK Familial Ovarian Cancer 
Screening Study (UCL and UCLH NHS Foundation Trust, 2011) respectively. 
 
UKCTOCS is a large, randomised controlled trial with a primary outcome measure of 
ovarian cancer mortality at seven years from baseline in 202,638 post-menopausal 
women aged 50-74 years. The trial has three arms; a control group (n=101,359), a 
group where participants are offered annual screening with serum CA125 as the primary 
test and CA125 and transvaginal ultrasound scans (TVSs) as the secondary test 
(n=50,640) and a group where participants are given an annual TVS as the primary test 
and repeat TVS in 6-8 weeks as the secondary test (n=50,639). Initial findings are 
promising in terms of feasibility, but final results are awaited (Menon et al., 2009). 
 
UK FOCSS is a slightly smaller trial, with a single arm, but two phases. The primary 
outcome is the sensitivity, specificity and positive predictive value for the detection of 
primary epithelial ovarian and fallopian tube cancer in women with a minimum lifetime 
risk of ovarian cancer of 10% (based on family history or predisposing mutations). 
Phase I of the trial comprised annual TVSs and CA125 measurements. Phase II of the 
trial comprised CA125 screening every four months and annual TVS. From the Phase I 
data, the authors concluded that more frequent screening (<one year between screens), 
strict adherence to screening schedules and fast responses to abnormal results may 
increase the proportion of earlier stage diagnoses (Rosenthal et al., 2013), although the 
results from Phase II are still awaited. 
 
Both the UKCTOCS and UK FOCSS trials are important in determining whether it is 
feasible to carry out screening for ovarian cancer, both in older women and in women 
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who have a higher predisposition to the disease. However, at present, it is not possible 
to say whether screening for ovarian cancer will be a possibility. 
 
1.8.2 Help-seeking 
In the absence of effective national screening strategies for most gynaecological 
cancers, early diagnosis is reliant upon timely patient help-seeking and appropriate 
action by healthcare professionals at patient presentation (i.e. appropriate investigations 
and/or referral to secondary care). In the literature, ‘patient delay’ is defined as the 
period from first detection of a symptom to the point at which medical attention is sought 
(de Nooijer, Lechner, & de Vries, 2001). In this thesis, the phrase ‘time to help-seeking’ 
has been used where possible, as opposed to the term ‘patient delay’, except where 
discussing literature that has used the latter term.  
 
Although widely used in the literature, the term, ‘patient delay’ is problematic for a 
number of reasons. For example, it assumes a conscious decision not to seek help, 
inferring that blame for any delays in help-seeking should be placed on the patient, and 
ignores other factors which may have led to a longer time to help-seeking such as 
access to a healthcare provider (Coates et al., 1996). It has been suggested that the 
term, ‘patient delay’ should be abandoned altogether and replaced with the terms, 
‘appraisal interval’ (the time taken to interpret bodily changes or symptoms) and ‘help-
seeking interval’ (the time taken to act upon these interpretations and to seek help)  
(Weller et al., 2012). These terms are also used in the most recent model of help-
seeking behaviour, the Model of Pathways to Treatment (Walter, Webster, Scott, & 
Emery, 2012), which is discussed in detail in Chapter Two. 
 
Another criticism of the term, ‘patient delay’ is that the term is inconsistently used (Scott 
& Walter, 2010). Although it is generally understood that ‘patient delay’ refers to the time 
period between first noticing a symptom and seeking medical help for that symptom (for 
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example, Facione, Miaskowski, Dodd, and Paul, 2002), the length of time that 
constitutes ‘delay’ has not always been clear or well-defined. The majority of the 
literature has traditionally used Pack and Gallo’s often-cited seminal research paper to 
determine the period of ‘patient delay’ (Pack & Gallo, 1938). This paper argues that it is 
reasonable for a patient to take up to three months to seek help for a symptom that may 
indicate cancer, but a longer period of time taken to seek help would be deemed 
‘undue’, although these time periods appear to be arbitrary, do not appear to be based 
on any clinical evidence, and may not be appropriately applied across all patients, all 
symptoms and all illnesses (for example, Andersen, Vedsted, Olesen, Bro, & 
Søndergaard, 2009; Bish, Ramirez, Burgess, & Hunter, 2005; Burgess et al., 2006). 
However, some of the literature has defined ‘patient delay’ as having occurred after 
much shorter periods of time (Hunter, Grunfeld, & Ramirez, 2003).  
 
Although an inconsistency with regards to what period of time should be referred to as 
‘delay’ has been noted within this body of literature, perhaps it may be more appropriate 
to explore what influences a longer time to help-seeking. For example, not all cancer 
tumours behave in a similar manner; speed of tumour growth and symptom progression 
can vary (Ford & Mitchell, 1999), meaning that it may be appropriate to seek help 
sooner for some tumour types than for others. Exploring a longer time to help-seeking 
then, rather than exploring what influences having waited for longer than a specific time-
point may be more appropriate. 
 
Although there is currently a national screening programme for cervical cancer, it is still 
important to explore reasons for a longer time to help-seeking for this gynaecological 
cancer, given that not all eligible women are attending and there are still a considerable 
number of both incidences and deaths from this cancer, as discussed above. 
Encouraging timely patient help-seeking is particularly important when considering the 
proportions of women diagnosed with a gynaecological cancer through emergency 
presentation or by death certificate only (for example, 33% of ovarian and 8% of uterine 
cancers in 2006-2008, Elliss-Brookes et al., 2012). However, research suggests that 
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women do not always seek help in a timely manner, nor do they always receive a timely 
diagnosis (for example,  Evans, Ziebland, and McPherson 2007). 
 
We know that at least for some of the gynaecological cancers, there are detectable 
symptoms in the earlier stages. For example, in ovarian cancer, the evidence shows that 
abdominal and pelvic pain may be present in over half of women with earlier stage 
disease (Hamilton, Peters, Bankhead, & Sharp, 2009) and that urinary symptoms are 
more likely in earlier stage disease than in later stage disease (Webb et al., 2004). 
Given the existence of detectable, earlier stage symptoms, we need to understand why 
some women may wait longer before seeking help for symptoms which may be 
indicative of a gynaecological cancer. 
 
1.9 Summary 
The above has established that there is room for improvement in survival rates for 
gynaecological cancers in the UK, and that this may be achieved through increasing the 
proportion of lower volume tumour diagnoses in ovarian cancer and increasing earlier 
stage diagnoses for the remaining gynaecological cancers. Increasing the proportion of 
earlier stage or lower volume tumours in these cancers may be realised through 
encouraging prompt help-seeking upon symptom presentation. 
 
In the next two chapters I have explored the literature on variables associated with time 
to help-seeking for female cancers and the literature on models of health behaviour or 
help-seeking. This will increase understanding of the help-seeking process, and where 
the associated variables may be most influential. In Chapter Four, I have laid out the 
aims of the following chapters (Chapters Five, Six, Seven and Eight) which will report on 
new data and analyses. 
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CHAPTER TWO – MODELS OF HEALTH BEHAVIOUR AND HELP-SEEKING 
2.1 Introduction 
2.1.1 Background 
In the previous chapter, I discussed the importance of early diagnosis of gynaecological 
cancers, and how this might be achieved through encouraging prompt help-seeking 
once symptoms appear. I concluded that by encouraging prompt help-seeking, it may be 
possible to increase the proportion of earlier stage diagnoses of these cancers, and, as 
such, improve survival rates. However, in order to encourage prompt help-seeking, it is 
important to understand the processes and stages that women may experience and 
move through respectively, on the pathway from detection of a symptom to action. 
 
As mentioned in the previous chapter, a longer time to help-seeking (patient delay) is 
defined in the literature as the time period between becoming aware of a symptom and 
seeking medical attention for the symptom (de Nooijer et al., 2001). However, this 
pathway is complex, and many different variables can influence how an individual 
moves through it. The factors that influence help-seeking behaviour are discussed in-
depth in the next chapter. 
 
The idea that a symptom may be perceived and evaluated differently and acted upon (or 
not), depending upon different factors (such as the socio-demographic characteristics of 
the person experiencing that symptom) has previously been defined as ‘illness 
behaviour’ (Mechanic & Volkart, 1960). More recent research has expanded on this, and 
has demonstrated that medical help-seeking is not necessarily a linear or simple 
process (Corner & Brindle, 2011). Individuals may choose routes other than seeking out 
a medical practitioner, such as self-management or looking for advice on the internet. 
Models of heath behaviours aid our understanding of the complex processes involved in 
deciding that one is ill, that one needs help, and how one might go about accessing that 
help. 
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2.2 Models of patient delay (help-seeking) 
Within the health psychology literature, several models have been widely used to 
provide frameworks within which we can understand or predict responses to a health 
threat or utilisation of health services. These models often describe a number of different 
factors that may interact to determine a health behaviour. However, despite the 
development of models developed specifically to understand ‘patient delay’, such 
models have not been used consistently within the literature (Scott & Walter, 2010; 
Walter et al., 2012). This makes it difficult to determine an overall picture of the variables 
or factors which are most influential in the decision process to either seek help or not, 
how one might seek help, as well as the time taken to decide and act on one’s decision. 
Using models when researching time to help-seeking for symptoms of cancer allows 
comparative research to emerge and a better overall picture of which factors are most 
influential at what point in time in the process of deciding to seek help. The more 
prominent models used within the health psychology literature are discussed below, 
followed by a discussion of the models designed to aid understanding of ‘patient delay’. 
 
2.2.1 The Socio-Behavioural Model and the Health Belief Model 
Earlier, dominant models of health service utilisation include the Socio-Behavioural 
Model (SBM) (Andersen, 1968) and the Health Belief Model (HBM) (Maiman & Becker, 
1974; Rosenstock, 1974). The SBM describes predisposing factors’ (including 
demographic, social and cultural variables), ‘enabling factors’ (including knowledge and 
ability to seek care) and ‘the need for care’ (which may be influenced by the severity of 
the symptoms experienced) which influence the likelihood of health care utilisation. Later 
revisions of the model acknowledged the role of the healthcare system, social support 
and personal health practices and incorporated the outcomes of having sought health 
care (including consumer satisfaction, evaluated health status and perceived health 
status), which may then influence subsequent perceived need for health services and 
predisposing factors (Andersen, 1995). 
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Unlike the SBM, which focuses more specifically on illness behaviour and the utilisation 
of health care services at a societal level, the HBM focuses on the social psychology of 
the individual; the likelihood of health behaviours (such as utilising health services) or 
prevention behaviours (such as ceasing to smoke) are influenced by individual 
perceptions and beliefs. Earlier versions of the HBM consisted of four dimensions which 
accounted for an individual’s readiness to act: ‘perceived susceptibility’, ‘perceived 
severity’, ‘perceived benefits’ and ‘perceived costs (or barriers)’. A further dimension, 
‘cues to action’ (which can be internal, such as symptom characteristics or external, 
such as advice from others and mass media campaigns) are said to convert readiness 
into action. Later, ‘health motivation’ (Rosenstock, Strecher, & Becker, 1988) and ‘self-
efficacy’ (Rosenstock et al., 1988) were added to reflect differences in the degree of 
concern about health matters and confidence in the ability to carry out the health 
behaviour, respectively. Within the HBM, demographic, sociopsychological and 
knowledge factors all act to modify perceptions and consequently can indirectly 
influence behaviour. 
 
Both the SBM and the HBM were influential models in health utilisation research during 
the 1960’s, which was dominated at that time by sociology, rather than health 
psychology (Pescosolido & Kronenfeld, 1995). However, as stated above, the HBM was 
originally developed in the field of social psychology, whereas the roots of the SBM 
appear to lie in medical sociology. The differences in the focus of the models, then, can 
perhaps be explained by these roots. The SBM cannot adequately explain individual 
responses to a symptom, as it is assumed that the only options are to either utilise 
health services or not. Alternatives, such as self-management, which may be 
appropriate, are not considered. Further, the model does not consider the influences of 
symptom attribution, nor emotional responses to symptoms in the process of seeking 
help or not. 
 
The HBM has been used more widely within health psychology, which, again, is likely to 
be a result of its stronger focus on the individual and its roots in psychology. However, 
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this model too has been criticised. For example, as with the SBM, the HBM cannot 
account for the influence of emotional factors on the likelihood of a health behaviour. 
Further, despite the wide use of the HBM, it is rare that all of the components of the 
model are explored (Jones, Smith, & Llewellyn, 2014), making it difficult to investigate 
the overall usefulness of the model, and to determine which variables may hold the most 
predictive value. Finally, there is evidence that the HBM may not be that useful in 
predicting future health behaviours. For example, a review conducted in 1992 
demonstrated significantly larger effect sizes for some of the HBM components in 
retrospective studies than in prospective studies (Harrison, Mullen, & Green, 1992). 
Consequently, the HBM may not be as useful as other models in predicting future help-
seeking for symptoms of a gynaecological cancer. 
 
2.2.2 The Theory of Reasoned Action / Theory of Planned Behaviour 
The Theory of Reasoned Action (TRA) was developed by Ajzen and Fishbein (1980) to 
predict health actions, based on the premise that individuals will consider the 
consequences of their behaviour before carrying it out (or not). As with the HBM, the 
model was developed within the field of social psychology. The model assumes that 
behaviour is a function of intention which is influenced by attitudes towards a particular 
behaviour and subjective norms (i.e. how an individual perceives that the behaviour will 
be responded to by others important to that individual). Broadly, strong intentions to 
carry out a behaviour will result from a positive attitude towards the behaviour and a 
belief that others will respond positively to that individual carrying out that behaviour, 
although both attitudes and subjective norms will have weights assigned to them by the 
individual, meaning that either variable may influence intention more than the other. 
 
Although there has been evidence for the predictive value of the TRA (Sheppard, 
Hartwick, & Warshaw, 1988), the model has been found to be lacking in the ability to 
explain situations where the behaviour in question may not completely be under an 
individual’s volitional control. As such, the model was revised (and renamed the ‘Theory 
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of Planned Behaviour’ or TPB, Figure 2.1) to account for actual control over a behaviour 
(i.e. an individual’s ability to carry out a behaviour based on availability of resources and 
opportunities) as well as ‘perceived behavioural control’ (Ajzen, 1985, 1991). Perceived 
behavioural control describes an individual’s perception of how easy or difficult carrying 
out a particular behaviour would be. The TPB posits that behaviour is a function of both 
intention and perceived behavioural control. 
 
Figure 2.1 The Theory of Planned Behaviour, from (Ajzen, 1991) 
 
However, although there is evidence for the useful application of the TPB in predicting 
health behaviours (for example Gerend & Shepherd (2012)), this model is only useful in 
explaining predictors of intention to perform a behaviour and predictors of performing the 
behaviour itself (Hunter et al., 2003), and there is evidence that intention cannot fully 
predict behaviour (Sheeran, 2002). It would be difficult, then to explain the whole 
pathway from initial detection of a bodily change to the response one will have to this 
new somatic information. Again, as with the models described above, the TPB does not 
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adequately describe the role of emotions, the inclusion of which may increase the 
predictive power of the model (Perugini & Bagozzi, 2001). 
 
Finally, the TPB assumes that a health threat already exists, and fails to explain how 
one determines whether there is a health threat or not. Given that our bodies are 
constantly processing both internal and external sensations, bodily changes may be 
perceived regularly, and it is important to understand how these are interpreted, either 
as a health threat or not. 
 
The SBM, HBM and TPB are less applicable to the work undertaken in this thesis for a 
number of reasons. The SBM’s sociological roots make it difficult to explain individual 
behaviours. Further, it focuses on healthcare utilisation or not, rather than allowing for 
other, perhaps more appropriate, responses to a symptom. Evidence suggests that the 
HBM may not be useful in predicting future behaviours, which means that it is less 
relevant for research attempting to determine factors that may influence potential future 
help-seeking in women with symptoms. Finally, as described above, the main limitations 
of the TPB are the evidence for an intention-behaviour gap and its failure to explain how 
a health threat may come to be appraised as such. 
 
2.2.3 The Common Sense Model of Self-regulation of Health and Illness 
The Common Sense Model of Self-regulation of Health and Illness (CSM) (Leventhal, 
Meyer, & Nerenz, 1980), shown below in Figure 2.2, is an extension of Leventhal’s 
parallel process model (Leventhal, 1970). The three main constructs of this model are 
the representation of the illness experience, the coping response (or planning of action) 
and performance of this coping response, and finally an appraisal of the coping efforts. 
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Figure 2.2. The Common sense Model of Self-regulation of Health and Illness 
(Leventhal et al., 1980) 
 
Unlike the TPB, the CSM aims to explain how an individual processes and responds to a 
threat to their health (or an illness threat). The model assumes that an individual will be 
an active problem solver, and describes the active parallel cognitive (the nature of the 
health threat and how one can respond to it) and emotional processes (how one feels 
about the health threat, and how one can cope with those emotions) involved in 
regulating a response to a health threat. 
 
Within the cognitive pathway, there are five domains that all contain specific semantic 
and perceptual information; ‘identity’ (i.e. symptoms and names), ‘timeline’ (i.e. how long 
the health threat is expected to last), ‘consequences’ (i.e. what will happen as a result of 
this health threat) ‘internal and external causes’ (i.e. whether the health threat was 
caused by something external to the individual or whether it was caused by something 
internal), and ‘control’ (i.e. whether the health threat is something that the individual has 
control over, whether it was preventable and whether or not it is curable). In the context 
of the current research, an individual who believes that the symptom is indicative of 
cancer, that it will last for a long time, that it may cause pain, disability and eventually 
death and that the symptom is not something that the individual has control over, but is 
curable, may be more likely to seek medical attention as a coping strategy. The five 
domains described are shown below, in Figure 2.3. 
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Figure 2.3 The Five Domains of illness representations (based on a figure from 
Leventhal, Brissette, and Leventhal, 2003) 
 
 
Further, more recently, ‘rules of thumb’ or ‘common sense’ heuristics which influence the 
interpretation of a symptom, and the response to it (for example, whether a symptom 
warrants medical attention or not) have been described. These heuristics can reflect 
basic understandings of human anatomy, learnt information through universal somatic 
experiences, or can be based upon social comparisons (Leventhal, Forster, & 
Leventhal, 2007) (see Table 2.1). In turn, these rules of thumb lead to a cognitive 
representation of the health threat (or symptom). 
 
The CSM can clearly be applied to help-seeking research, as it describes how an 
individual processes a cognitive representation of the health threat (for example, a 
symptom may be interpreted as being indicative of cancer or another illness) and allows 
for decisions around how one might respond to this, which may or may not include 
seeking medical attention. Further, unlike the TPB, the CSM explicitly describes the role 
of emotion through the inclusion of a regulation of emotional control (for example, a 
feeling of fear, or anxiety, which may be alleviated by seeking medical attention). The 
model also allows for the influence of social and cultural factors (Diefenbach & 
Leventhal, 1996; Leventhal et al., 2003), and there is evidence for the influence of these 
factors specifically in the literature investigating help-seeking for cancer symptoms (for 
example, Burgess et al., (2006)). 
 
48 
 
Table 2.1 Rules of thumb (heuristics) for understanding a somatic change 
Heuristic Description of heuristic 
Symmetry Symptoms require labels, and labels need symptoms 
Pattern How the symptom behaves influences interpretation 
Location The location of the somatic change influences interpretation 
Rate of 
change 
The speed at which the somatic change progresses (for example, a 
change that gets worse quickly may lead to an interpretation that 
something is wrong) 
Response to 
care 
If a symptom responds to self-medication, this may indicate that it is not 
serious 
Novelty 
If the symptom is unusual, this may lead to an interpretation that it is 
worthy of further investigation, potentially from a health care 
professional 
Duration 
If a symptom lasts a short period of time it may be interpreted as less 
serious than a symptom that lasts for a longer period of time 
Stress-illness 
A belief that the somatic change is caused by stress, and therefore 
nothing can be done medically 
Age-illness 
A belief that the somatic change is caused by age, and therefore it is 
just part of the normal bodily processes 
Gender 
An individual's gender may influence interpretation. For example, if 
there is a history of heart disease through the male family line, heart 
pain may be interpreted as serious by a male, but potentially not by a 
female 
Similar 
exposure 
If an individual experiences stomach pains following a meal, and others 
who ate the same meal experience the same pains, this somatic 
change may be interpreted as non-serious and due to the meal eaten 
Similar 
vulnerabilities 
An individual who smokes and experiences a cough may be more likely 
to interpret this as indicative of a serious illness if they know another 
person who smoked, had a cough and was diagnosed with cancer 
Prevalence 
Rarer symptoms may lead to an increased concern, and, in turn, an 
interpretation that they are serious 
 
Note: Based on a Table from (Leventhal et al., 2007) 
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The influence of perceived risk is also explained within this model. For example, the 
stimulus for a perception of a health threat may come from a media campaign about risk 
factors for development of an illness, such as cancer. If an individual recognises that 
they are at a higher perceived risk (for example, because they have a history of breast 
cancer), this in itself may act as a health threat. Alternatively, an individual may be 
encouraged to perceive a breast change which had been previously dismissed as 
nothing serious as a health threat in response to this additional information. 
 
Despite the clear usefulness of the CSM when applied to symptom appraisal and 
responses to symptoms (which may include medical help-seeking), this model does 
have some limitations. For example, some authors have argued that the complexity of 
the model make testing it fully a difficult task; Llewellyn, McGurk, and Weinman (2007) 
found it difficult to determine the dynamics of how and when outcome changes occurred 
over time and what factors were specifically related to those changes. Further, it has 
been argued that the interaction between the emotional representations of a health 
threat and cognitive factors require more investigation (Diefenbach & Leventhal, 1996), 
and that the role of emotion is often only considered in terms of anxiety, worry or fear in 
relation to the meaning of the health threat (Wyke, Adamson, Dixon, & Hunt, 2013). In 
the context of this thesis, other emotions may be important, such as embarrassment (for 
example, Marlow, McGregor, Nazroo, and Wardle (2013)) around seeking medical 
attention. This model is less well equipped to explain this, as it only describes the 
emotional response to the health threat and how coping with these emotions may 
involve help-seeking. However, the emotions associated with help-seeking itself are not 
considered. 
 
Importantly, again in the context of this thesis, studies which have explored the 
predictive value of the CSM in help-seeking behaviour for female cancer symptoms 
have found that the model predicted less than a third (7-27%) of the variance (Grunfeld, 
Hunter, Ramirez, & Richards, 2003; Hunter et al., 2003). Further, the mechanisms by 
which social or cultural influences influence the development of health representations 
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and coping mechanisms are not clearly defined within the model. Given that individuals 
may be influenced by these factors when interpreting a bodily change (for example, 
(Taib, Yip, & Low, 2011)), it is important to consider them. 
 
2.2.4 The Illness Action Model and the Network Episode Model 
The Illness Action Model (IAM, Dingwall, 1976) and the Network Episode Model  (NEM) 
(Pescosolido & Boyer, 1999) are both rooted in sociology. Bodily changes are 
experienced within the individual’s social networks and a decision to seek help for a 
symptom is both a product of social influence, cultural beliefs and individual choice. In a 
similar fashion to the CSM, these models allow for a more dynamic and iterative 
progression through the processes of symptom detection and the decision to seek help, 
influenced by many smaller decisions. Both the IAM and the NEM focus on how 
individuals come to feel unwell and what the responses they have to this. 
 
In Dingwall’s model, a symptom or bodily change may cause the person experiencing it 
to perceive a disruption in the stable relationship they have with their body. This 
perception, and how these bodily changes are interpreted can be influenced by new 
external knowledge (for example, an increase in prevalence of a disease, which may 
then lead an individual to feel at increased risk). Upon experiencing a bodily change, an 
individual will seek to restore equilibrium. 
 
The model allows for the influence of interpretive work by lay others (within the social 
context), health professionals and by the individual experiencing the symptom, which 
may lead to a belief that the symptom is normal or abnormal. If one decides the 
symptom is normal, no action will be taken. If the symptom is deemed to be abnormal, 
one may ignore the symptom, self-medicate, seek formal medical attention or informal 
care (for example from an individual deemed knowledgeable); decisions which are 
guided by knowledge about oneself, the world around an individual and possible 
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responses, which in turn may be influenced by personal experience and what is 
culturally available.  
 
As mentioned above, the IAM is iterative and dynamic, for example, if the decision is 
made to wait and see, one will move back to interpretive work, which then may lead to a 
different course of action. This model then is perhaps a little more relevant than the 
CSM to the research in the current thesis, as, although the CSM describes coping 
behaviour and appraisal of this coping behaviour, the IAM is explicit about what this may 
involve, allowing for numerous responses to a bodily change, including seeking formal 
medical attention or not. 
 
The IAM also explicitly describes the potential for immediate or delayed interpretation of 
a bodily change, which is clearly relevant in the context of this thesis. However, why 
interpretation may be immediate or delayed is not adequately explained. Understanding 
why delays in interpretation, and ultimately why longer times to help-seeking occur, is an 
integral part of the research undertaken in this thesis. Without a framework for 
understanding how this may occur, it is difficult to apply this model here.  
 
As with the IAM, the NEM places help-seeking within the context of social networks and 
influence, and assumes that all health behaviours are social actions. It is constructed of 
four basic components including ‘the illness career’, ‘social support system’, ‘treatment 
system’ and ‘social context’. According to this model, individuals will approach and 
respond to others upon symptom presentation. An individual may be encouraged to 
seek help or discouraged from the idea that their symptom is an inference of illness 
through their social networks and interactions. The NEM explains how (in a dynamic 
fashion) an individual may travel through the ‘illness career’, whilst constantly being 
influenced by aspects of their social networks, such as their strength of ties to, and the 
size of the network. This model puts help-seeking in a social context, rather than 
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attempting to explain the decision to seek help as one made solely by an individual, with 
no external influences. 
 
As with the IAM, however, the NEM does have its limitations. For example, within the 
illness career, key entry and exit points are both described. Although these may be 
influenced by the social support and the treatment system, there is no real explanation 
of at what point these influences may occur. Further, both the CSM and the IAM are 
explicit about the purpose of a response to a health threat, such as a symptom, whereas 
the NEM is not. However, both the IAM and the NEM acknowledge and describe the role 
of social and cultural factors within the response and appraisal of a symptom or threat, 
whereas the CSM does not offer an explicit and detailed description of the influence of 
these factors. 
 
The CSM describes the importance of regulation of the emotional response to a health 
threat, and appraisal of the efficacy of coping with this emotional response, neither the 
NEM nor the IAM explicitly mention the role of emotion at an individual level (Wyke et 
al., 2013). This may reduce the appropriateness of using these models to explain help-
seeking within the context of this thesis, given that it is likely that the experience of a 
potential cancer symptom would involve an emotional response. 
 
Finally, both the CSM and the IAM describe how a stimulus may come to be interpreted 
as a symptom. For example, within the CSM, there are a number of heuristics which 
influence the interpretation of somatic information, and within the IAM, an individual 
must decide whether or not a bodily change is normal (i.e. not a symptom) or abnormal 
(i.e. indicative of illness). However, the NEM assumes that this interpretive or appraisal 
work has already been undertaken. 
 
2.2.5 The General Model of Total Patient Delay (‘Andersen’s model’) 
A newer, prominent and widely used model explaining time to help-seeking for 
symptoms is The General Model of Total Patient Delay or ‘Andersen’s model’ 
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(Andersen, Cacioppo, & Roberts, 1995). This model was a development and expansion 
of an earlier, three stage model proposed by Safer, Tharps, Jackson, and Leventhal, 
1979). Unlike the earlier models described above, Andersen’s model (Figure 2.4) 
consists of stages of delay (longer time to help-seeking) through which one progresses. 
These include, ‘appraisal delay’ (time between detecting a bodily change and deciding 
that it is indicative of illness), ‘illness delay’ (time between inferring illness to deciding 
that medical help is needed), ‘behavioural delay’ (time between deciding to seek medical 
help and making an appointment), ‘scheduling delay’ (time between making an 
appointment and medical consultation) and finally, ‘treatment delay’ (time between 
seeking help and beginning of treatment). These stages of decision making and action 
describe the complexity of the help-seeking process: it is not simply a matter of noticing 
a symptom and going to see one’s GP. 
 
Within the context of Andersen’s model, the main stages of interest in the current 
projects are ‘appraisal delay’, ‘illness delay’, ‘behavioural delay’ and ‘scheduling delay’ 
as they determine the process from detecting a symptom to attending a GP 
appointment. Research has identified the most important stage of delay to be the 
appraisal stage for gynaecological tumours, contributing to around 79% of the total delay 
time (Andersen et al., 1995) and the most important factor influencing appraisal delay 
has been found to be the nature of the symptom experienced (Walter et al., 2012). 
 
Given that with some gynaecological cancers the symptoms of early stage disease can 
be vague and easily attributed to other, benign illnesses, this is certainly applicable to 
the current research. For example, Kirwan (2002) found that around half of the women 
who experienced a delay of three months or more between seeking help and referral 
(n=36) who were later diagnosed with ovarian cancer were initially misdiagnosed with 
irritable bowel syndrome (IBS). This was likely to be due to the gastrointestinal nature of 
the early symptoms for this cancer (bloating and abdominal/pelvic pain may be present 
in between 50 to 55% of early stage ovarian cancer cases (Hamilton et al., 2009; 
Rossing, Wicklund, Cushing-Haugen, & Weiss, 2010)). Although this study investigated 
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referral time, the finding that even health professionals can misattribute symptoms of 
ovarian cancer to a benign condition suggests that this may be a common occurrence in 
lay women. 
 
 
Figure 2.4 The General Model of Total Patient Delay (Andersen et al., 1995) 
 
As a stage model, Andersen’s model allows for different influences and different 
decisions at different points of the help-seeking journey, allowing interventions to focus 
on these stages, rather than exploring factors which influence time to help-seeking 
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overall. This more targeted approach may increase the success of such interventions, 
and there is evidence to support a staged pathway from detection of a bodily change to 
medical help-seeking (for example, Hedges et al. (1998)). However, the stages in this 
model are rigid; each patient is believed to only pass through each stage once, and in 
the same order, which may not reflect the true appraisal and help-seeking process (for 
example, Moloczij, McPherson, Smith, and Kayes (2008)). Although the CSM, IAM and 
NEM are not stage models, they do allow for iterative processes in appraisal and 
responses to a health threat or symptom. 
 
A further limitation of Andersen’s Model is that it does not adequately explain in detail 
the role of emotion, such as fear or anxiety, or alternatives, such as embarrassment, a 
criticism which also applies to the CSM, NEM and IAM (although the CSM does 
acknowledge the importance of emotion, it is not detailed and only relates to the 
emotional response to a symptom, not help-seeking). Further, Andersen’s Model also 
fails to completely describe the influence of social factors, again a criticism also levelled 
at the CSM. Finally, in a similar fashion to the NEM, Andersen’s model cannot explain 
how a bodily change may come to be interpreted as a symptom, unlike the IAM and 
CSM, which both describe this process. 
 
2.2.6 The Model of Pathways to Treatment 
In 2010, Scott and Walter critically appraised Andersen’s Model, highlighting areas for 
improvement. Some of the suggestions included a bi-directional relationship between 
detection of a bodily change and interpretation of this and an allowance for the option 
that those experiencing a symptom may decide to respond in a manner other than help-
seeking (such as self-medication). The subsequent year, Walter et al. (2012) proposed a 
revision of the model, following a review of its application in cancer diagnosis, namely 
the Model of pathways to treatment (referred to as the MPT from this point onwards, see 
Figure 2.5). The changes included combining ‘appraisal delay’ and ‘illness delay’ into 
one stage (‘appraisal interval’), combining ‘behavioural delay’ with ‘scheduling delay’ 
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(‘help-seeking interval’), adding a ‘diagnostic interval’ (the time between first 
appointment and formal cancer diagnosis) and including a final ‘pre-treatment interval’ 
(to describe the time between formal cancer diagnosis and treatment commencement). 
The authors also drew on relevant domains and heuristics from the CSM. Again, given 
the focus of the current research, the ‘appraisal interval’ and the ‘help-seeking’ interval 
are the intervals of interest. 
 
Figure 2.5 The Model of pathways to treatment (Walter et al., 2012) 
 
Walter et al.’s (2012) proposed model of help-seeking may be more applicable to time to 
help-seeking research in gynaecological cancers than the other models described 
above. For example, Andersen’s model describes rigid stages through which one 
moves; there is no iterative process whereby an individual may move backwards or 
forwards, depending on new information or amendments to bodily change attributions, 
whereas the MPT is more fluid. The model allows for movement between the stages in a 
bi-directional manner, which is perhaps more reflective of normal life, where we may 
receive new information or influences on a daily basis. 
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As with the Andersen stage model, the MPT also allows researchers to focus on specific 
areas of the pathway to help-seeking, and as such, allows us to identify which variables 
may be most influential at which point and consequently allows for the development of 
targeted interventions. Further, it explicitly allows for responses other than medical help-
seeking, such as self-management, which again may be more reflective of real life. For 
example, if one detects a symptom (referred to as a bodily change) and has inferred 
illness, but then decides that there is no need to discuss their symptom with a 
healthcare professional, they would remain in the appraisal stage. The model explains 
the processes of how this might occur (for example influences such as access to 
healthcare) and alternative actions that may have been taken (such as self-
management). 
 
As described above, the CSM, NEM, IAM and Andersen’s model could all be applied to 
the research within this thesis. However, the MPT may be more appropriate for a 
number of reasons. A stage model may be more helpful in understanding the influences 
on or barriers to help-seeking, and when these are most powerful. The finding that the 
appraisal stage may be most influential in the help-seeking pathway highlights the 
importance of breaking down help-seeking by interval. However, the static nature of 
Andersen’s model may not reflect real life, and as such, it is less appropriate here. 
 
The main limitations of the CSM are its complexity, which would make it difficult to apply 
the whole model to the research in this thesis, and its low predictive power for help-
seeking behaviour for symptoms of female cancers. However, the authors of the MPT 
did draw on the CSM when developing their model, and as such, the MPT has allowed 
for those parts of the CSM which may be applicable specifically in the area of patient 
delay. Further, although the model explains that there are influences, such as social, 
cultural and psychological influences at all points of help-seeking (and even prior to 
detection of the bodily change itself), there is no detailed explanation of how these 
contributing factors may influence each interval. 
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The NEM too, would be less appropriate than the MPT here, as it does not allow for 
interpretation of a bodily change and how this might influence the help-seeking process. 
Finally, the IAM states that interpretation of a bodily change may be delayed (which may 
ultimately impact upon time to help-seeking), yet how or why this occurs is not 
adequately explained, whereas the MPT explicitly describes the processes which may 
impact upon a longer time to help-seeking, including those which may influence 
appraisal. 
 
2.3 Approach of this thesis 
As detailed, there are a number of models which describe how and why one might seek 
help for a symptom, the processes by which this occurs, the variables which encourage 
or discourage help-seeking and the length of time one takes to do so. The MPT is the 
most appropriate model in the context of this thesis. It was specifically designed to 
explore factors that may influence time to diagnosis and treatment, including time to 
help-seeking. As such, this model has been used to direct the research within this 
thesis, and I have drawn on the model in the study described in Chapter Eight. 
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CHAPTER THREE – PREDICTORS OF HELP-SEEKING IN WOMEN WITH 
SYMPTOMS OF FEMALE CANCERS: A REVIEW OF THE LITERATURE 
 
3.1 Introduction 
Within the help-seeking literature for female cancers, the focus has largely been on 
breast cancer, with the focus on gynaecological cancers comparatively small. One 
explanation for this is the difference in incidence rates between female breast cancer 
and gynaecological cancers, which may have led to a much higher research interest in 
the former; the latest available data show that there were over 41,000 incidences of 
female breast cancer in England in 2011, compared to just over 16,000 incidences of 
gynaecological cancers as a group (Office for National Statistics, 2013a). 
 
Although the symptoms of breast cancer are different to those of gynaecological 
cancers, the factors that influence help-seeking behaviour for these types of cancers 
may well be similar. For example, there is evidence that there are commonalities across 
many cancers in terms of barriers to seeking medical attention, and that gender may 
play a role (Smith, Pope, & Botha, 2005). Furthermore, both gynaecological and breast 
cancers are associated with sexuality and femininity (Emilee, Ussher, & Perz, 2010; 
Howell, Fitch, & Deane, 2003; Lindau, Gavrilova, & Anderson, 2007) and occur within 
intimate body parts, and there is evidence that women feel embarrassment about help-
seeking for symptoms of both cancers due to this (Marlow, McGregor, et al., 2013). 
Consequently, the literature on predictors of help-seeking for breast cancer may be 
useful in furthering our understanding of the variables that may influence help-seeking or 
abstinence from help-seeking for gynaecological cancer symptoms. 
 
3.1.1 Methodological approaches to exploring help-seeking 
3.1.1.1 Prospective studies 
Ideally responses to symptoms would be measured prospectively. This would mean 
following patients from the moment a bodily change is noted, through the appraisal and 
attribution process, to the response (which may involve seeking help from a healthcare 
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professional or an alternative response, such as self-medicating). Measuring responses 
to symptoms prospectively would allow data to be collected on the full patient pathway, 
including influences at different points in the pathway, without the bias of knowing 
whether the symptom is indeed indicative of an illness or not. A prospective study would 
also be able to investigate those variables which lead to either seeking medical attention 
for a symptom potentially indicative of a gynaecological cancer or not, and, for those 
individuals who do seek medical attention, the factors that influence the time taken to do 
so. 
 
Although some studies have attempted to measure responses to symptoms using a 
prospective method (discussed below), such research designs are difficult in this area. 
For example, a prospective study would require a very large sample size to detect 
significant differences (Weller et al., 2012), given the number of potential outcomes 
(including monitoring a symptom, ignoring it, seeking advice from friends or family, 
seeking advice online, self-medicating or seeing a medical professional). These large 
sample sizes can lead to vastly inflated costs when compared to other methods. 
Moreover, it would be unethical to prospectively follow women with symptoms that may 
indicate a gynaecological cancer without intervening and advising them to seek medical 
attention. Consequently this methodology is not often used in the literature. 
 
3.1.1.2 Retrospective studies 
It has previously been noted that most studies in the help-seeking or ‘patient delay’ 
literature for cancer symptoms employ a retrospective method of collecting data (Walter 
et al., 2012; Weller et al., 2012). This method might involve asking patients with a 
diagnosis of cancer to recall what happened when they discovered a symptom, and how 
they responded to it (including information on when their symptom started and when 
they sought help), or may involve the use of patient medical notes to determine key 
time-points, or sometimes a combination of the two. Retrospective studies require 
smaller sample sizes than prospective studies (as the response to the symptom, and the 
outcome is known) and can therefore be easier and more cost-effective to run compared 
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with prospective studies. However, these types of studies do have associated 
limitations. It may be very difficult to retrospectively identify and recruit patients who 
experienced a symptom but never sought help, meaning that it is difficult for these types 
of studies to explore alternatives to help-seeking, and what factors might influence an 
individual to fail to seek help at all. Further, studies investigating help-seeking in those 
women diagnosed with a cancer rely upon accurate patient disclosure. However, some 
patients with a diagnosis of cancer who waited before seeking help may not want to 
reveal that they had waited or may not wish to divulge the reasons for waiting if they do 
not deem those reasons to be valid (in the context of their eventual diagnosis). 
 
Furthermore, even if patients do wish to fully and accurately disclose their journey and 
experiences, there remains the most common criticism of retrospective data, namely the 
potential for collecting inaccurate data as a result of patient recall bias (Neal & Allgar, 
2005; Weller et al., 2012). The time period between first noticing a symptom and 
diagnosis can be a long one, and consequently patient recall of dates and influences on 
help-seeking may well be inaccurate. The effect of the passing of time on recollection of 
cancer symptoms was demonstrated by Fransson (2005). He asked prostate cancer 
patients to report their symptoms (using a short form of the validated Prostate Cancer 
Symptom Scale) before commencing treatment and then asked them to recall the 
symptoms experienced at that time 12 months later. Patients reported an average 
(mean (M)) of 1.81 (standard deviation (SD)=1.49) urinary symptoms and 0.55 bowel 
symptoms (SD=0.86) at baseline, but when asked to recall these baseline symptoms a 
year later, they reported having had significantly more symptoms (M=2.19 (SD=1.81) 
urinary symptoms and M=0.88 (SD=1.26) bowel symptoms, p<0.001)) than they had 
done originally. 
 
Collecting data from patient notes removes the reliance upon accurate recall and 
disclosure as these data are not collected from patients, and are recorded at the time 
the patient sought medical help. However, it is recognised in the literature on diagnosis 
of gynaecological cancers that, as data in patient medical notes are not collected for 
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research purposes, they therefore may not contain the level of detail and accuracy of 
recording required to draw conclusions about medical help-seeking for symptoms of a 
gynaecological cancer (Tate, Martin, Murray-Thomas, Anderson, & Cassell, 2009). For 
example, it may be difficult to determine the full patient pathway (such as how long a 
patient had taken to interpret a change in their bodies as a symptom that may require 
medical attention, and from that point, how long it took to seek medical help). 
 
Finally, retrospective methodologies may fail to take into account the social and cultural 
context in which the symptoms were experienced (Andersen et al., 2009), which may be 
an important part of understanding symptom appraisal and attribution, as well as the 
help-seeking process for symptoms of cancer (Andersen, Paarup, Vedsted, Bro, & 
Soendergaard, 2010). Both the NEM (Pescosolido & Boyer, 1999) and the IAM 
(Dingwall, 1976), discussed in Chapter Two, explicitly highlight the importance of the 
social and cultural context within which a symptom is experienced, and the MPT (Walter 
et al., 2012) describes how social and cultural influences can act on how an individual 
processes a bodily change, and ultimately whether they move forward through the 
pathway to help-seeking. Although it is possible to ask patients about the context in 
which their symptoms occurred, as above, these data are limited to recall and full patient 
disclosure. 
 
It may be possible to mitigate some of the limitations of retrospective research, however. 
For example, collecting data from patients very soon after diagnosis is likely to reduce 
inaccurate patient recall, as events will be fresh in the patient’s mind. However, it may 
not always be ethical to approach cancer patients at this point in time. Another possible 
option is to combine retrospective patient report and data from medical notes. Doing so 
may help to provide a more accurate, less subjective dataset. However, again, these 
data may still be limited in accuracy and completeness. 
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3.1.1.3 Hypothetical help-seeking studies 
Another less commonly used method for collecting data on help-seeking or ‘patient 
delay’ involves measuring intention to seek help for a hypothetical symptom. Such 
studies usually take the form of surveys or questionnaires. Hypothetical studies may 
reduce ethical issues associated with prospective and retrospective studies by avoiding 
the emotional distress potentially caused by discussing a personal cancer diagnosis and 
by avoiding discussing actual experienced symptoms. However, there is an 
acknowledged gap between intention and behaviour (Sheeran, 2002), which may make 
it difficult to apply findings from hypothetical help-seeking studies to actual behavioural 
responses to real symptoms. Further, as discussed above, the context in which 
symptoms are experienced may influence help-seeking, and it may be difficult for 
participants in studies exploring hypothetical help-seeking to imagine the context in 
which those symptoms might occur. 
 
3.1.2 Chapter aims and methods 
The aim of the present chapter was to explore the literature on help-seeking for 
symptoms of female cancers, with a particular focus on the evidence for predictors of 
help-seeking and time to help-seeking. This allowed me to identify gaps in the literature 
that warranted further research.  
 
In order to identify relevant papers, I conducted a literature search using the EMBASE, 
MEDLINE and PsychINFO databases. I searched for abstracts or titles of journal papers 
published in English, where the full text was available, and where methods were 
adequately described. Although I did not limit the publication time period, as I wanted to 
identify all relevant papers, all of the papers I identified as appropriate were published 
from 1967 onwards. My initial search used the terms, ‘gynaecological’, ‘gynecological’, 
‘female’, ‘vulva’, ‘vulval’, ‘vulvar’, ‘womb’, ‘uterine’, uterus, ‘endometrium’, ‘endometrial’, 
‘endometrioid’ ‘ovarian’, ‘ovaries’, ‘ovary’, ‘vaginal’, ‘vagina’, ‘cervix’, ‘cervical’ or ‘breast’. 
I combined these individual search findings with those from a second search, using the 
terms, ‘cancer’ or ‘carcinoma’. These first two searches allowed me to identify journal 
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papers covering gynaecological or breast cancers. I then carried out a third search using 
the terms, ‘help-seeking’, ‘help seeking’, ‘helpseeking’, ‘care-seeking’, ‘care seeking’, 
‘careseeking’, ‘patient delay’ or ‘delay’, and combined this search with the already 
combined results from my first two searches. This allowed me to identify papers that had 
explored help-seeking for symptoms of a gynaecological or breast cancer. 
 
I read the abstracts or titles of all the papers identified during the literature searches to 
identify relevant studies. Any papers with abstracts which were deemed to be relevant to 
the interest of the review were read in full. Papers were deemed to be relevant if they 
had explored variables that predicted, or were associated with, help-seeking or time to 
help-seeking for symptoms of a gynaecological cancer or of breast cancer. I also 
searched the reference lists of all relevant articles for additional articles of interest. 
Finally, I searched for published research from well-known authors within the field. All 
relevant articles identified are discussed below. 
 
The literature exploring help-seeking for symptoms of a gynaecological cancer has been 
discussed first, followed by the literature exploring help-seeking for symptoms of breast 
cancer. Although there may be similarities in the influences on these types of cancers, 
as stated above, investigating the literature in this way allowed any differences to be 
teased out. As this thesis focuses on gynaecological cancers, it is important to 
determine whether there may be any variables influencing help-seeking which are 
specific to this group of cancers. 
 
3.2 Help-seeking for symptoms of gynaecological cancers 
As mentioned above, the literature exploring variables that are associated with, or 
predict, medical help-seeking for symptoms of gynaecological cancers is narrow. Most 
of the studies that have been published in this disease area concentrate on ovarian 
cancer, although there has been some research investigating help-seeking for uterine 
and cervical cancers and on gynaecological cancers as a whole (discussed below). 
Nearly all of these studies have been retrospective, in patients with a diagnosis of a 
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gynaecological cancer, although some have employed a hypothetical or prospective 
research design. Given the different limitations and strengths associated with each of 
these methods, I have structured the literature discussed below by methodology. 
 
3.2.1 Studies exploring hypothetical help-seeking for symptoms potentially 
indicative of a gynaecological cancer 
To my knowledge, at the time I reviewed the literature (other than the publication of the 
study described in Chapter Six), only two studies had previously explored hypothetical 
help-seeking for symptoms of a gynaecological cancer (Cooper, Polonec, Stewart, & 
Gelb, 2013; Marlow, McGregor, et al., 2013) (Cooper et al. also included women with 
actual symptoms). Recently, however, another study was published (Brain et al., 2014). 
Brain et al. and Marlow et al. both carried out their studies with British women, whereas 
Cooper et al. conducted their study in the United States (US). 
  
Cooper et al. (2013) conducted fifteen focus groups with 132 women, some of whom 
had a symptom potentially indicative of a gynaecological cancer, and some of whom did 
not. The findings related to women with hypothetical symptoms are discussed below, 
where possible, as the authors did not always distinguish between those women who 
actually had a symptom, and those who were asked to imagine that they did. The 
findings relating to experienced symptoms in Cooper et al.’s study are discussed later in 
this chapter (see section 3.2.1.4). 
 
Women were given a list of symptoms associated with each of the five gynaecological 
cancers. However, they were not told that these symptoms could indicate a 
gynaecological cancer and the word ‘symptom’ was not used on the list. Participants 
were then asked to indicate whether any of the symptoms would concern them and what 
they would attribute the symptoms to if they had experienced them. Time to real or 
intended help-seeking was defined as appropriate if it was within two weeks of symptom 
onset, in line with guidance from the Centers for Disease Control and Prevention 
information on gynaecological cancers (Centers for Disease Control and Prevention, 
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2012). Any women not having sought or intending to seek help within this time period 
were deemed to have delayed seeking care. 
 
A range of intended times to help-seeking was observed, influenced in some cases by 
the symptom the participants had imagined experiencing. For example, when asked 
about their hypothetical response to changes in the skin of the vulva, no women 
reported that they would wait longer than a couple of weeks before seeking help, 
whereas for the remaining symptoms, women reported a range of anticipated times to 
help-seeking, from immediately to never.  
 
Although the authors did distinguish between women with real and hypothetical 
symptoms for the findings related to time to help-seeking, they did not do so for the 
findings related to influences on time to help-seeking. Women reported that they had or 
would seek help within a two-week period if they were concerned that the symptom may 
be indicative of a serious underlying condition, worsening of a current condition or the 
recurrence of a past condition, if they had a personal tendency to seek care promptly or 
if they were in pain. 
 
Reasons for waiting (or anticipating waiting) longer than two weeks included a belief that 
the symptom was indicative of a benign condition, a personal tendency to delay, 
concerns about the cost of medical treatment and a lack of or a tolerable level of 
discomfort. Although the participants typically stated that they had or would see a 
primary care physician or a specialist in response to the symptoms under investigation, 
women also mentioned using the internet, self-treating or seeking advice from those 
close to them either alongside medical help-seeking or instead of it. 
 
Cooper et al.’s study is important, as it is currently the only study that has explored 
hypothetical responses to symptoms potentially indicative of all five gynaecological 
cancers. Further, the authors explored this in women who had not received a diagnosis 
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and outside of the context of cancer, or even illness, which may be similar to what 
occurs in the real world. Moreover, the authors’ use of qualitative focus groups means 
that they were able to investigate any previously unknown influences on help-seeking 
and time to help-seeking.  
 
However, the study does have some limitations. The authors did not always clearly 
differentiate between women who had anticipated help-seeking for a hypothetical 
symptom and those who had experienced actual symptoms (nor did the authors provide 
information about how many symptoms were hypothetical and how many were real). 
This makes it difficult to isolate the influences on help-seeking for women with actual 
symptoms. Further, the study was conducted in the US, which has a different healthcare 
system to the UK and perhaps other cultural differences in attitudes to help-seeking. For 
example, cost considerations are unlikely to act as a barrier to help-seeking in the UK, 
as healthcare is free at the point of delivery. 
 
Brain et al. (2014) also explored hypothetical help-seeking for symptoms of ovarian 
cancer in a sample of 1,043 Welsh women. Data were collected using the Awareness 
and Beliefs about Cancer-Ovarian measure (ABC-O), adapted from the Awareness and 
Beliefs about Cancer measure (ABC) (Simon, Forbes, et al., 2012), the Cancer 
Awareness Measure (CAM) (Stubbings et al., 2009) and the ovarian specific version of 
the CAM (Simon, Wardle, et al., 2012). The authors also used the Ovarian Cancer 
Worry Scale (Andersen et al., 2007). 
 
Most women in the study reported that they would seek help within two weeks (72%), 
with almost half (49%) stating that they would seek help immediately. Significant 
predictors of anticipated delay of more than three weeks were being educated to degree 
level or higher, perceiving more practical barriers, having a lower level of confidence in 
detecting symptoms of ovarian cancer and anticipating more emotional barriers. 
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Brain et al.'s (2014) study is subject to the limitations befalling research exploring 
hypothetical help-seeking for symptoms of cancer, as described above. The authors 
also suggest that the use of the ABC-O may have led to a dilution of the effects of 
symptom awareness on anticipated delay, as a function of its adaption from three 
different measures, as they did not find the relationship between these two variables that 
has been demonstrated in previous studies (Robb et al., 2009). One of the strengths of 
this study was the definition of delay. The authors defined delay as having occurred if 
women had anticipated waiting for more than three weeks before seeking help (based 
on guidelines relating to symptom frequency and persistency, and a sensitivity analysis 
that showed that a three week threshold reflected anticipated delay better than a two or 
one week threshold), rather than using the arbitrary, standard period of three months or 
more, commonly used in the literature, as discussed above. 
 
Finally, in 2013, Marlow et al. used a qualitative interview methodology to investigate 
hypothetical help-seeking in a sample of ethnically diverse women from London. The 
researchers interviewed 54 women about their anticipated responses to experiencing 
symptoms of either breast or cervical cancer and about factors that might either 
facilitate, or act as barriers to, help-seeking. The researchers did not specify a delay 
period, but did state that no women anticipated waiting for longer than three months.  
 
Common barriers to help-seeking were fear of a cancer diagnosis, perceived service,  
emotional or practical barriers including having a negative attitude towards a GP, not 
wanting to seek help because of past experiences in the healthcare setting (such as 
having spent long periods of time in hospital as a child) or being too busy. Specifically 
relating to a cervical or breast cancer symptom, a few women mentioned that they would 
feel embarrassment about seeking help because of the personal nature of the location 
of the symptom, practical barriers, such as being too busy, or having competing 
priorities such as weddings or holidays which they would put before help-seeking 
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Marlow et al. also identified some variables that the women anticipated would 
encourage them to seek help for a symptom of either cervical or breast cancer. 
Interestingly, although many women stated that fear would act as a barrier to help-
seeking, some felt that it would encourage them to seek help quickly. For some this was 
because they would want to seek reassurance that their symptom was not indicative of a 
cancer. Perhaps linked to this, many of the women interviewed said that they would 
seek help quickly because they were aware of the importance of early diagnosis, which 
itself was, in some cases, influenced by having known someone who had either been 
diagnosed early and survived or diagnosed late and died. 
 
As with Cooper et al.’s (2013) study, use of a qualitative, semi-structured interview 
methodology in Marlow et al.’s (2013) study allowed new themes to emerge, which may 
not have been considered previously, and may not have been identified using a 
quantitative methodology. However, it is subject to the limitations of hypothetical 
research, discussed above. Further, the sample of women in this study was much more 
ethnically diverse than the UK population (86% of the population in England and Wales 
are from a White ethnicity (Office for National Statistics, 2013b), compared to 20% in 
Marlow et al.’s study), all were from London, and all were highly educated. Although the 
aim of the study was to explore anticipated help-seeking in an ethnically diverse sample 
of women, the findings here may not apply to British women in general. 
 
3.2.2 Studies exploring retrospective help-seeking for symptoms potentially 
indicative of a gynaecological cancer 
As discussed above, the majority of research on help-seeking for symptoms of a 
gynaecological cancer is in ovarian cancer. I did not identify any studies which had 
retrospectively explored help-seeking specifically for symptoms of vaginal or vulval 
cancers. However, I did find a number of studies which looked at all of the 
gynaecological cancers combined. 
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The considerably higher incidence of ovarian cancer compared to vaginal and vulval 
cancers (see Chapter One) is a possible explanation for the higher volume of research 
in help-seeking for symptoms of ovarian cancer. Moreover, the wide availability of 
cervical screening, and the introduction of the HPV vaccination means that the majority 
of potential cervical cancers are prevented, again reducing the need for research 
exploring help-seeking for this cancer in comparison to the need for such research in 
ovarian cancer. 
 
Uterine cancer incidence is currently higher than that of ovarian cancer, and is 
increasing (see Chapter One for all incidence data). It is unusual, then that there is a 
very small body of research exploring time to help-seeking for symptoms of uterine 
cancer. One explanation for this may be that, unlike ovarian cancer, there is evidence 
that uterine cancers are mostly diagnosed at an early stage (Donnelly, 2013; The 
National Cancer Registration Service, Eastern Office, 2009; White, 2013), leading to a 
lower perceived need to increase prompt help-seeking for this cancer. However, as 
discussed in Chapter One, 14% of these cancers are still diagnosed at the later stages 
and there is a possibility that this number may be higher, given the proportion of missing 
staging data (21% in some areas of the UK). Further, wide variation in survival rates 
between early and late stage disease suggest that any improvement in the proportion of 
earlier stage diagnoses could be beneficial. 
 
3.2.1.4 Uterine cancer 
The most common type of uterine cancer is endometrioid adenocarcinoma (American 
Cancer Society, 2013), and as such some of the literature on uterine cancer only 
focuses on this type. For example, in their 1986 study, (Cochran, Hacker, & Berek, 
1986) interviewed 37 women in the US diagnosed with endometrial cancer. They 
explored variables that may be associated with a longer time to help-seeking for 
abnormal bleeding (which is the most frequent symptom of uterine cancer (Amant et al., 
2005)). The authors found that women typically reported having waited between one 
and four months before seeking medical attention. Women who attributed the bleeding 
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to the menopause reported having waited longer before seeking help, while those who 
reported feeling alarmed by their symptom were more likely to have sought help 
immediately. Lower levels of social support also acted to increase the time taken to seek 
help. 
 
In another qualitative interview study conducted in the US ten years later, Coates et al. 
(1996) explored whether ethnicity could influence time to help-seeking for symptoms of 
uterine cancer in a population-based sample of 99 Black women and 232 White women 
who had been diagnosed with uterine cancer. Participants asked about the period 
between first noticing a symptom and seeking medical attention. 
 
The authors found no evidence that ethnicity influenced time to help-seeking in this 
sample of women. Both groups of women reported having sought help very soon after 
noticing a symptom; 38% of White women and 38% of Black women both stated that 
they had sought help within one week of recognising a symptom, and over 60% in both 
groups reported having done so at one month. However, the authors did note other 
characteristics that were associated with a longer time to help-seeking. They found that 
older women reported having sought help more quickly than younger women, that 
women with higher grade disease sought help a little quicker than women with lower 
grade disease, and that women who had experienced vaginal bleeding had sought help 
faster than women with no bleeding and less identifiable symptoms. This study suggests 
that women may benefit from a higher awareness of symptoms of uterine cancer which 
do not involve bleeding. 
 
In a more recent UK-based study, Johnson et al., (2011) carried out a local audit in the 
South-West of England between March and May 2009, collecting data on all cases of 
uterine cancer diagnosed during that time. As part of the audit, data relating to time to 
help-seeking from symptom onset was collected retrospectively. The largest proportion 
of the patients had waited up to a month before seeking help (49%), although some 
women reported having waited more than 6 months (12%). Reflecting Cochran et al.’s 
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findings, women commonly reported having waited because they had not attributed their 
symptoms to a possible cancer. Other less common reasons for potentially delaying 
seeking medical attention included feeling scared about the possibility of cancer and 
experiencing service barriers, such as finding it difficult to access the GP, not being able 
to see their own GP or not being able to see a GP because work hours coincided with 
the GP surgery opening hours.  
 
This audit does have some limitations, however. For example, the authors are unclear 
about what was asked, and how, in the questionnaire given to participants. Further, 
although the authors collected data about why women may have waited longer to seek 
medical help, they were not clear about which period of time they had defined as ‘delay’, 
nor why. It was also difficult to determine the exact number of women who had 
responded to the questionnaire about reasons for waiting longer before seeking medical 
attention for their abnormal bleeding, as different denominators were given for each 
reason given, without explanation. Finally, this was a local audit, rather than a research 
study, and as such, the data are not generalisable. Despite this, the findings do reflect 
the literature on help-seeking for cancer symptoms generally with regards to reasons for 
a longer time to help-seeking (for example, Macleod, Mitchell, Burgess, Macdonald, and 
Ramirez, 2009; Robb et al., 2009; Smith et al., 2005). 
 
3.2.1.4 Cervical cancer 
There is very little literature exploring retrospective help-seeking for symptoms of 
cervical cancer; much of the literature focuses on exploring barriers to screening 
attendance, rather than barriers to help-seeking following discovery of a symptom. 
There are, however, some studies in developing countries, such as Africa and India 
(Dhamija, Sehgal, Luthra, & Sehgal, 1993; Kidanto, Kilewo, & Moshiro, 2002; Sarkar, 
Konar, & Raut, 2011; van Schalkwyk, Maree, & Dreyer Wright, 2008). However, due to 
the vast differences in healthcare and culture between these countries and the UK, it 
would be difficult to generalise the results. As such, these studies are not discussed 
here. 
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3.2.1.3 Ovarian cancer 
As discussed above, the majority of the literature exploring help-seeking for symptoms 
of a gynaecological cancer is retrospective, and focuses on ovarian cancer. However, 
even though this gynaecological cancer is the most researched in the help-seeking 
literature, I could still only identify six relevant studies, half of which collected qualitative 
data and half of which collected survey data. Further, only two of the six studies were 
conducted in the last ten years, highlighting that even this area may need more 
investigation. 
 
The earliest study was conducted in 1985, by Smith and Anderson. They used 
questionnaire data to investigate characteristics of symptoms, the perceived cause of 
those symptoms and time taken to seek medical attention in 83 US women with a 
diagnosis of ovarian cancer. The authors also collected data on stage, grade and 
histologic features of the ovarian cancer at diagnosis (using the SEER population-based 
cancer registry), in order to explore whether there was an association between patient 
reported factors and clinical factors at diagnosis. 
 
Women who reported having symptoms before diagnosis were asked about which of the 
symptoms they experienced had encouraged them to seek medical attention. Abdominal 
swelling and abdominal pain were the symptoms most likely to have convinced the 
women in this study to seek help. Women aged 40 years or older were significantly 
more likely to have reported that they had a symptom which convinced them to see 
medical attention. 
 
On average, the women in this study reported having waited for a month (Median=four 
weeks) before seeking medical attention for their symptoms, although more than half 
reported having sought help within one month (53%). The most common reasons for a 
longer time to help-seeking (defined in this study as more than one week between first 
recognition of symptom(s) and the date at which medical attention was sought) were 
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fear (23%), repeat appearance of a previously experienced benign condition (23%) and 
interpreting symptoms as ‘non-serious’ (18%). However, using logistic regression, the 
authors found no association between any of these variables and delay in help-seeking, 
nor between fear and delay in help-seeking. The lack of significant associations may 
have been a result of the unusually short period of time referred to as ‘delay’ (more than 
one week) or a result of the small sample size, which may have meant that significant 
differences could not be detected. For example, Chan, Ng, Lee, Ngan, and Wong (2003) 
also explored help-seeking in just 80 Hong Kong women with ovarian cancer. They 
explored time to help-seeking and associated variables, reporting that most women had 
sought help within two weeks, and that there were significant associations between any 
of the variables measured (symptom type and coping styles) and time to help-seeking. 
 
Flam, Einhorn, and Sjövall (1988) had a much larger sample size (n=362) in their study 
conducted in a secondary care oncology department with women diagnosed with 
ovarian cancer in Sweden. However, only descriptive statistics were reported; the 
authors only assessed how long women had taken to seek help and what had prompted 
them to do so, rather than exploring associations with time to help-seeking. Further, the 
methods of data collection were unclear, as the authors only stated that they had ‘asked 
women specific questions concerning their initial symptoms and those leading to 
medical consultation’. The majority of women reported having sought help within three 
months of symptom detection (>70%). The main symptoms prompting help-seeking for 
women with both early and advanced disease were abdominal pain (24% and 23% 
respectively) and abdominal swelling (18% and 28% respectively). 
 
The more recent studies conducted in this area have used qualitative methodologies to 
explore the factors that may influence help-seeking behaviour for symptoms of ovarian 
cancer, possibly in response to the lack of strong evidence supporting any influences in 
the previous literature. In 2002, Fitch, Deane, Howell, and Gray interviewed 18 women 
in Canada with a diagnosis of ovarian cancer about their experiences of diagnosis, 
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treatment, and follow-up care. The women reported that, in some part, delays in their 
diagnoses were due to a lack of symptom awareness and the vagueness of the 
symptoms experienced (although no period of delay was specified). For example, the 
women in the study described often dismissing their symptoms as being part of, or 
related to, normal bodily functioning, such as childbirth, menopause or responses to 
stress. As the symptoms of ovarian cancer, such as abdominal bloating and distension 
are common (for example, Pitts et al., 2011; Sandler, Stewart, Liberman, Ricci, and& 
Zorich, 2000) and can be similar to those of other, benign conditions including irritable 
bowel syndrome (Jiang et al., 2008), this finding is unsurprising. 
 
In the only UK-based study I found, Evans, Ziebland, and McPherson (2007) conducted 
telephone interviews with 43 women who had received a diagnosis of ovarian cancer.   
Women were asked about their experiences, including pre-diagnostic symptoms. The 
main focus of this study was to explore delays in diagnosis related to the period between 
seeking medical attention and a diagnosis (often referred to in the literature as 
‘practitioner delay’), within the context of Andersen’s Model of Total Patient Delay 
(Andersen et al., 1995). As such, although the authors recorded ‘patient-attributable 
delays’, they did not provide any further information. Delays reported to be attributable to 
the patients were a misattribution of the symptom to stress, the menopause or previous 
benign conditions (such as bowel problems, irritable bowel syndrome and pelvic 
inflammatory disease) or due to a lack of recognition of symptoms as serious. 
 
The finding that women who attribute their symptom to the menopause tend to wait 
longer before seek help reflects the findings for influences on delay for symptoms of 
uterine cancer, discussed above (Cochran et al., 1986), and in other studies 
investigating delay in help-seeking for ovarian cancer symptoms (Fitch et al., 2002). 
Misattributions to benign conditions or stress have also been found to influence help-
seeking in the literature discussed above (Fitch et al., 2002; Smith & Anderson, 1985). 
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The most recent study was conducted in 2011 in Denmark (Seibaek, Petersen, 
Blaakaer, & Hounsgaard, 2011). The authors used registry data covering primary and 
secondary care in a sample of 666 women who had been diagnosed with either a 
borderline ovarian tumour, ovarian cancer, or cancer of the fallopian tubes, alongside 
interview data from 19 women who had been newly diagnosed with ovarian cancer 
during 2008 – 2009. This study mostly focused on the number of healthcare touch-
points (GP or secondary care visits) the women had had before being referred or 
diagnosed and on symptom interpretation, rather than time to help-seeking. However, 
during analysis of the interviews, the authors identified three sub-themes, including 
‘bodily sensations’, ‘from bodily sensations to symptom’ and ‘health seeking and 
treatment start’. The data within the latter theme showed that women with a higher SES 
and a higher level of education were more likely to have reported seeking help sooner 
and more likely to have asked their GP for referral to a specialist or secondary care than 
women from a lower SES, and with lower levels of education.  
 
One strength of this study was the combination of two interviews with the women, both 
in the hospital setting and in their own homes, pre-surgery and post-surgery 
respectively. Further, although most of the women interviewed were at stage III+, the 
sample also included three women who were diagnosed at stages IA-IC. As symptoms 
may vary, depending upon how advanced the cancer is (for example, Hamilton et al., 
2009), the inclusion of women at both earlier and later stages might help to understand 
the factors that influence help-seeking for women with both early and late stages 
disease. Moreover, the healthcare systems in Denmark and the UK are very similar (The 
Commonwealth Fund, 2013), and as such, the data from this study is useful in 
understanding risk factors for delayed presentation for symptoms of ovarian cancer in a 
UK population. However, the focus of this study was not to explore the reasons why 
women might have waited longer before seeking medical attention, and the semi-
structured interview guide did not specifically ask women this question. As such, the 
data on this topic may have been limited. For example, although the authors state that 
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women from a higher SES were more likely to have sought help sooner, there was no 
description of the time periods that the women had mentioned. 
 
3.2.1.4 All gynaecological cancers 
Earlier, I discussed Cooper et al.'s (2013) study, which included both hypothetical and 
actual help-seeking for symptoms of all of the gynaecological cancers (Cooper et al., 
2013). I discussed the study methods and results relating to hypothetical help-seeking 
above (see section 3.2.1), and have discussed the findings relating to actual symptoms 
here. 
The women who had experienced symptoms reported a range of times to help-seeking, 
from a few days to never. As discussed above, when reporting their findings relating to 
influences on time to help-seeking and from whom advice was sought, the authors did 
not differentiate between those women who had anticipated seeking help and those who 
had actually done so. Consequently, the findings reported in section 3.2.1 for this study 
are also applicable here. 
Above, I discussed the strengths and limitations of this study. An additional strength in 
the data from women with actual symptoms is that these data are even more likely to 
reflect what happens in real life, as these women were describing their actual responses 
to real symptoms outside of the context of cancer or illness. 
 
I also identified one other study which had explored help-seeking for gynaecological 
cancers retrospectively, and one study which had explored this in a number of different 
cancers (including gynaecological cancers). In a much earlier study than Cooper et al.’s, 
(Andersen et al., 1995) also explored time to help-seeking in all five gynaecological 
cancers, in a total sample of 34 US women with a recent diagnosis (within two weeks of 
recruitment to the study) of a gynaecological cancer (14 women with cervical cancer, 11 
women with endometrial cancer, six women with vulval cancer, two women with ovarian 
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cancer and one woman with vaginal cancer). Andersen et al. asked the women to 
identify the dates at which they travelled through the five stages (appraisal, illness, 
behavioural, scheduling and treatment delay) of Andersen’s Model of Total Patient 
Delay (Andersen et al., 1995), which is described in detail in the previous chapter. They 
were then interviewed about their experiences. The authors also collected demographic 
and clinical information about the women from participants themselves, their medical 
records and their doctors. 
 
Women reported having waited an average (Mean) time of 97 days between first 
detecting a symptom and first receiving medical attention. The majority of this (77 days, 
79%) was attributed to the time taken to appraise a symptom. The authors found 
evidence for a significant relationship between the number of ‘cancer explanations’ (a 
belief that a symptom may have been caused by cancer) reported by patients prior to 
diagnosis and ‘appraisal delay’ and ‘total patient delay’ (i.e. all stages of the model 
combined), and also between the total number of general, non-specific symptoms 
experienced initially and appraisal. 
 
This study demonstrates that attributions and the type of symptom experienced can 
affect time to help-seeking for gynaecological cancer symptoms. This study is valuable 
in understanding the pathways women travel through prior to diagnosis, and rare by the 
use of a model to guide the study design and interpret the findings. Further, aside from 
the potential ethical issues involved in asking women to talk in detail about the events 
leading up to their diagnosis of cancer so soon after receiving it, this method may have 
led to an underestimation of the different stages of delay, and inaccurate recall or 
representation of the events that influenced the women’s actions due to the emotions 
likely experienced as a function of the recentness of their diagnosis. 
 
Finally, Risberg, Sørbye, Norum, and Wist (1996) explored the use of alternative 
medicine, delays involved in diagnosis, treatment and any psychological distress caused 
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by a delay in diagnosis in 252 Norwegian patients diagnosed with a cancer. The sample 
included 122 women, of whom 13 had been diagnosed with a gynaecological cancer. 
Although the authors did not stratify the results by cancer type, they did report that 33% 
of the female patients reported having sought medical attention less than a week after 
symptom onset, and 65% within one month. The authors reported no significant 
differences overall in time to help-seeking by age, level of education or other patient 
specific factors. Given that the results were not stratified, and the study included both 
men and women diagnosed with more than 11 different types of cancer, it is impossible 
to make any conclusions about help-seeking related specifically to gynaecological 
cancers here. 
 
3.2.3 Predictors of a longer time to help-seeking or a longer anticipated time to 
help-seeking for symptoms potentially indicative of a gynaecological cancer 
The definition of ‘delay’ varied by the different studies discussed above. Many of the 
studies reported the proportion of women who waited for longer than three months, 
although most did not specify a particular time-point at which women had ‘delayed’. Two 
of the three studies that did specify a time-point (Brain et al., 2014; Cooper et al., 2013) 
justified having done so. The literature that did not specify a particular cut-off explored 
those variables which were associated with a longer time to help-seeking. This is 
reassuring, given the lack of a consensus about what constitutes a ‘delay’ in having 
sought medical attention for a symptom of cancer, and the argument made earlier that it 
may not be appropriate to apply one period of ‘delay’ to all types of cancer. Further, 
using a specific time cut-off may mean that some variables that may have been 
significantly associated with another time cut-off are missed (for example, Smith and 
Anderson, 1985). 
 
There was evidence for a difference in the variables associated with hypothetical ‘delay’ 
and actual ‘delay’. Part of this difference may be explained by the intention-behaviour 
gap, discussed earlier. For example, it may be difficult for women to anticipate those 
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factors which would actually influence their time to help-seeking, whereas women who 
have had a symptom and have sought help are able to state what they believed actually 
influenced their behaviour. 
 
Factors that women believed would lead them to wait longer before seeking help 
included having a belief that the symptom was indicative of a benign condition, having a 
personal tendency to delay, having concerns about the cost of medical treatment, a lack 
of (or tolerable level of) discomfort, perceiving more service barriers (such as finding it 
difficult to make an appointment with a doctor), emotional barriers (such as a worry 
about what the doctor might find or embarrassment), and practical barriers (such as 
being too busy or having competing priorities). Women who had a lower confidence in 
their ability to detect a symptom and women who had higher levels of education were 
also more likely to anticipate delay. Finally, having a fear of a cancer diagnosis was 
associated with anticipating waiting longer before seeking medical help. 
 
A fear of cancer was also associated with anticipating seeking help promptly. Some 
women expanded on this, stating that seeking help promptly would alleviate their 
concerns. Women also anticipated seeking help promptly if they had concerns that the 
symptom may be indicative of a serious condition, worsening of a current condition or 
recurrence of a previous condition. Other women anticipated seeking help promptly if 
the symptom was causing them pain, or because they were aware of the importance of 
the early diagnosis of cancer, often through knowing someone who had been diagnosed 
with cancer. Finally, women with a personal tendency to seek help promptly or to be 
conscientious about their health were more likely to anticipate seeking help promptly. 
 
Women who had had symptoms and sought help were more likely to have waited longer 
before doing so if they had attributed their symptom to something other than cancer, and 
usually to something that they may have had little concern about. For example, these 
women reported having attributed their symptom to the menopause, something non-
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serious, normal bodily functioning, such as stress or a previous benign condition. 
Further, having had a fear of cancer or alarm about the symptom were associated with 
having waited longer before seeking help. Part of this misattribution may have occurred 
because of the perceived ambiguity of the symptom. For example, some women 
reported having waited longer before help-seeking because the symptom was vague or 
non-specific. Moreover, women with lower grade disease were also found to have 
waited longer for symptoms of uterine cancer (Coates et al., 1996). It is possible that 
symptoms associated with lower grade disease may be less painful or alarming and 
easier to attribute to something benign. 
 
There was some evidence that older women may seek help more quickly than younger 
women. For example, Coates et al. (1996) reported this finding. However, given that this 
was a qualitative study, no statistical analyses were undertaken to determine whether 
this relationship was significant. Further, Smith and Anderson (1985) reported that 
women aged 40 years or older were more likely to have a symptom that convinced them 
to seek medical attention for ovarian cancer, however, this finding may simply reflect the 
differences in symptoms experienced. 
 
As with intention to wait longer, service barriers also acted to negatively influence time 
to help-seeking in women with actual symptoms. Interestingly, although symptom 
awareness wasn’t associated with hypothetical help-seeking, I did find evidence that it 
was with actual help-seeking. This may be a result of the differences in the time periods. 
For example, most of the women in Brain et al.'s (2014) study anticipated seeking help 
within two weeks, with almost half saying that they would do so immediately, whereas 
the data from most of the retrospective studies showed that women had waited longer 
(Cochran et al., 1986; Johnson et al., 2011; Smith & Anderson, 1985). 
 
Again, as with hypothetical help-seeking, there were a number of factors associated with 
prompt help-seeking. Women who had experienced a bleeding symptom, abdominal 
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pain or abdominal swelling reported having sought help more promptly or had reported 
that these were the symptoms that encouraged them to seek help at all. Further, women 
who attributed more ‘cancer explanations’ were less likely to spend longer appraising 
their symptom (appraisal delay has been argued to account for the longest period of 
‘total delay’ (Andersen et al., 1995)). Women with a higher SES and women who were 
educated to higher level were also more likely to have sought help promptly. This finding 
may be a result of an increased knowledge of symptoms, or potentially an increased 
confidence in seeking medical attention. 
 
3.3 Help-seeking for symptoms of breast cancer 
3.3.1 Help-seeking for symptoms of breast cancer (including literature published 
between 1975 and 2004) 
As discussed above, the body of literature exploring help-seeking for symptoms of 
breast cancer is considerably larger than that exploring help-seeking for symptoms of 
gynaecological cancers. As a result of this much larger research interest in the former, 
there have been a number of reviews of the literature. In the literature below, I have 
discussed these reviews, along with original research papers not included in the 
reviews, and more recent papers. Again, as mentioned above, there may be similarities 
in the factors that influence a longer time to help-seeking for symptoms of 
gynaecological cancers and breast cancers. In examining the breast cancer literature 
below, I aimed to identify all possible factors that may influence a longer time to help-
seeking for symptoms of gynaecological cancers. When discussing the literature relating 
to gynaecological cancers above, I stratified by research design (studies exploring 
hypothetical help-seeking and studies exploring retrospective help-seeking). The breast 
cancer literature discussed in the reviews below mostly relates to retrospective data, in 
patients with a diagnosis of cancer. Where hypothetical help-seeking data is discussed, 
this has been made clear. 
 
83 
 
In 1993, Facione published a critical review of the literature on help-seeking for 
symptoms of breast cancer, and calculated a frequency weighted average of the time 
taken to seek medical attention for the women in these studies. This calculation showed 
that around 34% of the women in the literature had waited for three months or more 
before seeking help. When applying this frequency weighted average to the studies 
carried out in Britain (Adam, Horner, & Vessey, 1980; Macarthur & Smith, 1981; Nichols, 
Waters, Fraser, Wheeller, & Ingham, 1981), Facione reported that the proportion of 
women who had waited longer than three months was lower (24%). 
 
In her review of the literature, Facione included both studies that explored intention to 
seek help and actual, retrospective help-seeking. The studies investigating intention to 
seek help supported an association between a longer time to anticipated help-seeking 
and having negative beliefs about the consequences of a breast cancer diagnosis and 
social normative influences (such as perceived social role demands). 
 
In the literature exploring time help-seeking retrospectively in women diagnosed with 
breast cancer, Facione found support for possible associations between a longer time to 
help-seeking and attribution of a symptom to a benign process (such as previous benign 
breast disease), the presence of symptom other than a lump, fear (expressed as fear of 
dying, of discovering the cause of the symptom and of mastectomy), being from a non-
White ethnicity and possibly being older. Facione also reported that economic factors 
(such as no having medical insurance) may also be associated with time to help-seeking 
in patients diagnosed with breast cancer, although this finding would not be applicable in 
the UK, where healthcare is free at the point of delivery, as mentioned earlier. The 
literature was unclear about whether the attribution of a lump symptom to cancer 
increased the time taken to seek help, or reduced it.  
 
Facione’s review demonstrates evidence for some of the potential influences on both 
intention to seek help for symptoms of breast cancer, and actual help-seeking. However, 
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there were some limitations. For example, Facione reported that the majority of the 
studies included in the review had extracted data from patient medical notes or tumour 
registries, rather than patient report. I have discussed the limitations of using data from 
patient medical records to determine time to help-seeking above (see section 3.1.1.2). 
Similar issues apply to the use of registry data. 
 
During 1996 and 1998, Ramirez et al. (1999) carried out a systematic review of factors 
predicting delay in help-seeking for symptoms of breast cancer in the literature from 
1960 onwards (and therefore covering some of the literature discussed in Facione's 
(1993) review) to identify factors that may be relevant in modern times. The authors 
identified 19 papers including original data on risk factors for delayed presentation 
attributable to breast cancer patients. The literature only showed strong evidence for an 
effect of older age and strong evidence against marital status as predictors of delay in 
help-seeking for breast cancer. There was moderate evidence for having fewer years of 
education, being from a non-White ethnicity, discovery of a symptom other than a breast 
lump, non-disclosure of symptoms to others and misattribution of the symptom to 
something other than breast cancer.  
 
The most recent review focusing on factors associated with delay in help-seeking for 
breast cancer symptoms I identified was carried out by Bish et al. (2005). This review 
covered the literature discussed in the previous reviews, as well as newer literature (the 
authors did not describe the time periods from which they reviewed the newer literature, 
although the most recent study cited was published in 2004). Combining the findings of 
the reviews described above (Facione, 1993; Ramirez et al., 1999) with newer literature, 
the authors concluded that older age, reduced knowledge of symptoms, less than 
prompt disclosure to another person and treatment concerns were all associated with 
either a longer time to help-seeking for symptoms of breast cancer or an intention to wait 
longer. 
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Finally, in 2009, Macleod et al. also reviewed some of the literature relating to a longer 
time to help-seeking for a number of different cancers, including breast and 
gynaecological cancers, reporting results from two previous systematic reviews, one 
focusing one breast cancer (Ramirez et al., 1999, discussed above) and one focusing 
on a number of different cancers, including breast and gynaecological (Macdonald et al., 
2004). Relevant papers relating to gynaecological cancers have been discussed earlier. 
The review here mainly reported the findings relating to breast cancer reported by 
Ramirez et al. However, the authors did consider some newer literature (Burgess, 
Hunter and Ramirez, 2001, discussed below), which used a qualitative methodology to 
investigate delay in help-seeking for symptoms of breast cancer in women with newly 
diagnosed breast cancer.  
 
Burgess et al. (2001) interviewed 46 women using semi-structured interview guides, 
eight weeks after diagnosis. The women were purposively selected from a larger study 
(Burgess et al., 1998), to represent both women who had waited for a longer (>3 
months) and a shorter (≤2 weeks) period of time before seeking help. The authors found 
evidence that women who had waited for a shorter period of time had recognised the 
seriousness of the symptom more quickly than those who had waited longer, which was, 
in turn, influenced by the nature of the initial symptom, and how well it matched the 
individual’s expectations of what a breast cancer symptom was. The researchers also 
reported that women who waited longer were more concerned about bothering the 
doctor than those who did not. Other factors more commonly mentioned by women who 
had waited longer included fears about cancer treatments (possibly influenced by past 
experiences of loved ones with cancer) and competing priorities (such as family, work 
and holidays). A change in the symptom or disclosure to others seemed to act as a 
facilitator to recognition of symptom seriousness. 
 
Although this was a qualitative study, and no statistical differences could be determined 
between those women who waited longer and those who did not, this study is useful in 
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understanding the complexities of the help-seeking process. Further, this study was 
conducted two months following diagnosis, which may have led to greater recall on the 
part of the women involved, without being too soon after to cause increased levels of 
distress. 
 
3.3.2 Help-seeking for symptoms of breast cancer (including literature published 
after 2004) 
The literature discussed below was published since the reviews described above were 
carried out. As these are individual papers, I have discussed them by methodology, as I 
did with the gynaecological cancer literature, above. Some of the literature exploring 
influences on a longer time to help-seeking or intention to wait longer before help-
seeking focuses on very specific groups of women or were carried out in countries with 
very different health systems or cultures to the UK (for example, Facione, Giancarlo, & 
Chan, 2000; Facione & Giancarlo, 1998), which would be difficult to apply to a UK 
population. As such, these studies are not discussed here.  
 
3.3.3 Studies exploring hypothetical help-seeking for symptoms potentially 
indicative of breast cancer 
I identified three studies which explored intention to seek help for a symptom of breast 
cancer (Facione et al., 2002; Forbes et al., 2011; Hunter et al., 2003). In 2002, Facione 
et al. investigated a likelihood to delay seeking medical attention for a symptom of 
breast cancer in a convenience sample of 699 asymptomatic US women. 
 
The authors used a number of different measures in this study, including the J-Delay 
scale (the Judgement to Delay scale), to measure likelihood to delay. The authors 
conducted a logistic regression analysis to determine factors significantly associated 
with anticipated time to help-seeking. The model explained 34% of the variance in 
likelihood to delay help-seeking for symptoms of breast cancer (correctly predicting 41% 
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of those likely to delay). Black and Latino women were around twice as likely to delay 
compared to White women. Being more likely to self-care for breast symptoms, 
perceiving more role constraints, having more fatalistic views about cancer, being a 
lower user of health services, and being less likely to engage in complex problem 
solving were also all significant predictors of an increased likelihood to delay. 
 
This study measured many different variables associated with a likelihood to delay, and 
showed that many of these predicted a likelihood to delay. Some of these variables, 
such as ethnicity, symptom awareness and perceived role demands have been explored 
in the literature discussed above. However the relationships between help-seeking 
(perceived or real) and cancer fatalism, health services utilisation habits, self-care of 
breast symptoms and disposition to engage in complex problem solving have been less 
well explored in the area of time to help-seeking for female cancers. 
 
The role of fatalism in intention to seek help for symptoms of cancer generally, however, 
has been explored previously. Beeken, Simon, Wagner, Whitaker, and Wardle (2011) 
explored the effects of fatalism on intention to seek help in a population-representative 
sample of 2,018 British adults, reporting that fatalism was significantly associated with 
being less positive about early detection of cancer and with being more fearful about 
help-seeking for a suspicious symptom. There is evidence that fatalism may be more 
influential on time to help-seeking in lower SES and non-White ethnic groups (Beeken et 
al., 2011; Dein, 2004). 
 
Self-care of symptoms, perceived access to healthcare services and a lower use of 
healthcare services may have been influenced by cost considerations in the sample in 
Facione et al.’s (2002) study. However, the study was carried out in the US, where 
healthcare is not free at the point of delivery, and these considerations may not be 
applicable in the UK. Further, although these variables were not included in the final 
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model, the authors did report that women who scored higher on the J-Delay scale were 
significantly more likely to have no health insurance or to have lower income levels. 
 
Between 2009 and 2010, Forbes et al. (2011) explored help-seeking for symptoms of 
breast cancer, using the Breast Cancer Awareness Measure (Linsell et al., 2010) in an 
ethnically diverse group of 1515 women in East London, UK. Similar to the findings with 
the generic Cancer Awareness Measure (Robb et al., 2009), they found that participants 
reported an intention to seek help quickly (73% reported an intention to seek help within 
one week). The most common barriers to help-seeking were a worry about what the 
doctor might find (47%), embarrassment (38%), a concern about wasting the doctor’s 
time (37%) and finding it difficult to make an appointment (35%).  
 
Although there were no ethnic differences in anticipated time to help-seeking, there were 
ethnic differences in endorsement of anticipated barriers to help-seeking. South Asian 
women were significantly more likely to report emotional barriers (such as a worry about 
what the doctor might find), embarrassment and lack of confidence in talking about 
symptoms than White women. Further, South Asian and Black women were significantly 
less likely to report that they were worried about wasting the doctor’s time than White 
women. 
 
Although it is interesting to explore the barriers to help-seeking that women anticipate, 
and in particular, which groups of women this may affect, the authors did not explore the 
relationship between these anticipated barriers and anticipated time to help-seeking. 
Further, the authors did not explore the relationship between breast cancer awareness 
and anticipated help-seeking. This makes it difficult to determine whether symptom 
awareness and perceived barriers would actually influence anticipated time to help-
seeking.  
 
89 
 
Unusually in the literature on help-seeking for symptoms of cancer, Hunter, Grunfeld, 
and Ramirez (2003) used theoretical models (the self-regulation model (Leventhal et al., 
1980) and the theory of planned behaviour (Ajzen, 1985, 1991)), which were both 
discussed in Chapter Two) to underpin their research. More than half (59%) of the 546 
UK women who completed postal questionnaires for the study stated that they would 
seek help immediately for a breast symptom, and over a third (38%) said they would 
within a month. Just 3% said that they would wait for two months or more before seeking 
help. The authors classed any women who anticipated waiting for a period of time 
before help-seeking as potential delayers, and found that older age was a significant 
predictor of intention to seek help.  
 
The authors entered the two models into a hierarchical multiple regression, which 
revealed that the self-regulation model explained 22% of the variance in intention to 
seek help, and the theory of planned behaviour increased the variance explained to 
29%. Identity, attitude towards help-seeking and perceived behavioural control were all 
significant predictors in the model. Potential delayers scored significantly lower on the 
identity scale than those who intended to seek help immediately, suggesting that those 
who anticipated seeking help promptly had accurately identified more symptoms. 
Prompt help-seekers were more likely to have positive attitudes towards help-seeking 
and greater perceived behavioural control about seeking help for a symptom.  
 
The findings here fit with the research discussed above, which also demonstrated an 
association between recognition and attribution of symptoms and help-seeking. The 
findings in relation to greater perceived control in seeking help and having a positive 
attitude about seeking help also reflect some of the findings above. For example, Forbes 
et al. (2011) found that over a third of the women in their sample had anticipated finding 
it difficult to make an appointment as a barrier to help-seeking, suggesting a lower level 
of control over their ability to seek help. The relationship between lower levels of 
perceived control were also reflected in Facione et al.’s (2002) study, which 
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demonstrated that women who perceived more constraints and reported more fatalistic 
views were more likely to delay seeking help. 
 
3.3.4 Studies exploring retrospective help-seeking for symptoms indicative of 
breast cancer 
There were many more studies exploring help-seeking for symptoms of breast cancer 
retrospectively, in women who had been diagnosed, than studies exploring intention to 
seek help. As with the body of research investigating an intention to wait for a longer 
time before seeking help, some of the literature here involved very specific groups of 
women, or women from very different cultures, which would make the research findings 
difficult to apply to a UK population (for example, Montazeri, Ebrahimi, Mehrdad, Ansari, 
& Sajadian, 2003; Norsa’adah, Rahmah, Rampal, & Knight, 2012). Again, these studies 
are not discussed here. 
 
Since the reviews discussed above were conducted, a number of studies have been 
published exploring help-seeking for symptoms of breast cancer. These will now be 
discussed, in order to achieve an understanding of the most recent evidence for factors 
which influence delay. 
 
Freidman and colleagues (Freidman et al., 2006) explored help-seeking in women who 
had been referred to a medical oncology breast surgery clinic, but who had not been 
diagnosed with cancer. They collected data at one time-point, asking 99 mostly Hispanic 
(57%) women to complete a number of questionnaires while waiting for their 
appointment. The authors explored symptoms, time to help-seeking, risk perception, 
spirituality, barriers to help-seeking and initial emotional response to the symptom. 
 
Analyses showed that the women had reported waiting a mean of nine months from 
symptom onset to help-seeking, and that almost half (45%) of the women had waited for 
91 
 
more than three months. The most common reason for delay (defined here as three 
months of more between symptom onset and help-seeking) was a worry that the 
symptom might indicate cancer, endorsed by 39% of the women. Other common 
reasons, cited by around a quarter of the women were difficulty making an appointment 
(28%) and cost (24%). 
 
Although education level alone was not predictive of number of months to help-seeking, 
there was a ‘lump by education’ interaction. Having a non-lump symptom was a 
significant predictor of number of months to help-seeking, but only in women with a low 
education. This interaction explained 13% of the total variance in number of months to 
help-seeking. Additional predictors were cost (11.5%), lower perceived risk (7.4%) and 
lower levels of spirituality (6.5%). The total model explained 38.4% of the total variance 
in number of months to help-seeking.  
 
The authors also used a logistic regression to explore time to help-seeking as a 
dichotomous variable, dichotomising number of months into ≤3 months and >3months. 
Again, the overall model was significant, with younger age, less education, perceived 
risk and endorsing cost as a barrier to treatment all significant predictors of having 
waited longer than three months from symptom onset before seeking medical attention. 
 
Freidman et al.'s (2006) study was the only other study I found (alongside Cooper et al., 
2013) that had explored time to help-seeking in women who had symptoms, but had not 
yet received a diagnosis. As discussed above, most of these retrospective studies 
explored help-seeking in women who had been diagnosed with breast cancer. However, 
these women had probably seriously considered the likelihood that they would have 
such a diagnosis, given their referral to an oncology centre. As such, it is likely that the 
results here would have been similar to those found in studies exploring retrospective 
help-seeking in women with a diagnosis of cancer. For example, these women may still 
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have felt that they did not want to divulge how long they waited before seeking help from 
symptom onset, given their referral to an oncology centre. 
 
As stated above, most of the literature characterises ‘patient delay’ as having waited for 
three months or more before seeking medical attention. Although the authors in this 
study also do this, their inclusion of the analysis of variables that may predict number of 
months waited before seeking help is unusual. Interestingly, the predictor variables were 
different in both models. For example, although cost, perceived risk and education level 
played a significant role in both models, education alone only predicted waiting for more 
than three months before help-seeking. The effect of education on number of months 
taken to seek help was only significant if women experienced a non-lump symptom. 
Further, although age was a significant predictor of whether women took longer than 
three months to seek help, it was not a predictor of number of months taken to seek 
help, and although level of spirituality was a significant predictor of a higher number of 
months taken to seek medical attention, it was not a predictor of having waited more 
than three months. Again, as mentioned earlier, for some cancers, it may be important 
to seek help sooner than three months. As such, the results relating to a specific time 
period (i.e. three months or more) may be less relevant than the results exploring 
predictors of longer to help-seeking. 
 
A number of studies that have explored predictors of (or variables associated with) a 
longer time to help-seeking for breast cancer have done so in groups of women who 
may be at a higher risk. For example, Burgess et al. (2006) focused on women aged 65 
years and older (45% of new cases of breast cancer diagnosed in 2011 occurred in this 
age group (Office for National Statistics, 2013a)). Burgess interviewed 69 women 4-8 
weeks post-diagnosis, and delay was defined as having waited for three months or more 
from symptom onset to help-seeking. 
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Less than half of the women (42%) reported having waited for three months or longer 
before seeking medical attention for their symptom. Women were significantly more 
likely to have waited for three months or more before help-seeking if the first symptom 
experienced was a non-lump symptom, if they had attributed their symptom to nothing or 
a vague cause, if they had reservations about seeing their GP or if they had fears about 
the consequences of the diagnosis and treatment of cancer. Women who had disclosed 
their symptom to someone else within a week of discovery were significantly more likely 
to have sought help within three months, as were women who were self-motivated to 
seek help (as opposed to being prompted by another). 
 
In 2010, Rauscher et al. (2010) examined factors associated with a longer time to help-
seeking in a population-based sample of 436 women diagnosed with breast cancer. The 
authors reported that 16% of the women said that they had waited for more than three 
months before seeking medical attention. Logistic regression analyses showed that 
women with a greater number of misconceptions about breast lumps were significantly 
more likely to have reported waiting for three months or more, as were women who had 
a history of benign breast problems, women who did not have a regular health provider, 
and women who had a lower score on the recency of care scale. 
 
The authors did not report any demographic differences between women who had 
waited longer and women who had waited for a shorter time before help-seeking. 
However, they did note that the participant response rate was 56%, and analyses 
showed that non-responders were significantly different in terms of ethnicity and age to 
responders. Although the authors did use analytic weights in their models to adjust for 
ethnicity, it is possible that age and ethnicity could have been significant predictors of a 
longer time to help-seeking (particularly as there is evidence for the effects of these 
variables in the literature described above). Some of the findings here would not be 
relevant in a UK population (such as having medical insurance). It was interesting, 
however, that misconceptions about breast symptoms were predictive of a longer time to 
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help-seeking. In the research discussed above, it is a common finding that attributing a 
symptom to something non-serious is likely to lead to a longer time to help-seeking. 
Misconceptions, such as believing that a lump should only be checked out if it is painful 
or growing, may suggest that women do not believe that these symptoms are indicative 
of something serious unless they exhibit these characteristics. 
 
A study conducted by (Taib et al., 2011) reflected some of the findings in the studies 
discussed directly above (Burgess et al., 2006; Rauscher et al., 2010). The researchers 
qualitatively explored the experiences of 19 women who had been diagnosed with 
breast cancer using semi-structured interviews. Although not explicitly stated, delay 
appeared to have been defined again, as three months or more. The authors found 
evidence of symptom non-recognition (both for lump and non-lump symptoms). As with 
the women in Rauscher et al.'s (2010) study, Taib et al. found evidence that women 
appraised non-painful symptoms (including a lump) as being harmless. Women also 
believed that family history needed to be present in order to be at risk of breast cancer, 
suggesting that they felt at lower risk if they had a symptom, but no family history of 
breast cancer. Again, women believed that breast cancer would present as a lump, and 
consequently did not attend to non-lump symptoms. There was also evidence here that 
women felt at lower risk of developing breast cancer if they had had previous symptoms 
which had been benign.  
 
Marcus, Lunda, and Fernandez (2013) investigated factors associated with having 
waited for three months or longer before seeking medical attention from symptom onset 
in 103 women presenting with a diagnosis of stage IIb or higher breast cancer. The 
authors performed two logistic regressions to demonstrate the significant predictors of 
either having sought help within three months versus three to six months or having 
sought help within three to six months versus having sought help more than six months 
after symptom discovery, as the authors felt that the variables which influence a longer 
time to help-seeking may vary by periods of time. Only having had a previous history of 
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cancer was a significant predictor of having waited for less than three months versus 
three to six months, with women more than three times as likely to seek help within 
three months if they did have a previous history. This was also a significant predictor of 
having waited for between three and six months (compared to more than six months) as 
well as age (women aged 55-64 were almost three times as likely to have waited 
between three and six months before seeking help than younger women). The authors 
also reported that having a secondary education or higher and being aged 45-54 were 
significant predictors of waiting for less than six months (but more than three). However, 
these predictors were significant at the 0.10 level, which is not usually accepted as 
statistically significant in the literature. A level of 0.05 is typically the highest level at 
which a finding is argued to be significant (for example, Coolican, 2014). 
 
The authors acknowledge that their findings may have been different if women with 
more localised disease had been included in the sample. However, they do suggest that 
the observed relationship between having had an experience of cancer and having 
sought help promptly may indicate a higher awareness of signs of cancer in these 
women. As many women who discover symptoms may not have had an experience of 
cancer, the authors recommend that those who have, share their experiences with other 
women in a bid to encourage them to seek help more promptly.  
 
More recently, O’Mahony, McCarthy, Corcoran, and Hegarty (2013) developed a 
conceptual framework, based on a review of the literature exploring variables that may 
influence time to help-seeking for symptoms of breast cancer (Figure 3.1).
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Figure 3.1, A conceptual framework of ‘factors potentially influencing women's help-seeking behaviour on self-discovery of a breast symptom 
(reproduced from O’Mahony et al., 2013)
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The aim of their study was to explore women’s help-seeking behaviour within the 
Republic of Ireland, and the variables that may influence this, as depicted in Figure 3.1. 
The authors underpinned their research with the common sense model (described in 
Chapter Two), using a cross-sectional survey design to collect data from 449 
symptomatic women who were visiting a hospital for the first time, but who had not yet 
had a diagnosis.  
 
As described above, it is usually not possible to determine alternatives to help-seeking 
when exploring responses to symptoms retrospectively in women with a diagnosis of 
cancer, as all of the women in these studies have participated by virtue of their 
diagnosis, made after seeking medical attention. However, O’Mahony et al. (2013) did 
attempt to explore alternatives, finding that just under 80% of women had monitored 
their symptom, 43% had listened to the advice of others about visiting the GP, and the 
same proportion had prayed to God about their symptom. Although this information is 
interesting and important, and it is admirable that the authors collected these data, it 
must be noted that all of these women had eventually sought help, as they were 
recruited from a hospital setting. It is still important to explore the influences on women 
who never seek help. Knowledge relating to breast symptom identity (for example, a 
presenting symptom of ‘nipple indrawn/changes’), a belief in a longer symptom duration 
and a belief in ‘ignoring the symptom and hoping it would go away’, as opposed to 
seeking medical attention were all significant predictors of having waited for three 
months or more before seeking help. Prompt help-seeking was associated with being 
afraid upon symptom discovery.  
 
Again, as with some of the research discussed above, the authors found no relationship 
between any of the socio-demographic variables and time to help-seeking, nor any 
relationship between awareness of symptoms and time to help-seeking. However, the 
presence of a breast lump was associated with prompt help-seeking, whereas the 
presence of a non-lump symptom, such as nipple inversion or breast pain, were 
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associated with a longer time to help-seeking. This suggests that knowledge does play a 
part in time to help-seeking, in line with the research described above.  
 
Interestingly, the authors found evidence for an association between a belief that 
symptoms would last longer and a longer time to help-seeking. This finding is converse 
to expectations. The authors offer a number of possible explanations, including that 
these women may have had a more fatalistic, pessimistic outlook, leading them to a 
resignation that their symptom would be prolonged or that they believed that the 
symptom was due to a long-term condition, such as breast cancer, and consequently 
were likely to delay. Alternatively, women may have just wanted to monitor their 
symptoms and wait and see what happened. Having a pessimistic or fatalistic outlook 
seems to be the most likely explanation. Perhaps the women here felt that breast cancer 
would be a death sentence, and so there was little point in seeking medical attention, 
although they eventually did. Wanting to monitor the symptom seems like an unlikely 
reason for delaying seeking help if one believes that the symptom will last a long time, 
as monitoring implies that one is waiting to see whether the symptom continues or 
worsens.  
 
It was unsurprising that a belief in ignoring the symptom and hoping it would go away 
was a significant predictor of a longer time to help-seeking. This may have been driven 
by fear or by competing priorities (Facione, 1993). Fear has been found to be related to 
both prompt and delayed help-seeking, suggesting that other factors may mediate this 
relationship. The finding that disclosure of a symptom to another is associated with 
prompt help-seeking has been reflected in the research described above. Perhaps 
disclosure of a symptom may encourage discussion around possible causes, and lead 
to a deeper level of consideration of the symptom. Further, disclosure of a symptom to 
another person may lead to a sanctioning of help-seeking, which has also been found to 
be related to prompt help-seeking. 
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3.2.5 Predictors of a longer time to help-seeking or a longer anticipated time to 
help-seeking for symptoms potentially indicative of breast cancer 
As with the literature exploring factors associated with help-seeking for symptoms of 
gynaecological cancers, the time periods defined as ‘delay’ varied between studies 
exploring factors associated with help-seeking for symptoms of breast cancer, although 
the majority of research defined ‘delay’ as having waited for three months or more. 
Again, there were also some differences in the variables associated with an intention to 
wait longer before seeking help and actual time to help-seeking in women who had a 
diagnosis of breast cancer. A longer time to help-seeking in women with a diagnosis 
was associated with misattribution of a symptom (usually to something benign, vague or 
nothing at all). Women also reported non-recognition of their symptom, particularly if the 
symptom was a non-lump symptom. Given that reduced knowledge of symptoms was 
also associated with a longer time to help-seeking, this was unsurprising. Similarly, 
women who had had a history of benign breast problems were more likely to have 
waited longer. This is probably due to a reassurance built up by the non-seriousness of 
their previous symptoms. 
 
Other factors associated with a longer time to actual help-seeking were having 
competing priorities, a belief in ignoring the symptom and hoping it goes away, and non-
disclosure, or less than prompt disclosure of a symptom to someone else. Women with 
less education, no recent health checks (including mammography or breast health 
checks), those who did not have a regular healthcare provider, women from a non-White 
ethnic background and older women were all more likely to have waited longer before 
seeking help. A couple of service barriers also acted to negatively influence time to help-
seeking (difficulty in making an appointment to see a doctor and being concerned about 
bothering the doctor). In a few of the studies described above, fear of discovering the 
cause of the symptom, of dying and of treatment were all associated with a longer time 
to help-seeking. 
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As with symptoms of gynaecological cancers, fear also acted to influence prompt help-
seeking, as did having had a history of cancer, being self-motivated to seek help, and a 
change in the symptom. As non-disclosure of a symptom acted to influence a longer 
time to help-seeking, disclosure acted to reduce this time, as it helped women to 
recognise the seriousness of a symptom.  
 
Intention to wait longer was also associated with older age, being from a non-White 
ethnic background, reduced knowledge of symptoms, non-disclosure to another person, 
treatment concerns, concern about wasting the doctor’s time and perceived role 
demands. Additional influential factors were having negative beliefs about the 
consequences of a breast cancer diagnosis, embarrassment and concern about what 
the doctor might find. Individual factors such as being more likely to self-care, having a 
lower use of health services, and being more likely to engage in complex problem 
solving were all associated with a longer time to help-seeking. Intention to seek help 
promptly was associated with having more positive attitudes towards help-seeking and 
perceiving greater behavioural control about seeking help. 
 
3.4 Summary of the literature exploring variables associated with help-seeking for 
symptoms of female cancers 
In section 3.1, I discussed the possibility that the factors which were associated with a 
longer time to help-seeking for gynaecological cancers may be similar to those 
associated with a longer time to help-seeking for breast cancers. There seemed to be 
some evidence of this, as there were many variables associated with both hypothetical 
and actual help-seeking for all of these cancers. However, there were some variables 
that seemed to be specific to a longer time to help-seeking for gynaecological cancers, 
such as attributing the symptom to stress or the menopause and being younger. 
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There were also a number of interesting findings applicable to all of these cancers. For 
example, fear seems to act both to encourage prompt help-seeking and to delay it, 
which may be a product of what the fear relates to. For example, if women feared a 
cancer diagnosis, they seemed to be more likely to wait longer, although some women 
wanted to or had sought help sooner in order to receive reassurance. The idea, 
however, that these women would seek help sooner to seek reassurance suggests that 
they may not believe that their symptom is cancer as strongly as those women who 
would not seek help due to a fear of a cancer diagnosis. Interestingly, women in the 
breast cancer literature were afraid of the treatment for this cancer, which acted to 
elongate the time taken to seek care, whereas this was not a factor in the 
gynaecological cancer literature. This may be a result of a higher awareness of the 
treatment for breast cancer due to the much larger levels of incidence. 
 
3.4.1 Model of Pathways to Treatment 
In Chapter Two, I discussed the MPT (Walter et al., 2012; see page 57), which is the 
most recent model to be applied to the help-seeking literature. In this model patients go 
through processes to move through intervals in the help-seeking pathway. The model 
also mentions contributing factors which may influence the transition from one interval to 
another. Within my thesis I am interested in the processes involved in detection of a 
bodily change, appraisal and help-seeking. 
 
Although none of the literature discussed above has used this model to explore time to 
help-seeking for either breast or gynaecological cancers, two studies (Andersen et al., 
1995; Evans et al., 2007) did underpin their research with the General Model of Total 
Patient Delay (‘Andersen’s Model’) (Andersen et al., 1995). However, Evans et al. 
(2007) only used the model to explore those ‘delays’ attributable to practitioners, 
whereas Andersen et al. (1995) explored influences on the full model. 
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As mentioned above, the majority of the time taken to seek help occurred in the 
appraisal stage, which is also evident in the MPT. A number of variables were identified 
in this review which could affect the time taken to appraise a symptom potentially 
indicative of a gynaecological cancer. For example, there was evidence for a 
relationship between a longer time to help-seeking and the influence of patient factors 
such as attributing the symptom to the menopause, something non-serious or benign 
(such as the menopause or stress, which may be influenced by previous experience or 
comorbidities) and a lack of symptom awareness. Disease factors also play a role, as 
women with a lack of (or tolerable level of) discomfort (which may have led women to 
misattribute their symptom to something benign) were more likely to wait longer, 
whereas women experiencing alarming symptoms such as bleeding or abdominal pain 
were more likely to seek help promptly. 
 
Variables which may affect the time taken to seek help, once a symptom has been 
appraised as potentially requiring medical assistance or advice, seemed to also include 
some disease factors, such as fear of a cancer diagnosis or alarm about the symptom. 
Patient factors also play a part, with feeling embarrassed, being younger, having a 
higher level of education and a personal tendency to delay all being associated with a 
longer time to help-seeking. There was evidence for the contribution of healthcare 
provider and system factors, as women who perceived or anticipated more service 
barriers (such as not wanting to bother the GP), emotional barriers (such as a worry 
about what the doctor might find) and practical barriers (such as being too busy or 
having competing priorities) were more likely to wait longer before seeking help.  
 
3.5 Summary and links to next chapter 
The literature exploring help-seeking behaviour for symptoms of gynaecological cancers 
demonstrates a lack of consensus about the time period defined as ‘delay’. Most studies 
investigate variables associated with a longer time to help-seeking, although I did find 
some studies that did use a specific time-point at which ‘delay’ was deemed to have 
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occurred. Reassuringly, two of the three studies that did this justified having done so 
(Brain et al., 2014; Cooper et al., 2013). It may be more appropriate to explore time to 
help-seeking, rather than defining ‘delay’ as having occurred at a specific time-point. As 
discussed above, one period of ‘delay’ may not always be appropriate for all cancers, or 
indeed, all types of illness. It may be more appropriate to determine whether a patient 
has ‘delayed’ seeking help within the context of different cancers or illnesses, and at 
what time-point from symptom onset it becomes harmful to have waited. Further, 
different factors may be associated with different periods of delay, for example, Marcus 
et al. (2013)  found that a number of variables influenced seeking help within three to six 
months (compared to six months or more), which did not influence help-seeking in less 
than three months (compared to three months or more). In assigning an arbitrary cut-off 
at which one is deemed to have delay, potentially influential factors may be missed. 
 
This review has highlighted the scarcity of research exploring help-seeking for 
symptoms of gynaecological cancers. In Chapter One I highlighted the importance of 
improving the proportion of earlier diagnoses in these cancers, and that the absence of 
a national screening programme for all but cervical cancer creates a need for prompt 
help-seeking in women who develop symptoms and prompt action on the part of the 
healthcare professional from whom help is sought. As such, it was surprising to discover 
the dearth of research investigating the factors associated with prompt help-seeking, or 
those associated with a longer time to help-seeking.  
 
It is clear that more research is needed in this area, particularly for cervical, uterine, 
vulval and vaginal cancers. Many of the variables which influence a longer time to help-
seeking seem to be related to misattribution, non-recognition of symptom seriousness or 
lack of awareness of symptoms, and there is evidence that a higher awareness of 
cancer symptoms can increase the likelihood of help-seeking for that cancer (Quaife et 
al., 2014). Further, GPs have reported that, from their experience, the most common 
reason for a longer time to presentation for gynaecological cancer symptoms is low 
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symptom awareness, which results in women failing to understand the significance of 
symptoms when they arise (Evans et al., 2014). However, to my knowledge, at the point 
I began research on this thesis, there were no studies which had explored symptom 
awareness and the relationship between this and time to help-seeking for symptoms of 
gynaecological cancers. Exploring this relationship may be most important in ovarian 
cancer, as this is the most lethal gynaecological malignancy (see Chapter One), and 
there is potential for increasing survival rates through earlier detection of low volume 
disease. However, it is also necessary to determine levels of awareness before efforts to 
increase awareness are made. With this in mind, Chapters Five and Six will explore 
symptom awareness for cervical and ovarian cancers. The data in these chapters were 
collected prior to my commencement of this PhD. As such, I was only able to explore the 
relationship between symptom awareness and help-seeking for ovarian cancer. Data 
were also collected for risk factor awareness for both these cancers, and these data are 
discussed further in Chapters Five and Six. 
 
The studies reported in Chapters Seven and Eight discuss data collected during my 
PhD. They explore responses to symptoms potentially indicative of the five 
gynaecological cancers quantitatively (Chapter Seven) and qualitatively (Chapter Eight). 
In Chapter four, I have described the four novel studies carried out and reported as part 
of this thesis. 
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CHAPTER FOUR – THESIS AIMS AND RESEARCH QUESTIONS 
In Chapter One I determined that survival rates for gynaecological cancers could be 
improved in the UK. It may be possible to achieve an improvement through increasing 
the proportion of earlier FIGO stage diagnoses (stages I and II) for uterine, cervical, 
vaginal and vulval cancers, and by reducing the proportion of high grade serous ovarian 
cancers, possibly through earlier diagnosis or increasing diagnoses of low volume 
tumours. I established that this may be realised though increasing prompt help-seeking 
in symptomatic women. 
 
In Chapter Two I discussed the existing models of health behaviour and help-seeking. 
The most recent model, the MPT (Walter et al., 2012), was developed from the General 
Model of Total Patient Delay or ‘Andersen’s Model’ (Andersen et al., 1995), which itself 
was an extended and expanded version of an older model, proposed by Safer et al. 
(1979). I established that Andersen’s Model is the most widely used model in the time to 
help-seeking literature. However, the recently developed MPT aimed to address some of 
the limitations of Andersen’s Model, and as such I have used this model to underpin the 
research described in Chapters Seven and Eight, and I have explored how this model 
might help explain help-seeking specifically for symptoms of a gynaecological cancer in 
Chapter Nine. 
 
In Chapter Three, I explored the literature on help-seeking for female cancers. The aim 
of this chapter was to underpin the research in Chapters Seven and Eight. Although the 
data had already been collected for the studies described in Chapters Five and Six, prior 
to the commencement of my PhD, the literature discussed in Chapter Three helped to 
guide the analysis and discussion within these chapters. 
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To reiterate the questions I laid out in Chapter One, I have addressed the following 
questions within this thesis, using original data and analyses: 
1. How much do women in the United Kingdom currently know about gynaecological 
cancer symptoms and risk factors? 
2. What variables predict time to hypothetical help-seeking for symptoms of ovarian 
cancer? 
3. How do women respond both behaviourally and emotionally to symptoms which may 
indicate a gynaecological cancer? 
4. What factors explain the different behavioural and emotional responses women may 
have to an experienced symptom of a gynaecological cancer? 
 
I have addressed question one in Chapters Five and Six, and question two in Chapter 
Six, building on the literature discussed in Chapter Three. Questions three and four are 
addressed in Chapters Seven and Eight. 
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CHAPTER FIVE - CERVICAL CANCER SYMPTOM AND RISK FACTORS 
AWARENESS (STUDY 16) 
 
5.1 Introduction 
5.1.1 Background 
In Chapter Three I established that two of the biggest influences on help-seeking 
behaviour symptoms of female cancers were symptom misattribution and non-
recognition of symptom seriousness (for example, O’Mahony, McCarthy, Corcoran, & 
Hegarty, 2013; Seibaek, Petersen, Blaakaer, & Hounsgaard, 2011), which may be the 
product of low symptom awareness. Risk factor awareness is also important as it allows 
women to make informed lifestyle choices and to modify any behaviours that may 
increase risk, such as not attending cervical screening appointments (Cancer Research 
UK, 2012a). Awareness of risk factors might also allow women who are at increased risk 
due to non-modifiable factors (such as age (Cancer Research UK, 2013b)) to be more 
sensitive to changes in their bodies. For example, as discussed in Chapter Three, there 
is evidence that women who perceive themselves to have a lower risk of developing 
breast cancer are more likely to intend to wait for a longer period of time before seeking 
medical attention for symptoms (Bish et al., 2005). 
 
The influence of risk factor awareness on help-seeking can also be understood in the 
context of the models discussed in Chapter Two. For example, within the IAM, new 
external knowledge, such as knowledge about risk factors for a disease, can influence 
interpretation of a bodily change and within the CSM, the representation of a health 
threat may also be influenced by an increased perceived risk. Further, the MPT 
describes how the influence of previous experience, psychological, social and cultural 
factors can all influence help-seeking or appraisal, and perceived risk certainly fits within 
these variables (for example having previously had a cancer may make an individual 
more likely to perceive themselves at risk of a future cancer). This suggests that by 
increasing awareness of symptoms and risk factors for cervical cancer, it might be 
possible to increase prompt and appropriate help-seeking.  
                                                          
6
 A version of this chapter has been published elsewhere and can be found in Appendix 3 (Low, Simon, 
Lyons, Romney-Alexander, & Waller, 2012) 
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However, before attempting to increase awareness, it is necessary to establish current 
levels of awareness. In doing so, it will be possible to determine areas of poor 
knowledge (such as specific risk factors or symptoms) and demographic groups who 
may benefit from targeted health education programmes. 
 
5.1.2 Existing literature on cervical cancer symptom awareness 
In 2010 the Department of Health launched their key messages for cervical cancer (NHS 
Choices, 2011). The messages include information about symptoms and risk factors for 
cervical cancer, with unusual bleeding (particularly post-coital or post-menopausal 
bleeding) and blood stained or unpleasant smelling discharge highlighted as the most 
common symptoms. Other symptoms include pain during sex, blood in the urine or stool, 
unexplained weight loss, changes in bowel habits (including persistent diarrhoea) and 
lower back or pelvic pain (Cancer Research UK, 2013b; A. Neal & Hoskin, 2009; 
Turkington & Edelson, 2005). 
 
There has not yet been not been a systematic attempt in the UK to assess population 
levels of cervical cancer symptom awareness, either for established common symptoms 
such as unusual vaginal bleeding or for less common ones, such as pain or discomfort 
during sex (NHS Choices, 2012a). However, there is evidence that cancer symptom 
awareness in general is low in British women (for example, Robb et al., 2009)). As such, 
it is likely that a low level of awareness will also be found in the current study. 
 
The lack of research in this area may be a result of the dramatic reduction in cervical 
cancer mortality and incidence in the UK overall in recent years, as described in Chapter 
One, which in turn is a result of the establishment of a national screening programme in 
1988 (Sasieni & Adams, 1999). In the context of declining incidence of cervical cancer 
and a national screening programme, it seems logical that symptom awareness may be 
a less important area of research. However, again, as described in Chapter One, the 
latest data show there are still almost 1000 deaths attributable to this cancer in the UK 
annually (Office for National Statistics, 2012a) and that incidence may still be rising in 
some groups (Patel et al., 2012). Consequently, it is necessary to attempt to encourage 
prompt help-seeking through increasing awareness of symptoms. 
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5.1.3 Existing literature on cervical cancer risk factor awareness 
There are a number of established factors that increase the risk of developing cervical 
cancer (Parkin et al., 2011). These mostly include factors related to sexual activity, 
including having many sexual partners, early sexual debut (Appleby et al., 2009), early 
age at first pregnancy (Louie et al., 2009) increasing parity, taking the contraceptive pill 
and HPV infection (Berrington de González, Green, & International Collaboration of 
Epidemiological Studies of Cervical Cancer, 2007), as well as number of previous 
sexual partners of partner (Burk et al., 1996), unprotected sex or contracting a sexually 
transmitted infection or disease (STI/STD) or virus (Binswanger, Mueller, Clark, & 
Cropsey, 2011) including Chlamydia (Dahlström et al., 2011). There are also some 
factors unrelated to sexual activity that may increase the risk of developing cervical 
cancer such as smoking, not attending regular cervical screening (Berrington de 
González et al., 2007), having a weakened immune system (Sun et al., 1997) and family 
history of cervical cancer (possibly as a function of shared genetic susceptibility or 
lifestyle factors, rather than direct heritability) (de Freitas, Gurgel, Chagas, Coimbra, & 
do Amaral, 2012).  
 
Although there is evidence that all of the above increase the risk of developing cervical 
cancer, some of these factors are associated with a higher risk than others. It is now 
accepted that HPV is the most important risk factor for cervical cancer, with evidence 
that this virus is present in almost 100% of invasive cervical carcinomas (Walboomers et 
al., 1999), and that 100% of cases can be attributed to infections in the UK (Parkin et al., 
2011). As HPV is sexually transmitted, the sexual behaviours discussed above could 
also be classed as having a higher risk than non-sexual behaviour risk factors, as they 
increase the chances of HPV infection (Burk et al., 1996; Dunne et al., 2007). Research 
suggests that risk factors unrelated to sexual behaviour, such as smoking (which may 
only be related to 7.2% of cervical cancers (Parkin et al., 2011)), may aid the transition 
of HPV-infected epithelia to cervical pre-cancer (Luhn et al., 2013). 
 
In contrast to symptom awareness, there has been a larger research interest in 
awareness of cervical cancer risk factors, although this has been slow-growing. In 2003 
Adlard and Hume conducted a literature review exploring cancer knowledge literature in 
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the British population between 1982 and 2002. They found just eleven studies, of which 
only two had explored cervical cancer risk factor awareness (Wardle, Waller, Brunswick, 
& Jarvis, 2001; Yu & Rymer, 1998), although neither study primarily aimed to determine 
cervical cancer risk factor awareness specifically. 
 
The first of these studies (Yu & Rymer, 1998) investigated awareness of cervical cancer 
and attitudes towards screening in 650 UK women aged between 15 to 75 years as part 
of a cross-sectional survey at two hospitals in London. Women were presented with a 
list of possible risk factors and asked which they thought increased the risk of cervical 
cancer. Awareness was highest for having many sexual partners (44%) and smoking 
(37%), but endorsement of the remaining risk factors was lower. Just under a fifth of 
participants endorsed genetic causes (inherited risk) (19%) and bad luck (12%). A small 
number of participants believed that alcohol (6%), lack of exercise (3%) and pollution 
(2%) were risk factors. 
 
The second study (Wardle et al., 2001) investigated prompted awareness of risk factors 
for a number of different cancers, including three risk factors related to cervical cancer 
(having many sexual partners, a virus or infection and smoking) in a population 
representative sample of men and women aged 16 years and older. Awareness that 
having many sexual partners could increase the risk of cervical cancer was higher in the 
female participants in this study than was reported in Yu and Rymer’s (1998) study 
(67%), although awareness of the link between cervical cancer and smoking was lower 
(28%). Awareness of virus or infection was low in female participants (31%). This 
suggests that although many women knew about the link between cervical cancer and 
sex, they did not understand the role of HPV in the relationship, particularly as the 
awareness reported in this study reflects knowledge of the link between a generic virus 
or infection and cervical cancer, not specifically the link between HPV and cervical 
cancer, which may have been lower still.  
 
The differences in awareness between Wardle et al.'s (2001) study and the findings 
presented by Yu and Rymer’s (1998) could be the result of the timing of the studies. For 
example, Wardle et al.’s study was conducted more recently than Yu and Rymer’s 
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study. It may be the case that awareness of the potential health implications of risky 
sexual behaviour had increased during this time. Secondly, women may have been 
more likely to endorse smoking as a risk factor in Yu and Rymer’s study due to their 
presence in a healthcare environment at the time they were asked about their 
knowledge of risk factors. It is possible that these women had been exposed to health 
messages regarding smoking at the time they were asked about risk factors for cervical 
cancer (due to their immediate environment), which led them to endorse this risk factor 
more than the women in Wardle et al,’s study, who participated from within their homes. 
 
Since Adlard and Hume’s (2003) review was conducted, there has been an increase in 
studies exploring cervical cancer risk factor awareness. This is possibly in line with the 
increased interest in ensuring that girls and women are aware of the relationship 
between sexual activity, HPV and cervical cancer with the advent of HPV testing and the 
availability of the HPV vaccination in the last decade. 
 
In 2003 Philips and colleagues (Philips, Johnson, Avis, & Whynes, 2003) asked female 
university students aged 18-23 about their knowledge of a number of risk factors for 
cervical cancer using a multiple-choice questionnaire. Again, as with previous research, 
participants demonstrated high levels of awareness for the role of sexual activity, with 
79% of the sample aware that multiple sexual partners and 56% aware that early sexual 
debut act as risk factors, but lower awareness of HPV (51%). Just under half of the 
sample (49%) identified smoking. 
 
Awareness of both multiple sexual partners and HPV as risk factors for cervical cancer 
was higher in this study than in Wardle et al.’s (2001) (compared to awareness of a virus 
or infection). However, the pattern of awareness was similar: women were more aware 
of the relationship between sexual activity and cervical cancer, but less aware of the 
processes involved in that relationship (i.e. infection with a virus (HPV)). Awareness of 
smoking was also considerably higher. It should be noted however, that while 51% 
endorsed HPV as a risk factor, the authors reported that only 31% said that they had 
heard of HPV, suggesting that 20% of the participants who endorsed HPV as a risk also 
said they had not heard of it. The high level of endorsement of HPV as a risk factor may 
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have been because the framing of the question effectively prompted agreement in 
participants.  
 
This study was the first to investigate awareness of other variables related to sexual 
activity which can increase the risk of developing cervical cancer. The researchers found 
that the majority of women in their study could identify early sexual debut (56%), but 
found lower awareness for the link between the contraceptive pill (48%), Chlamydia 
(43%), increasing number of pregnancies (31%) and early first pregnancy (29%) and 
cervical cancer risk. 
 
The higher awareness of having many sexual partners, HPV (compared to virus or 
infection) and smoking observed in this study compared to previous research (discussed 
above) may have been reflective of the high level of education of the participants (all 
were university students). Further, due to their age and surroundings, these students 
may have been given information on general and sexual health, including information on 
smoking, STIs and STDs when they started university, which may have increased their 
awareness compared to the general population. Finally, this study focused specifically 
on cervical cancer, whereas Wardle et al.’s (2001) focused on a number of different 
cancers. This focus may have led participants to consider their knowledge about cervical 
cancer in a bit more depth. 
 
Waller, McCaffery, and Wardle (2004a) were the first group to explore unprompted 
awareness of cervical cancer risk factors in a British population consisting of 846 men 
and 1091 women aged ≥16 as part of the Office for National Statistics (ONS) monthly 
omnibus survey. Participants were asked about what they thought either increased or 
reduced the risk of cervical cancer. Just under half of the women in the study mentioned 
any link with sex, STIs (sexually transmitted infections) or condom use (46%), 41% 
mentioned sexual activity, 30% identified many sexual partners, 13% knew that early 
first intercourse was a risk factor, and 5% mentioned frequent sexual activity. Very few 
women mentioned HPV (<1%), although more explicitly mentioned STI, STD or lack of 
condom use (9% mentioned ‘STD’ or named an STD, 6% said ‘STI/STD’, 15% said ‘STI 
or not using condoms’, 5% named an STI and 7% stated ‘Not using condoms’).  
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Awareness of risk factors related to sexual activity was considerably lower in this study 
than in previous studies (for example, Philips et al., 2003; Wardle et al., 2001), as was 
awareness of smoking (15%). This was likely to be a function of the open question used 
in this study, compared to the prompted questions used in previous research. It is well 
established that recall and recognition scores vary widely, with studies using the latter 
method reporting considerably higher awareness scores (for example, Power et al., 
2011; Simon, Juszczyk, et al., 2012). However, despite the lower awareness, as with 
previous research, participants were still most aware of the influence of having many 
sexual partners. 
 
In 2005 Philips et al. conducted a self-complete questionnaire study with 1244 women in 
east-central England aged 20-64, exploring awareness of the same risk factors as those 
investigated by Philips and colleagues (2003), as well as awareness of unprotected sex. 
Women eligible for cervical screening were invited to complete the questionnaire while 
attending a GP consultation (not related to screening) or when being called for 
screening. Participants were shown twelve risk factors and asked to label them as a 
major risk, minor risk or no risk for cervical cancer, or to state that they did not know. 
 
Awareness of smoking as a risk factor (either minor or major) was considerably higher 
(79%) than had been observed in previous studies (15% to 49%) (Philips et al., 2003; 
Waller et al., 2004a; Wardle et al., 2001; Yu & Rymer, 1998), although  the proportion of 
women identifying smoking as a major risk factor was comparable (46%). Endorsement 
of sexual behaviours as risk factors varied, with 77% reporting many sexual partners, 
73% reporting unprotected sex and 63% stating early sexual debut. The majority of 
women believed that having unprotected sex and early first intercourse were either 
minor risk factors, posed no risk or they did not know (61% and 64% respectively), but 
that having had many sexual partners was a major risk factor (56%). 
 
Few women believed that reproductive or contraceptive factors were major risk factors 
(17% said using the contraceptive pill, 12% said early first pregnancy and 7% reported 
number of pregnancies). Around a third of the women in the sample knew that HPV was 
a major risk factor (33%) (51% endorsed HPV as either a major or a minor risk factor), 
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which was similar to the proportion of women who endorsed Chlamydia (35%). The 
findings in relation to HPV compared to findings from previous studies appear to show 
that awareness is steadily increasing for this risk factor, although there is perhaps room 
for education about the significance of it, given the lower endorsement of HPV as a 
major risk factor here, and the finding that almost half (47%) of the women said that they 
did not know whether HPV was a risk factor at all. Despite the apparent increase in 
awareness, however, it still appears that the relationship between sexual behaviour, 
HPV and cervical cancer was not fully understood in the sample, as although most 
women endorsed having many sexual partners as a major risk factor, the majority did 
not do so for other sexual behaviours explored here. Further, although the percentage of 
women endorsing HPV as a risk factor was the same as it was in Philips et al.’s (2003) 
(51%), fewer women in this study knew that HPV was a major risk factor. 
 
In 2007, Marlow et al. tested unprompted recall of several risk factors for cervical cancer 
(including not going for regular screening) and prompted recognition of HPV in a 
population-representative sample of women aged 16-97 years. The findings in this study 
were analysed along with the data from Waller and colleagues’ study (Waller et al., 
2004a), collected in 2002, to analyse change in knowledge over time. 
 
Marlow et al found that recall was low for all of the risk factors, including HPV (3%) and 
not going for regular screening (5%) and even when prompted, only 24% of participants 
endorsed HPV, although 7% were aware that an STD or STI could act as a risk factor 
for cervical cancer when unprompted. Few women were able to spontaneously identify a 
risk factor associated with sexual activity (14% said that having many sexual partners 
was a risk factor, 7% said young age at first intercourse, 5% said unspecified sexual 
activity, 3% identified not using a condom and 3% mentioned having more frequent sex). 
There were significant improvements in awareness between 2002 and 2007 for HPV 
and for all the risk factors associated with sexual activity except unspecified sexual 
activity. However, although unprompted awareness of HPV had improved since 2002 
(3% vs. 1%), prompted awareness was lower in this study compared to previous studies 
using prompted questions, which may have been a result of participant characteristics. 
For example, although the prompted awareness of HPV was higher in Philips et al.’s 
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(2007) study and in Philips et al.’s (2005) study, the samples in these studies were not 
representative of the British population. 
 
5.1.3.1 Existing literature on HPV awareness 
The studies discussed above explored awareness of various risk factors related to 
cervical cancer. However, more recently a number of studies have concentrated 
exclusively on awareness of HPV. In 2008, Klug and colleagues (Klug, Hukelmann, & 
Blettner, 2008) completed a systematic literature review which aimed to summarise 
awareness of HPV in a number of different groups (the general public, students, patients 
and health professionals). They identified six studies in the UK (Philips et al., 2005, 
2003; Pitts & Clarke, 2002; Waller et al., 2003, 2004a; Wardle et al., 2001) (five of which 
explicitly explored HPV risk factor awareness, and one of which (Wardle et al., 2001) 
explored awareness of ‘virus or infection’). Pitts and Clarke (2002) and Waller et al. 
(2003) were the first studies to explore HPV awareness in more depth, including 
awareness of how the virus is contracted and awareness of factors that might increase 
the risk of contracting it. 
 
Pitts and Clarke’s study (2002) explored understanding and knowledge of HPV as a risk 
factor for cervical cancer in 400 English women aged 19-64, using a questionnaire. 
Their sample consisted of female staff at a university in the North West of England. The 
majority of women in their study (70%) had not heard of HPV. Of those who had, 38% 
knew that cervical cancer was a possible long-term effect of HPV, meaning that overall 
only 11% of the women in this study both were aware of HPV and knew that it was a risk 
factor for cervical cancer. 
 
In 2003, Waller et al. explored HPV awareness in 1032 women aged 16 years and older 
who had attended an NHS well woman clinic in central London using a questionnaire. 
Again, around a third of women (31%) had heard of HPV. Of those women, 65% knew 
that HPV was sexually transmitted and 40% knew that it was the main cause of cervical 
cancer. These findings showed a slight increase in the proportion of women who were 
both aware of HPV and aware that it is a risk factor for cervical cancer (12%), compared 
to data collected a year earlier (Pitts & Clarke, 2002). 
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In 2009, Marlow, Wardle, Forster, and Waller explored ethnic differences in the 
awareness of HPV in 950 women (750 of whom were from ethnic minority 
backgrounds). Women were asked whether they had heard of HPV prior to the study, 
with 39% of White British women saying that they had. Awareness was much lower in 
the minority ethnic groups. It might be expected that awareness would have risen 
between this study and the previous one (Marlow et al., 2007), as in the interim the HPV 
vaccination was introduced in Britain, which this study demonstrates in White women. 
However, caution must be taken when interpreting these findings, as, again, the sample 
was not population-representative. 
 
The most recent study exploring cervical cancer risk factor awareness (specifically HPV) 
was conducted in 2013 by Marlow and colleagues (Marlow, Zimet, McCaffery, Ostini, & 
Waller, 2013), with 2409 participants aged 18-70 recruited from the UK, US and 
Australia. HPV awareness was the highest recorded in studies with British women at 
62%, and awareness that HPV can cause cervical cancer was very high in those women 
who had heard of the virus (86%). It is likely that the increased awareness observed in 
this study compared to previous studies may be a result of the ongoing awareness 
campaigns for the national HPV vaccination programme. 
 
Across the above literature, it seems that women are most aware of the risks for cervical 
cancer associated with sexual activity (in particular, having multiple sexual partners) and 
smoking. Awareness appears to be much lower for the main risk factor, HPV, across the 
board. Overall, it appears that risk factor awareness was not particularly high, especially 
when considering risk factors which were not related to sexual activity. Even when 
considering these risk factors, the highest levels of awareness (79% for having had 
many sexual partners) would still mean that 20% of women were not aware of this risk 
factor. 
 
Almost all of the previous studies using recognition to measure awareness of risk factors 
have not done so in a population-representative sample; instead exploring awareness in 
students (Philips et al., 2003) or university staff (Pitts & Clarke, 2002), women attending 
117 
 
a well woman clinic  (Waller et al., 2003) or in patients from one GP practice in one area 
of England (Philips et al., 2005). Those in education or in an academic institution may 
have higher levels of knowledge than the population at large due to their higher 
education levels or exposure to more information on STDs/STIs or cancer through 
literature available in their surroundings. Women attending a well woman clinic may 
naturally have a higher level of interest in sexual health, and may be prone to looking for 
information relating to this. Similarly, a population from one GP practice is unlikely to be 
representative of the population. 
 
As they explored awareness in a population representative sample, Marlow et al.’s 
(2007) findings may be closer to the actual level of cervical cancer risk factor awareness 
in the British population when unprompted. However, these data were collected in 2006 
and consequently may not be reflective of current awareness. Moreover, while recalled 
awareness was measured across a number of risk factors, recognition awareness was 
only tested for HPV. 
 
5.1.4 Factors associated with awareness of cervical cancer risk factors and 
symptoms 
As may be expected, given the proximity of the disease, a personal or family history of 
cancer has been associated with higher awareness of cancer in general (Adlard & 
Hume, 2003), as has a higher SES (Robb et al., 2009). Higher awareness of some 
cervical cancer risk factors has also been found in women with higher levels of 
education and income (associated with a higher SES) (Marlow et al., 2007; Waller et al., 
2004a). This is possibly because women who are more educated have a propensity to 
seek out health information more than those who are less educated (Tu & Hargraves, 
2003). 
  
Higher awareness of HPV in particular has been found in women from a White ethnic 
background, which may be due to a reluctance to discuss topics related to sexual 
activity (Marlow et al., 2009) or an avoidance of places where one might be exposed to 
such information in women of a non-White ethnic background. Research exploring age 
differences in awareness of a number of different cervical cancer risk factors has found 
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that while participants aged 16-24 were significantly more likely to be aware of not 
attending for regular cervical screening than the oldest age group (75 and over), they 
fared poorly in awareness of most other risk factors compared to the other age groups in 
the study (Waller et al., 2004a). However, other research has found the opposite, that 
younger women displayed a higher awareness of HPV than older women (Marlow et al., 
2009). This would appear to contradict Waller et al.’s (2004a) findings. However, Marlow 
et al (2009) only recruited women to their study, whereas Waller et al. (2004a) recruited 
both men and women and did not stratify awareness by both age and gender, making it 
impossible to determine awareness in women by age group. The evidence relating to 
awareness by age then suggests that younger women would be more aware of at least 
some of the cervical cancer risk factors. 
 
I was unable to find any literature exploring predictors of symptom awareness for 
cervical cancer symptoms specifically. However, there is evidence that predictors of 
higher symptom awareness for cancer in general include older age, White ethnicity and 
higher SES (Robb et al., 2009). There is also evidence that having known close family 
members or friends who have experienced cancer can increase awareness of some 
symptoms of cancer (Adlard & Hume, 2003). 
 
A higher awareness of cancer symptoms in general in older women compared to a lower 
awareness of cervical cancer symptoms in older women may be a result of health 
promotion campaigns. Given that cervical cancer occurs most commonly in younger 
women (incidence is highest in women aged 30-34 years at 17.7 per 100,000 women, 
but is almost as high in women aged 25-29 at 17.4 per 100,000 (Office for National 
Statistics, 2012b)), it is likely that risk factor awareness literature would be aimed at 
these groups. Further, medical knowledge about cervical cancer risks factors was much 
lower when the older women were younger than it is today and consequently these 
women may have never been targeted by health campaigns aimed at increasing cervical 
cancer risk factor awareness.  
 
The higher awareness of symptoms observed in older women in the literature exploring 
generic cancer symptom awareness may be a function of the inclusion of a number of 
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different cancer types. Generally cancer is much more common in older people, and 
consequently this may have led to a higher level of awareness in older participants 
through targeted health literature. 
 
5.1.5 The current study 
As mentioned above, there has not yet been any research which has attempted to 
determine awareness of a number of known cervical cancer symptoms in a population-
representative sample of English women. Although some research has attempted to 
explore risk factor awareness, much of this research tends to involve samples which are 
not population-representative, making it difficult to apply these findings to the population. 
Research which has recruited a sample representative of British women has tended to 
focus on HPV awareness, rather than other known risk factors.  
 
The present study aimed to explore awareness of both symptoms of and risk factors for 
cervical cancer in a population representative sample of English women. Both open and 
closed questions were used to measure recall and recognition respectively. 
 
5.1.6 Hypotheses 
i. Risk factor awareness will be low, particularly for HPV 
ii. Symptom awareness will be low 
iii. Both higher symptom and risk factor awareness will be associated with higher 
education level, having a personal or close experience of cervical cancer and 
White ethnicity  
iv. Older age will be associated with symptom awareness, while younger age will 
be associated with risk factor awareness 
v. Higher occupational social class will be associated with higher risk factor and 
symptom awareness 
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5.2. Methods 
5.2.1 Recruitment 
English women aged ≥16 years were recruited through the social research agency, 
BMRB (now TNS BMRB7) using random location sampling. The sample was stratified by 
ACORN characteristics (CACI, 1975) and region. Respondents were then selected from 
a small group of homogenous streets with probability proportional to population.The 
survey (the Cervical Cancer Awareness Measure (Cervical CAM)8 (Simon, Wardle, et 
al., 2012) formed part of BMRB’s omnibus survey. This survey runs weekly and consists 
of different modules from various clients merged into a common questionnaire. Just 
under 1400 (1392) women completed the Cervical CAM survey module in the omnibus. 
Women self-completed the Cervical CAM (a site-specific version of the generic CAM; 
Stubbings et al., 2009), at home using Computer Assisted Personal Interviewing (CAPI) 
in the presence of fully trained interviewers. 
 
The study was exempt from ethical approval as no identifiable information was collected 
from participants, and data were completely anonymous. This is in line with the UCL 
Research Ethics Committee Exemptions guidelines, which state that ‘Research involving 
the use of non-sensitive, completely anonymous educational tests, survey and interview 
procedures when the participants are not defined as "vulnerable" and participation will 
not induce undue psychological stress or anxiety’ is exempt (UCL Research Ethics 
Committee, 2013). 
 
Data were collected between November and December 2009, prior to the 
commencement of this PhD. All background literature discussion, analyses and 
discussion of the findings were undertaken as part of this PhD thesis. 
 
                                                          
7
 www.tns-bmrb.co.uk 
8
 The full Cervical Cancer Awareness Measure can be download from the NAEDI website at 
www.naedi.org.uk 
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5.2.2 Measures 
5.2.2.1 Participant characteristics 
Ethnicity was dichotomised into ‘White’ or ‘non-White’. White non-British women were 
included in the ‘White’ category. A level of spoken English adequate to understand the 
survey was a pre-requisite for participation. Age was measured as a continuous 
variable. Education was grouped into ‘low-level/none’ (women educated to ONC, BTEC, 
O Level/GCSE A-G and those with no formal education), ‘mid-level’ (women educated to 
A-Levels/Highers, Higher education below degree and those who answered ‘Other’ or 
were still studying) and ‘high-level’ (degree level or higher). The small number of women 
who answered ‘other’ (N=48) were placed into the ‘mid-level’ education group. Analysis 
of variance showed that these women were not able to recall or recognise significantly 
more symptoms or risk factors than any of the other education categories, suggesting 
that these women were not significantly different to any of the other education 
categories. However, Table 5.1 shows that, at face value, the mean awareness for risk 
factors and symptoms for women who endorsed ‘other’ was most similar to the ‘mid-
level’ education group, overall. 
 
 
Table 5.1 Mean recall and recognition for risk factors and symptoms by education group 
(n=1392) 
  
Recalled 
symptoms 
Recognised 
symptoms 
Recalled risk 
factors 
Recognised 
risk factors 
  M (SD) M (SD) M (SD) M (SD) 
Low-Level/None 0.52 (0.70) 5.88 (3.00) 0.45 (0.70) 4.78 (2.60) 
Mid-Level 0.56 (0.73) 6.22 (2.67) 0.56 (0.75) 4.87 (2.40) 
High-Level 0.84 (0.91) 6.59 (2.56) 0.77 (0.99) 5.54 (2.30) 
Other 0.62 (0.84) 5.37 (2.91) 0.55 (0.79) 4.99 (2.36) 
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SES was measured using the National Readership Survey (NRS) social grading system 
(National Readership Survey, 2007). In this system, social grade is divided into six 
different classifications (see Figure 5.1) based on occupation of the chief income earner 
(CIE) for each household. Income is not used to determine social grade within the NRS 
system. For the analyses in the current study, participants were dichotomised into those 
with a high-level occupation (A, B, and C1) and those with a low-level occupation (C2, 
D, and E), as is the convention in the literature (for example, Waller et al., 2009). 
Further, this dichotomy allows professionals and non-professionals to be analysed 
separately. 
 
I decided to analyse the data using two markers of SES: education and occupation 
(measured using the NRS system, as described above) rather than one or the other as, 
although there is evidence that the two are correlated, there is an argument that these 
two variables measure different phenomena and that they may each be better predictors 
of different types of health outcome (for example, Geyer, Hemström, Peter, & Vågerö, 
2006). In order to explore all effects on risk factor and symptom awareness, I deemed it 
appropriate to explore the relationship between both education level and occupation and 
awareness. 
 
Finally, respondents were asked whether they had had cervical cancer and/or whether 
they had known a close family member or friend with cervical cancer. Respondents 
scored ‘1’ if they had and ‘0’ if they had not. 
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Figure 5.1. National Readership Survey (NRS) social grading system (source: 
www.nrs.co.uk/lifestyle-data) 
 
5.2.2.2 Awareness of cervical cancer risk factors 
Risk factor awareness was measured with both open and closed questions. The open 
question (presented before the closed question to reduce bias) measured recall and 
read, ‘What things do you think affect a woman’s chance of developing cervical 
cancer?’. Respondents were given a blank space to freely respond. The closed question 
(measuring recognition) read, ‘The following may or may not increase the chance of 
getting cervical cancer. How much do you agree or disagree that the following can 
increase the chance of getting cervical cancer?’.  Participants were presented with 10 
cervical cancer risk factors (see Table 5.3) and the response options, ‘strongly agree’, 
‘agree’, ‘neither agree nor disagree’, ‘disagree’ or ‘strongly disagree’. A refusal to 
answer was coded as ‘missing’. 
 
For the open question, the responses were dichotomised into ‘recalled’ (mentioned) or 
‘not recalled’ (not mentioned) and for the closed question responses were dichotomised 
into ‘recognised’ (response ‘strongly agree’, ‘agree’) or ‘not recognised’ (responses 
‘neither agree nor disagree’, ‘disagree’ or ‘strongly disagree’). Scores from the open and 
closed questions were each summed to create an overall score for recall and for 
recognition (range for both questions = 0-10). 
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5.2.2.3 Awareness of cervical cancer symptoms 
As with the risk factor questions, awareness was measured using both open and closed 
questions. Symptom recall was measured using the open question: ‘There are several 
warning signs and symptoms of cervical cancer. Please type in as many as you can 
think of’. Participants were presented with a blank space for responses and were also 
given the option of answering ‘Don’t know’ or ‘Refuse’. Again, recognition was measured 
with a closed question: ‘The following may or may not be warning signs for cervical 
cancer. We are interested in your opinion’. Participants were presented with 11 
symptoms of cervical cancer (see Table 5.5) and offered response options ‘Yes’, ‘No’, 
‘Don’t know’, as well as the option to refuse to answer the question. If participants chose 
this option, their data were coded as ‘missing’. Responses to the closed question were 
dichotomised into ‘recognised (response ‘yes’) or ‘not recognised’ (responses ‘no’/‘don’t 
know’) and responses to the open question were dichotomised into ‘recalled’ 
(mentioned) or ‘not recalled’ (not mentioned). 
 
Each recognised or recalled risk factor or symptom was given a score of ‘1’. For each 
risk factor or symptom which wasn’t recalled or recognised, a score of ‘0’ was given. 
Scores were summed for both recognition and recall of both symptoms and risk factors 
to give overall four overall scores (ranging from 0-10 for risk factors and 0-11 for 
symptoms). A full list of the risk factors and symptoms measured can be seen in Tables 
5.3 and 5.5 respectively. 
 
Responses to the open questions for risk factor and symptom awareness were coded by 
the BMRB interviewers according to a coding frame developed during the interview 
stage. Coding was verified by another BMRB team member, allowing any errors or 
inconsistencies to be corrected. To allow comparisons between levels of recalled and 
recognised awareness, I have reported all those responses from the open risk factor 
question that corresponded with the closed question list of risk factors. In addition, I 
have reported awareness of ‘virus/STI/STD/infection’, ‘unprotected sex’ and 
‘hereditary/genetics/in the family’. Although these risk factors did not match the closed 
question responses, they are not incorrect. In a similar manner, I have reported 
responses from the open question for symptom awareness that directly corresponded 
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with the closed question responses, as well as a number of responses that are not 
incorrect (‘unusual/irregular bleeding’, ‘spotting’ and ‘bleeding (no detail)’). 
 
5.2.3 Analyses 
Data were analysed using SPSS version 19 (IBM Corporation, 2010). Two multiple 
linear regressions9 were run; firstly to determine independent predictors of awareness 
(recognition) of symptoms and secondly to determine independent predictors of risk 
factor awareness. Recognition score was used in the regression as opposed to recall 
score as both recall and recognition of cancer symptoms have been shown to have 
similar correlates; however, recognition levels are usually considerably higher than recall 
(for example Power et al., 2011; Robb et al., 2009; Simon, Juszczyk, et al., 2012). I 
decided to use recognition scores rather than recall scores to determine group 
differences in the regression analyses, as an overall floor effect was observed in the 
recall scores, with many symptoms achieving a recall rate of zero. Further, in their 2009 
study of generic cancer symptom awareness using the Cancer Awareness Measure, 
Robb et al. (2009) reported that symptom recognition scores were an independent 
predictor of time to help-seeking. 
 
To determine those variables which were significantly associated with either the total 
symptom recognition score or the total risk factor recognition score (shown in the results 
section) before entering those variables into the two linear regressions using the forced 
entry method, I performed a number of bivariate analyses. I tested the relationship 
between age and awareness of both risk factors and symptoms using a Pearson’s 
correlation. To explore differences in awareness between education and occupational 
groups, I used analysis of variance and t-tests respectively. I also used t-tests to explore 
differences in awareness between ethnic groups and those who had had a close 
experience of cancer or not. These analyses (reported below) allowed me to identify the 
predictive value of each of the variables independently.  
 
                                                          
9
 Linear regression is appropriate when both the predictor variables and the outcome variables 
are continuous data. 
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For both regression models, age, ethnicity, education level, occupation and experience 
of cervical cancer were entered as predictor variables. Although ethnicity and 
experience of cervical cancer were not associated with risk factor recognition score in 
bivariate analyses, the literature suggests that these variables may be related to risk 
factor awareness and so they were kept in the model.  
 
As HPV is the most important risk factor for cervical cancer, and previous research 
seems to suggest that there is a lack of understanding of the relationship between 
sexual activity and HPV (for example, Waller et al., 2004a), I explored whether those 
who were aware that sexual activity was a risk factor were also aware that HPV was a 
risk factor.  
 
5.2.3.1 Weighting 
Weights were provided by BMRB. Data were weighted using a rim weighting technique, 
in which target profiles were set for five separate demographic variables (occupational 
status, parity, age group, social grade and geographical region) to achieve a 
demographic profile within the sample which was representative of women aged 16 and 
over in England. Weighting had the biggest effect on occupational social class (with 51% 
of the unweighted sample in the C2DE group, compared to 43% in the weighted sample) 
and on the 25-39 years age group (with 11% of the unweighted sample in this age 
group, compared to 15% in the weighted sample). Smaller effects were observed in all 
of the other demographic variables (see Table 5.2). 
 
5.2.3.2 Missing data 
Although each question in the survey offered participants the option to refuse to answer, 
there were few missing data. The highest amount of missing demographic data were 
observed for the education variable, where 0.9% of data were missing. There were a 
very small amount of missing data for ethnicity (0.2%) and no missing data for 
experience of cervical cancer or age. For each of the risk factor and symptom 
awareness closed questions, less than 0.02% were missing. Where a case was missing 
data, I excluded that case from any analyses in which the missing value would have 
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been required. Given the small amount of missing data it is unlikely that this would have 
affected the findings. 
 
5.2.3.3 Parametric assumptions 
Data were tested for normality and homogeneity of variance to be certain that any 
significant results were down to genuine group differences in means. Linear regressions 
were used as the skewness and kurtosis of the outcome variables (number of symptoms 
participants were aware of and number of risk factors participants were aware of) were 
both within normal distribution ranges (-1 – 1+). 
 
5.3. Results 
5.3.1 Participant characteristics 
The sample consisted of 1392 women. Participants were aged 16-94, with a Mean age 
of 47 years (range=16-94, SD=18.70). Most were from White ethnic backgrounds (91%), 
which meant that the number of non-White women was very small. Consequently these 
women were grouped together into the ‘non-White’ category. Women from a non-White 
ethnic background were slightly over-represented compared to the female population in 
England and Wales (9.2% versus 12%, respectively) (Office for National Statistics, 
2014b). Most women either had no formal education or were educated to a low level 
(51%) and fell into the higher SES group (ABC1) (57%). Although the women here were 
similar to the British population in terms of SES (56% of the British population fall into 
this group (Ipsos MediaCT, 2009)), the highest education group was under-represented 
when compared to the female population of England and Wales (21% compared to 36%, 
respectively) (Office for National Statistics, 2014a). However, the data from Office for 
National Statistics is only presented as a combination of males and females. 
Consequently, it is difficult to state how different the population here were compared to 
the female population in England. It is likely that, the weights applied by BMRB were 
applied to all of the participants who took part in the whole survey, and not just the 
Cervical CAM module, and this may explain the demographic differences in the sample 
here compared to the British population. 
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The majority of participants had not had cervical cancer themselves, nor had they known 
anyone close to them who had (85%). A more detailed description of the sample 
characteristics can be found in Table 5.2 (which presents both weighted and unweighted 
data). 
 
Table 5.2. Sample Characteristics (Weighted/Unweighted n=1392) 
  Unweighted   Weighted 
  N %*   N %* 
Age           
     16-24 158 11.4   208 14.9 
     25-39 425 30.5   343 24.7 
     40-59 416 29.9   431 30.9 
     60 + 393 28.2   410 29.5 
      
Ethnicity           
     White 1240 89.1   1261 90.6 
     Non-White 149 10.7   128 9.2 
      
Education           
      High-Level 256 18.4   285 20.5 
      Mid-Level 230 26.9   233 27.9 
      Low-Level/None 749 53.8   705 50.7 
      
Socioeconomic status           
      ABC1 687 49.4   794 57.0 
      C2DE 705 50.6   598 43.0 
      
Close experiences of cancer           
      No-one 1171 84.1   1179 84.7 
     At least one person 221 15.9   213 15.3 
* where %<100%, this is due to missing data 
 
 
5.3.2 Awareness of cervical cancer risk factors 
Two-thirds of respondents (65%, n=905) were unable to recall any of the target risk 
factors (M=0.44, SD=0.67), but when open responses ‘virus/STI/STD/‘infection’ (and 
‘unprotected sex’ were included, this figure dropped to 764 (55%). The remainder 
correctly recalled at least one (n=487 35%, and n=628, 45% respectively). ‘Having many 
sexual partners’ was the most recalled target risk factor (20%, n=272). The least 
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recalled were ‘having many children’ (<1%, n=3) and ‘having a weakened immune 
system (for example, because of HIV/AIDS, immunosuppressant drugs or having a 
transplant)’ (<1%, n=2). Mean recall score was slightly higher (M=0.52, SD=0.78) when 
open responses ‘virus/STI/STD/‘infection’ (recalled by 1%, n=20) and ‘unprotected sex’ 
(recalled by 7%, n=101) were included. See Table 5.3. 
 
Just under a third (28%, n=392) of the sample were able to recall at least one of the risk 
factors relating to sexual activity (starting to have sex at a young age; having many 
sexual partners; unprotected sex or having a sexual partner with many previous 
partners). Although I attempted to explore whether women who recalled a sexual activity 
risk factor were significantly more likely to endorse HPV as a risk factor than those who 
did not, the numbers of women in these groups were too small for a meaningful 
difference to be detected using statistical analyses (n=12 and n=3, respectively). 
 
Overall awareness was substantially higher when measured by recognition (with 95% 
able to identify at least one risk factor), however on average women still only correctly 
identified half of the risk factors presented (50%, M=4.96/10, SD=2.50). The most 
recognised risk factors were ‘Not going for regular smear (Pap) tests’ (75%) and ‘Having 
many sexual partners’ (64%). The least recognised was ‘having many children’ (12%) 
(Table 5.3). 
 
When prompted, 1029 (74%) of the women were able to recognise at least one risk 
factor relating to sexual activity. As with recall, women who recognised at least one risk 
factor relating to sexual activity were significantly more likely to also endorse HPV 
(n=563, 55%) than women who did not recognise any risk factors related to sexual 
activity (n=79, 23%) (χ2 (1,1375)=106.73, p<0.001). 
 
In bivariate analyses, older age was significantly correlated with a higher knowledge of 
risk factors when prompted (r(1377)=.10, p<0.001). Those with a higher level of 
education were able to recognise significantly more risk factors (M=5.54) than those with 
a mid (M=4.88) or lower level of education (M=4.78) (F(2, 1371)=9.67, p<0.001), as 
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were those in the occupational group ABC1 (M=5.15) compared to those in the 
occupational group C2DE (M=4.72) (t(1377)=-3.19, p=0.001). 
 
There was no difference in recognition of risk factors between the women who had had 
cervical cancer or had known someone with cervical cancer and those who had not. 
Similarly, there was no difference in risk factor recognition between White and non-
White groups. 
 
Table 5.3. Number of recalled and recognised cervical cancer risk factors (weighted 
n=1392) 
Risk factor 
Recalled 
 
Recognised 
(n) % 
 
(n) % 
Having many sexual partners 272 19.5 
 
884 63.5 
Hereditary/genetics/in the family 177 12.7  - - 
Smoking any cigarettes 121 8.7 
 
706 50.7 
Starting to have sex at a young age 111 8.0 
 
758 54.4 
Unprotected sex 101 7.3 
 
- - 
Not going for regular smear (Pap) tests 78 5.6 
 
1046 75.2 
Infection, STI/STD or virus 20 1.4 
 
- - 
Infection with Chlamydia 19 1.4 
 
748 53.7 
Infection with HPV 15 1.1 
 
643 46.2 
Long term use of the contraceptive pill 4 0.3 
 
460 33.0 
Having a sexual partner with many previous partners 4 0.3 
 
740 53.1 
Having many children 3 0.2 
 
167 12.0 
Having a weakened immune system 2 0.1 
 
692 49.7 
 
 
When risk factor recognition score was regressed onto the demographic and cancer 
experience variables the model accounted for a small but significant proportion of the 
variance (Adj. R2=0.03, F(5,1365)=7.94, p<0.001). Older age and a higher level of 
education significantly predicted higher awareness of cervical cancer risk factors in the 
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model, whereas ethnicity, SES and cancer experience did not. The standardised beta 
for age (beta=0.12, p<.001) and education level (beta=0.11, p<.001), were similar 
suggesting a roughly equal influence on risk factor awareness (Table 5.4). 
 
 
Table 5.4 Regression for predictors of cervical cancer risk factor knowledge 
(recognised) (weighted n=1372) 
  
  
Beta† SE p 
Constant - 0.32 <.001 
Age 0.12 <.0001 <.001 
Ethnicity -0.03 0.24 0.28 
Occupation 0.04 0.15 0.18 
Education 0.11 0.09 <.001 
Cancer experience 0.04 0.18 0.14 
Adj R
2
= 0.03, p<.001. 
†
Standardised 
Note: Ethnicity, occupation and cancer experience are categorical variables, coded as Non-
White=0, White=1, 0=Group C2DE, 1=Group ABC1 and 0=no-one, 1=Me or someone close, 
respectively. Education is an ordinal variable, coded as Low-level=1, Mid-level=2 and High-
level=3. 
 
5.3.3 Awareness of cervical cancer symptoms 
Two thirds of the women were unable to recall any of the target symptoms (75%, 
n=1049). This figure was lower (55%, n=764) when responses ‘irregular 
bleeding’/’spotting’/‘non-specific bleeding’ were included (M=0.59, SD=0.77). 
Recognition of the target symptoms was better than recall, with 93% (n=1287) correctly 
recognising at least one symptom of cervical cancer. On average however, women only 
recognised just over half of the symptoms (55%, M=6.08/11, SD=2.85). 
 
Although not on the target list, unusual vaginal bleeding (including responses: ‘irregular 
bleeding’/‘spotting’/‘non-specific bleeding’) was the most recalled symptom of cervical 
cancer (29%), followed by ‘persistent, abnormal or unusual vaginal discharge’ (15%). 
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Patterns were different when women were asked to recognise symptoms, with 
recognition highest for ‘vaginal bleeding between periods’ (73%), and ‘persistent pelvic 
pain’ (70%). Few women knew that ‘persistent diarrhoea’ was a symptom of cervical 
cancer as it was both the least recalled (0%) and recognised (12%) symptom (Table 
5.5). 
 
Table 5.5. Awareness of cervical cancer symptoms (weighted n=1392) 
Symptom 
Recalled   Recognised 
(n) %   (n) % 
Unusual vaginal bleeding* 397 28.5   - - 
Persistent/abnormal/unusual vaginal 
discharge 
202 14.5   861 61.9 
Vaginal bleeding between periods 61 4.4   1020 73.3 
Heavier/longer periods than normal 46 3.3   723 52.0 
Vaginal bleeding during/after sex 32 2.3   886 63.7 
Pain/discomfort during sex 28 2.0   864 62.0 
Persistent pelvic pain 20 1.4   971 69.8 
Unexplained weight loss 14 1.0   778 55.9 
Blood in stool/urine 12 0.9   598 43.0 
Persistent lower back pain 11 0.8   602 43.3 
Vaginal bleeding after the menopause 4 0.3   923 66.3 
Persistent diarrhoea 0 0.0   164 11.8 
*Includes any reference in the open responses to non-specific vaginal bleeding, including 
‘unusual/irregular bleeding’, ‘spotting’ and ‘bleeding (no detail)’ that did not match with the 
target symptoms in the closed question 
 
In bivariate analyses, an older age was significantly correlated with a higher knowledge 
of symptoms when prompted (r(1379)=.07, p<0.01). Those with a higher level of 
education were able to recognise significantly more risk factors (M=6.59) than those with 
a lower level of education (M=5.88) (F(2, 1372)=6.37, p<0.01), as were those in the 
occupational group ABC1 (M=6.35) compared to those in the occupational group C2DE 
(M=5.71) (t(1379)=-4.17, p<0.001). Women from a White ethnic background (M=6.22) 
were able to recognise significantly more symptoms than women from a non-White 
ethnic background (M=4.76) (t(1376)=-5.61, p<0.001), as were women who had had a 
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close experience of cancer (M=6.56) compared to those who hadn’t (M=5.99) (t(1379)=-
2.70, p<0.01). 
 
The multiple linear regression model explained 4% of the variance in symptom 
recognition (Adj R2=0.04, F(5,1366)=1.7128, p<.001). A White ethnic background, being 
in the occupational group ABC1, a higher level of education and having a close 
experience of cervical cancer all predicted higher cervical cancer symptom recognition. 
The standardised beta value was highest for ethnicity (beta=.15, p<.001). Occupation 
(beta =.08, p<.01), education level (beta =.09, p<.01) and having a close experience of 
cervical cancer (beta =.07, p<0.01) all had lower beta values, suggesting that they have 
a weaker influence on risk factor awareness than ethnicity (Table 5.6). 
 
Table 5.6. Regression for predictors of cervical cancer symptom recognition 
(weighted n=1373) 
  
Beta† SE P 
  
Constant - 0.36 <.001 
Age 0.05 <.0001 0.072 
Ethnicity 0.15 0.26 <.001 
Occupation 0.08 0.16 0.008 
Education 0.09 0.10 0.002 
Cancer experience 0.07 0.21 0.005 
Adj R
2
= 0.04, p<.001. 
†
Standardised 
Note: Please see note under Table 5.4 
 
 
5.4. Discussion 
This was the first study to explore cervical cancer symptom awareness in an English 
female population-based sample, and to attempt to determine predictors of symptom 
awareness. It was also the first study to explore cervical cancer risk factor awareness 
(including awareness of HPV) in this sample, along with predictors of awareness, 
following the introduction of the HPV vaccination, Cervarix® in 2008, although since this 
study was conducted, further research exploring awareness of HPV has been conducted 
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(Marlow, Zimet, et al., 2013). Further, the data in the current study were collected just 
prior to the launch of the Department of Health’s key messages on cervical cancer in 
2010 (NHS Choices, 2011). Measuring awareness at this unique point in time and using 
a validated measure (the Cervical CAM), allows for a comparison of awareness 
following the introduction of these messages, therefore enabling a measurement of the 
impact of the key messages, particularly as no formal evaluation of the impact of these 
key messages has been undertaken. 
 
Women demonstrated very poor knowledge of symptoms and risk factors for cervical 
cancer when they were not prompted, with most unable to recall any. Awareness was 
much higher for both when prompted; although even then women were only able to 
recognise around half of the symptoms and risk factors presented. These findings are 
reflective of existing research that has used both recall and recognition questions to 
explore awareness of cancer symptoms (for example, Power et al., 2011; Simon, 
Juszczyk, et al., 2012; Waller, McCaffery, & Wardle, 2004b). That these two types of 
measurement produce different results in the present study highlights the differences in 
the cognitive processes involved in recall and recognition. Not only was recall much 
lower, but the patterns of those risk factors and symptoms for which participants were 
most and least aware of was different when the two different measurements were used. 
For example, the most recalled risk factor was having many sexual partners, whereas 
the most recognised risk factor was not going for regular smear tests. 
 
Recalled knowledge is an active retrieval of memory, whereas recognition could be 
argued to be more passive and less taxing in terms of cognitive processes. There is 
even evidence that the two processes are dealt with by different brain areas (Rugg & 
Yonelinas, 2003). However, whilst recall could be argued to be a more accurate 
measure of ‘true’ memory, given that no prompting is required to elicit this information, 
these measurements should be assessed in the context of this research. With 
symptoms in particular, the symptom itself would act as a prompt to recognise that this 
may be a sign of cervical cancer. Again, with risk factors, the act of risky behaviour itself 
may act as a prompt to recognition. Therefore recognition may actually be a more 
135 
 
ecologically valid measure of awareness in this particular study and other similar 
studies. 
 
Although the most recognised risk factor was ‘not going for regular smear (Pap) tests’ 
(>75%), a quarter of women were not able to identify this risk factor even when 
prompted. It has been suggested that lack of awareness of the function of the cervical 
cancer screening programme can negatively affect attendance (Hansen et al., 2011). 
Currently around 20% of eligible women are not participating in screening and coverage 
for women in the higher risk age group (25-49 years) is falling (Health and Social Care 
Information Centre, Screening and Immunisations team, 2012). Increasing awareness 
that the cervical screening programme can reduce the risk of cervical cancer may help 
to increase attendance, resulting in lower incidence and consequently lower mortality. 
 
Recognition of ‘smoking’ (51%) and ‘infection with Chlamydia’ (54%) as risk factors for 
cervical cancer appears to have improved in this study compared to earlier research 
(Philips et al., 2005), with over half of respondents able to recognise each. It was 
disappointing however, that unprompted awareness of HPV in particular was very low 
(1%) and that, despite the introduction of the HPV vaccine in 2008 and the associated 
publicity, unprompted awareness of this risk factor was similar to that recorded in 2004 
(<1%) (Waller et al., 2004a) and lower than it was reported to be in a survey carried out 
in 2006 (2.5%) (Marlow et al., 2007). 
 
Previous studies have highlighted the apparent lack of understanding about the link 
between cervical cancer and sex and the mechanism for this (i.e. HPV infection) (for 
example, Marlow et al., 2007). In the current study I attempted to explore whether 
women were significantly more likely to mention HPV if they also mentioned a risk factor 
related to sexual behaviour than if they did not. This analysis would have been 
interesting, as it would have provided an indication of whether the relationship between 
sexual activity, HPV and cervical cancer is now better understood than it has been in the 
past (Waller et al., 2004a). However, it was not possible to carry out these analyses due 
to the small numbers of women in each group. However, even if the results here had 
shown an increased understanding, there is still more work to be done as a substantial 
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amount of those who endorsed a sexual activity risk factor either when prompted (45%) 
or unprompted (97%) did not endorse HPV. Previous research on public understanding 
of the link between cervical cancer and smoking has highlighted the importance of 
having a coherent model linking a risk factor to an outcome (Hall, Weinman, & Marteau, 
2004), and future research might investigate ways of helping women understand the role 
of sexual activity in cervical cancer aetiology.  
 
In contrast to my hypothesis, I found that younger, not older women had lower 
awareness of risk factors for cervical cancer. This is concerning, as incidence is highest 
in women aged 30-34 (NHS Cancer Screening Programmes, 2011; Office for National 
Statistics, 2012b) and there is evidence that younger women may be more vulnerable to 
some risk factors such as infection with Chlamydia (Health Protection Agency, 2010). 
One explanation for these findings may be the use of a composite risk factor score, 
whereas previous research has investigated awareness of individual risk factors for 
cervical cancer (for example, Marlow et al., 2007) or cancer risk factors in general 
(Adlard & Hume, 2003). A composite score may lead to higher awareness in older 
women as younger women may be more aware of specific risk factors (such as HPV 
(Marlow et al., 2009)) but less aware of risk factors overall. 
 
The most recalled symptoms were ‘unusual vaginal bleeding’ (29%) and 
‘Persistent/abnormal/unusual vaginal discharge’ (15%). This was particularly reassuring 
given that they are the most common symptoms of cervical cancer and are highlighted 
in the Department of Health’s Key Messages (NHS Choices, 2011). However, less 
reassuring was the fact that most women were unable to recall any symptoms and even 
for these common symptoms recall was still quite low. 
 
Recognition was good for the ‘bleeding’ and ‘pain’ symptoms (Table 5.5), reflecting 
earlier findings that, when participants were presented with symptoms of cancer more 
generally, two of the three most recalled symptoms were bleeding and pain symptoms 
(Robb et al., 2009). This suggests that women think of cervical cancer symptoms as 
relatively alarming or dramatic.  As they are not necessarily so, it may be useful to raise 
awareness of the less dramatic or vaguer symptoms of cervical cancer, such as 
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‘unusual vaginal discharge’ as recognition was not as high for this common symptom 
(62%) as it was for the bleeding symptoms. Studies of help-seeking behaviour support 
this conclusion; women are more likely to seek help promptly for gynaecological cancers 
if they perceive their symptom to be alarming (for example bleeding) or serious (for 
example pain) and are less likely to do so for cancer symptoms in general if they 
experience a symptom which is perceived as more common or vague (Macleod et al., 
2009). These findings can be explained within the MPT, described in Chapter Two, 
which posits that ‘contributing factors’ can explain how an individual moves from the 
‘appraisal interval’ to the ‘help-seeking interval’. Patient or disease factors may 
contribute towards the appraisal of a symptom as alarming, serious, common or vague. 
For example, if an individual knows of a number of other women who have experienced 
a similar symptom which was found to have a non-serious cause, they may be less likely 
to appraise their own symptom as serious. 
 
As expected, White ethnicity, having a higher level of education, working in a higher 
level occupation group and having had a close experience of cervical cancer all  
predicted higher recognition of symptoms, reflecting earlier research for cancer 
symptoms in general (Robb et al., 2009). We know that lower SES and non-White 
women have poorer outcomes when diagnosed with cancer (Jack, Davies, & Moller, 
2009; Rachet et al., 2010). We also know that GPs are less likely to refer these groups 
of women to secondary care (Morris, Sutton, & Gravelle, 2005). If women are unaware 
of the symptoms for cervical cancer, they may be less likely to insist on referral for 
further investigation. Increasing awareness in these groups could ultimately affect 
survival rates by increasing confidence when seeking help for symptoms, and thus 
increasing referrals for these women.  
  
5.4.1 Strengths and limitations 
This study was strengthened by the use of a validated tool to systematically measure 
both risk factor and symptom awareness for cervical cancer. Further, these data were 
collected just prior to the launch of the cervical cancer key messages; using the 
validated cervical CAM to assess awareness again in the future may give an indication 
of the impact of these key messages on awareness.  
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As the sample was population representative, the proportion of non-White participants 
was inevitably small (in 2011 approximately 12% of the population of was non-White 
(Office for National Statistics, 2011)). Given that women from non-White backgrounds 
had lower symptom awareness than White women, future research may explore ethnic 
differences in samples with a higher proportion of non-White women. 
 
Another limitation of this study was the small amount of variance explained by each 
model, suggesting that there are other, stronger influences on awareness that were not 
measured. Further work should be carried out to identify these variables. Further, one of 
the aims of the study was to explore awareness of symptoms and risk factors. However, 
the structure of the question exploring risk factor awareness in particular may have 
meant that personal opinion was tapped into, rather than awareness that each risk factor 
was related to cervical cancer. Awareness was measured using a Likert scale, which 
gave women the option of agreeing or disagreeing on a sliding scale about whether an 
option was a risk factor or not. This may have led to women who had heard of a 
particular risk factor, but did not agree that it increased the chances of developing 
cervical cancer disagreeing. This would then incorrectly be measured as a lack of 
awareness. It is recommended that in future research, wording of questions designed to 
measure awareness is considered carefully. 
 
A number of potential risk factors for cervical cancer were not explored in this study; 
namely early age at first pregnancy, family history of cervical cancer and unprotected 
sex. Although early first pregnancy also indicates early sexual debut, which is a known 
risk factor, and was explored here, there is some evidence that suggests that a shorter 
period between age at sexual debut and first pregnancy may increase the risk of cervical 
cancer over and above that posed by a younger age at sexual debut alone (Louie et al., 
2009). As such, future research might explore awareness of this as a separate risk 
factor to early sexual debut. 
 
The role of family history of cervical cancer is not yet fully understood and the genes 
associated with this process are not yet clear (de Freitas et al., 2012). However, there is 
evidence that risk factors for developing cervical cancer associated with lifestyle may 
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run in families. For example, Fidler, West, Jaarsveld, Jarvis, and Wardle (2008) found 
that children with just a non-biological parent who smoked (i.e. their biological parent did 
not smoke) when they were aged 11-12 were almost three times as likely to be smokers 
themselves between the ages of 11 and 16 compared to those who had neither a 
biological or non-biological parent who smoked. Future versions of the Cervical CAM 
might include family history or cervical cancer as a risk factor once this relationship 
becomes clearer. 
 
Finally, the literature exploring protective effects of condom use was far from consistent 
at the time the Cervical CAM was developed (Manhart & Koutsky, 2002), and as such, 
awareness of this risk factor was not included. However, a recent review has concluded 
that there is evidence for a partial, but good level of protection against HPV associated 
with condom use (Lam et al., 2014). Again, future versions of the Cervical CAM might 
include this risk factor. 
 
There were a small proportion of missing data (<1%) for education and ethnicity, and 
those cases with missing data were removed from analysis. However, the size of the 
missing data meant it was very unlikely that removing these cases would have affected 
my overall findings. As such, I feel it was not necessary to run sensitivity analyses. 
Finally, I was unable to accurately report a response rate for this survey as TNS do not 
record the number of addresses they attempt to recruit from. 
 
5.4.2 Conclusions 
Awareness of both risk factors and symptoms of cervical cancer is low in English 
women. Future research in this area should investigate awareness of the link between 
sexual behaviour, HPV and cervical cancer as it was not possible to explore this 
relationship here. 
 
Some population subgroups may benefit from more education on risk factors and 
symptoms in general – including younger women, ethnic minorities, those from a lower 
SES and those with less education. It is hoped that by improving awareness in these 
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groups, prompt help-seeking will be encouraged, reducing the chances of a poor 
outcome. 
 
The study discussed in the present chapter provides useful information about data gaps 
and where additional education may be needed. Further, as discussed in Chapter Two, 
perceived risk and symptom awareness may play a part in time to help-seeking. For 
example, the CSM aims to explain how an individual appraises and responds to a threat 
to their health, and then attempts to cope with this threat. If an individual believes 
themselves to be at risk of an illness, a coping strategy may involve seeking medical 
help. Again, within the MPT, perceived risk may be influenced by contributing factors 
within the model, which in turn may lead to movement from the appraisal interval to the 
help-seeking interval. Further, it is important to identify those factors that may influence 
levels of awareness. In Chapter Three, I also discussed the lack of literature exploring 
help-seeking for symptoms of female cancers. In the next chapter, therefore, I have 
explored symptom and risk factor awareness, and the relationship between these two 
variables and anticipated time to help-seeking for symptoms of ovarian cancer. 
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CHAPTER SIX - OVARIAN CANCER SYMPTOM AWARENESS AND ANTICIPATED 
TIME TO HELP-SEEKING FOR SYMPTOMS (STUDY 2)10 
 
6.1 Introduction 
6.1.1 Background 
In Chapter Three I discussed the literature exploring predictors of help-seeking for 
symptoms of female cancers. The literature revealed a strong evidence base for the 
negative effects of symptom misattribution and non-recognition of symptom seriousness 
on help-seeking for symptoms of female cancers, including ovarian cancer. I also found 
inconclusive evidence for the effects of age and fear. Factors that may encourage 
prompt help-seeking include fewer perceived barriers to help-seeking (Robb et al., 2009) 
and a personal experience of cancer (Macleod et al., 2009). 
 
In Chapter Five I discussed how increasing awareness of symptoms for cervical cancer 
might lead to a higher level of symptom recognition, and therefore increase the 
likelihood of accurate symptom attributions, leading to appropriate and timely help-
seeking. However, although I explored symptom and risk factor awareness in Chapter 
Five, I did not investigate this in relation to help-seeking, as I was limited by the data 
produced by the Cervical CAM (collected prior to this PhD), which only included the 
question, ‘If you had a symptom that you thought might be a sign of cervical cancer how 
soon would you contact your doctor to make an appointment to discuss it?’, rather than 
asking women about each symptom. Given the evidence that help-seeking may be 
influenced by symptom type (as discussed earlier), I did not use this data and therefore, 
I was unable to explore influences on help-seeking for cervical cancer symptoms. 
 
                                                          
10
 A version of this chapter has been published elsewhere and can be found in Appendix 4 (Low, Waller, et 
al., 2013) 
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Given my conclusions in Chapter Three, I would expect that higher levels of awareness 
of symptoms of ovarian cancer may lead to a reduced chance of symptom misattribution 
and consequently a reduced time to help-seeking. As the existing data for this chapter 
(collected in 2009, prior to the commencement of my PhD) included awareness of 
symptoms and anticipated help-seeking for hypothetical symptoms of ovarian cancer, I 
was able to test the relationship between awareness of symptoms and anticipated time 
to help-seeking. As discussed in the previous chapter, before awareness can be 
increased, current levels of awareness must be established.  
 
6.1.2 Existing literature on ovarian cancer symptom awareness 
As mentioned above, higher symptom awareness may play a part in time to help-
seeking for symptoms of ovarian cancer, although in Chapter Three I only found the 
effects of this in actual help-seeking, and not in intention to seek help. Nevertheless, 
given that the area is under-researched, and that there is evidence that symptom 
awareness may influence actual help-seeking for symptoms of ovarian cancer and 
intention to seek help for other cancers (for example, Quaife et al., 2014), it is worth 
investigating this relationship. 
 
To my knowledge, there was very little literature that had explored awareness of 
symptoms of ovarian cancer, and none that had done so in the UK, prior to the 
undertaking of the study reported here. The two studies that I did find were both 
published in the US (Cooper, Polonec, Stewart, & Gelb, 2013; Lockwood-Rayermann, 
Donovan, Rambo, & Kuo, 2009). Since a version of this chapter has been published, 
however, one study was published in the UK (Brain et al., 2014). 
 
Lockwood-Rayermann et al. (2009) surveyed 1,211 US women in 2006 to determine 
their awareness of ovarian cancer, including symptoms. They found that very few 
women felt familiar with the symptoms (15%). Women were most familiar with ‘pelvic 
and/or abdominal swelling, bloating and/or feeling of fullness’ (47%), ‘ongoing unusual 
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fatigue’ (36%), and ‘unexplained weight gain or weight loss’ (36%). Women were least 
familiar with ‘unexplained changes in bowel habits’ (28%) and ‘frequency and/or urgency 
of urination in the absence of an infection’ (26%). However, women were prompted, as 
they were presented with symptoms and asked to identify them. Unprompted awareness 
may have been lower still. 
 
In Chapter Three, I discussed the focus group study findings presented by Cooper et al. 
(2013). A second study was published using data from the same women, collected at 
the same time. Although, again, all five gynaecological cancers were investigated, I 
have only discussed the findings related to ovarian cancer here. Reflecting Lockwood-
Rayermann et al.'s (2009) findings, Cooper et al. (2013) found that the majority of 
women in the focus groups had heard of ovarian cancer, although overall, women were 
mostly unaware of all of the symptoms. Overall then, prior to the commencement of this 
study, the existing research indicated that awareness was generally low. 
 
In a similar fashion to Lockwood-Rayermann et al.'s (2009), Brain et al. (2014) surveyed 
1043 Welsh women about their knowledge of ovarian cancer (the findings relating to 
help-seeking have been discussed in Chapter Three), asking them to identify symptoms 
from a list. The mean awareness score was 6.85 of the 11 symptoms investigated. 
Women were most aware of abdominal bloating (72%), increased abdominal size (69%) 
and back pain (68%) and least aware of difficulty eating (36%), and a change in bladder 
habits (32%). Interestingly, these levels of awareness were considerably higher than 
those reported by Lockwood-Rayermann et al.'s (2009). This is likely to be a result of 
varying levels of awareness in these different populations, which may also explain the 
differences in levels of awareness for individual symptoms. Low awareness of urinary 
frequency does seem to be a particular problem in both samples, however.  
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6.1.3 Existing literature on ovarian cancer risk factor awareness 
A number of factors may increase the chances of developing ovarian cancer, and just 
over a fifth (20.2%) of incident ovarian cancer cases in the UK may be attributable to 
lifestyle and environmental factors (Parkin et al., 2011). For example, there is evidence 
that the risk of ovarian cancer increases along with an increase in BMI (Reeves et al., 
2007) and with smoking status (Gram et al., 2012). Some research has suggested a link 
between talcum powder use and increased risk of ovarian cancer, although this 
relationship is not clear (Huncharek, Geschwind, & Kupelnick, 2003; Wu, Pearce, 
Tseng, Templeman, & Pike, 2009). 
 
Evidence also suggests a role for increasing number of ovulatory cycles (or factors 
which reflect longer exposure to ovulation) and increased ovarian cancer risk (Cramer, 
2012). For example, rates of ovarian cancer have been found to be higher in women 
who are nulliparous or have fewer children (Merritt et al., 2013), have undergone IVF 
(van Leeuwen et al., 2011) and hormone replacement therapy (HRT) (Tsilidis et al., 
2011). The increased risk associated with HRT may increase the risk of ovarian cancer 
in menopausal and post-menopausal women (along with the increase in incidence with 
age (94% of incident cases registered in 2011 in women aged ≥45 years, compared to 
just 11% (n=632) in women under 45 years (Office for National Statistics, 2013a)). 
 
Unsurprisingly, given the known risks associated with inheriting the BRCA1 and BRCA2 
genetic mutations for both breast and ovarian cancer (Welcsh & King, 2001), having a 
close relative who has also had ovarian cancer is a risk factor for developing the disease 
(Stratton, Pharoah, Smith, Easton, & Ponder, 1998), as is having a history of breast 
cancer (Bergfeldt et al., 2002). Finally, conditions that cause damage to the reproductive 
system have also been associated with an increase in risk of developing ovarian cancer, 
such as ovarian cyst removal surgery and endometriosis (Borgfeldt & Andolf, 2004). 
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Although there is a large body of literature exploring risk factors associated with ovarian 
cancer, the literature on awareness of these risk factors is small. In fact, I could only find 
one paper that had explored this area. In 2010, Fallowfield et al. asked a large sample of 
women (n=21,715) aged 50-74, who were participating in the UKCTOCS trial (UCL and 
UCLH NHS Foundation Trust, 2008, see Chapter One) to complete a number of 
measures exploring awareness of ovarian cancer risk factors, anxiety levels, general 
emotional health, and sexual activity. A high percentage of women were aware of the 
association between a family history of ovarian cancer and increased risk of the disease 
(87%), but not between a family or personal history of breast cancer and risk of ovarian 
cancer (27% and 20% respectively). Less than half of the women in this study were 
aware of the increased risks associated with being post-menopausal (38%), nulliparous 
(14%) or having had a benign ovarian cyst (20%). The authors also explored awareness 
of having refrained from breast-feeding (6.2%) and awareness of false risk factors, such 
as having had an abnormal smear (37%) and having taken the contraceptive pill (26%). 
Fallowfield et al. (2010) reported that awareness was higher in women who were 
younger, more educated and who had had more than one relative with breast cancer, 
versus none. 
 
Whilst the study described above is useful in understanding levels of risk factor 
awareness for ovarian cancer, the authors do acknowledge that these levels of 
awareness may have been inflated by the pre-recruitment information provided to these 
participants, as part of their participation in the UKCTOCS trial. Further, the women 
were given a list of the potential risk factors, and were consequently prompted for their 
answers. As evident in my previous chapter, levels of recognition of risk factors are 
considerably higher than levels of recall. However, the sample was similar to that of the 
general UK population, and may reflect at least the risk factors which were most 
commonly endorsed, if not the level to which they were endorsed. 
 
146 
 
6.1.4 The current study 
As described above, there has been very little research which has attempted to explore 
awareness of ovarian cancer symptoms or risk factors in a population-representative 
sample of English women. None of the research published on symptom awareness prior 
to the undertaking of this study was conducted in the UK. Although I did identify one 
study which had explored awareness of risk factors, the study sample consisted of 
women who were participating in a larger trial exploring the feasibility of screening for 
ovarian cancer, and may have consequently received information which could have 
increased their awareness above what would have normally been expected. 
 
The present study aimed to explore awareness of both symptoms of and risk factors for 
ovarian cancer in a population representative sample of English women. Both open and 
closed questions were used to measure recall and recognition respectively. 
 
6.1.5 Hypotheses 
Given the literature discussed in Chapter Three and in section 6.1, here, I tested the 
following hypotheses: 
i. Risk factor awareness will be low 
ii. Symptom awareness will be low 
iii. Lower symptom awareness, a personal experience of cancer or having known 
someone close with cancer (such as a close friend, partner or family member), 
and more perceived practical barriers to help-seeking will be associated with a 
longer anticipated time to help-seeking for symptoms of ovarian cancer 
 
I was unsure of the direction of the relationship between age and help-seeking and fear 
(measured here as an emotional barrier to help-seeking) and help-seeking due to 
inconsistent or inconclusive previous findings. Consequently I made no specific 
hypotheses with regard to these variables. As the incidence of ovarian cancer begins to 
rise at around age 45 (Cancer Research UK, 2013c), I tested the above hypotheses 
both in a population-based sample of women aged 16 years and over, and in a 
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subgroup of women aged ≥45. Finally, the relationship between awareness of risk 
factors for ovarian cancer and time to help-seeking has not been explored in the 
literature. As such, although I explored this relationship below, I had no hypotheses 
relating to this factor. 
 
6.2 Method 
6.2.1 Recruitment 
As part of the Target Ovarian Cancer Pathfinder Study (Target Ovarian Cancer, 2009), 
females aged ≥16 were recruited via Synovate (a global market research company) 
using random digit dialling. Quotas (i.e. target recruitment numbers for specific 
demographic groups) were used to achieve a population-based sample of women from 
different age groups, regions and working statuses. 1000 women11 were interviewed 
over the telephone by Synovate interviewers, using landlines only. Respondents were 
interviewed for approximately 15 minutes using the Ovarian Cancer Awareness 
Measure (Ovarian CAM) (Simon, Wardle, et al., 2012). The Ovarian CAM is a site-
specific version of the generic Cancer Awareness Measure (Stubbings et al., 2009). The 
Ovarian CAM was specifically designed and validated to be used for both telephone and 
face-to-face surveys (Simon, Wardle, et al., 2012); in the current study, telephone 
interviews were conducted as opposed to face-to-face interviews as this allowed faster 
and relatively inexpensive data collection. 
 
The study was exempt from ethical approval as no identifiable information was collected 
from participants, and data were completely anonymous. This is in line with the UCL 
Research Ethics Committee Exemptions guidelines (UCL Research Ethics Committee, 
2013). See page 121. 
 
                                                          
11
 Synovate does not record the number of people approached in order to fulfill quota samples. 
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6.2.2 Measures 
6.2.2.1 Awareness of ovarian cancer symptoms 
Respondents were asked one open question and a set of closed questions to measure 
awareness of ovarian cancer symptoms. The open question (which was asked before 
the closed question to avoid bias) measured recall and read: “There are several warning 
signs and symptoms of ovarian cancer. Please name as many as you can think of”. The 
closed questions measured recognition and read: “The following may or may not be 
warning signs for ovarian cancer. We are interested in your opinion”. Respondents were 
read a list of 10 known symptoms of ovarian cancer (see Table 6.1) taken from the 
Department of Health’s (DoH) Key Messages for ovarian cancer for health professionals 
(Department of Health, 2009). Response options to each symptom were ‘yes’, ‘no’ and 
‘don’t know’. If participants refused to answer, this was recorded as ‘missing’. Each open 
question response was dichotomised into ‘recalled’ (mentioned) or ‘not recalled’ (not 
mentioned) and each closed question response was dichotomised into ‘recognised’ 
(response ‘yes’) or ‘not recognised’ (responses ‘no’/‘don’t know’).  
 
6.2.2.2 Awareness of ovarian cancer risk factors 
Awareness of risk factors was measured in the same way as symptom awareness, with 
both open and closed questions. The open question read: “What things do you think 
affect a woman’s chance of developing ovarian cancer?” with the aim of again, eliciting 
recalled knowledge. The closed question, again used to measure recognition of risk 
factors listed 12 known risk factors for developing ovarian cancer (see Table 6.3), which 
were generated using the scientific literature, cancer information materials and websites 
available at the time the measure was developed (Simon, Wardle, et al., 2012) and 
asked participants to identify those they believed were risk factors with the question, 
“These are some things that can increase a woman’s chance of developing ovarian 
cancer. How much do you agree that each of these can increase the chance of 
developing ovarian cancer?”. Response options were ‘strongly disagree’, ‘disagree’, ‘not 
sure’, ‘agree’, and ‘strongly agree’. As with the symptoms data, each open question 
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response was dichotomised into ‘recalled’ (mentioned) or ‘not recalled’ (not mentioned) 
and each closed question response was dichotomised into ‘recognised’ (responses 
‘agree’ or ‘strongly agree’) or ‘not recognised’ (responses ‘not sure’, ‘disagree’ or 
‘strongly disagree’). Again, refusal to respond was recorded as ‘missing’. 
Participants were given a score of ‘1’ for each recognised or recalled symptom or risk 
factor, otherwise they were given a score of ‘0’. Scores were summed to give overall 
scores for risk factor recall and recognition (range 0-12 for both) and symptom recall and 
recognition (range 0-10 for both). The full list of ovarian symptoms and risk factors 
included can be seen in Tables 6.1 and 6.2, respectively. For both the open risk factor 
and symptom questions, responses were recorded verbatim and coded into a framework 
by Synovate interviewers. Coding accuracy was verified by a separate Synovate team 
who specialise in coding interviews. For ease of analysis, and to allow comparisons 
between numbers of recalled and recognised symptoms and risk factors, I have only 
reported those responses from the open questions that corresponded with those from 
the closed questions. 
 
6.2.2.3 Barriers 
Respondents were read a list of ten barriers and the question, “Sometimes people put 
off going to see the doctor, even when they have a symptom that they think might be 
serious. These are some of the reasons people give for delaying. Could you say if any of 
these might put you off going to the doctor?”`. Responses were dichotomised into ‘yes’ 
(responses ‘Yes sometimes’/‘Yes often’) and ‘no’ (responses ‘Don’t know’/‘No’). As 
previously described (Robb et al., 2009), barriers were grouped into emotional, service 
and practical barriers (Table 6.4). Responses were summed to give total scores for each 
group of barriers. Scores ranged from 0-4 for emotional barriers, 0-3 for service barriers 
and 0-3 for practical barriers. 
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6.2.2.4 Anticipated time to help-seeking 
For each symptom from the closed list, respondents were asked, ‘how soon would you 
contact your doctor to make an appointment to discuss it?’. There were ten response 
options on an ordinal scale ranging from ‘1-3 days’ to ‘never’. For ease of analysis I 
coded each time period in ascending order from 0 to 10 to measure anticipated time to 
help-seeking. I dichotomised the sample into those who anticipated waiting more or less 
time before help-seeking for each symptom. To do this, I calculated the median 
anticipated time to help-seeking for each symptom (using the scale from 0-10) and then 
dichotomised responses into a ‘longer anticipated time to help-seeking’ (>median; 
score=1) and a ‘shorter anticipated time to help-seeking’ (≤median; score=0). I used a 
dichotomous, as opposed to a continuous variable as the increments in time periods 
were unequal, making it an ordinal rather than an interval scale. 
 
Dichotomising the sample in this way allowed me to identify those women who were 
likely to wait longer than average before seeking help for each of the symptoms, rather 
than focusing on the length of time to help-seeking, as I acknowledge that responses 
may not reflect actual responses to symptoms. Further, I discussed the benefits of 
avoiding using a specific time cut-off in Chapter Three. Scores for each symptom (1 or 
0) were summed to create a scale of anticipated time to help-seeking (range 0-10). A 
higher score indicated that the respondent would anticipate waiting longer than the 
median before seeking help for a greater number of symptoms.  
 
6.2.2.5 Participant characteristics 
Age was measured as a continuous variable. I created a subgroup of women aged ≥45 
years for analysis who were at high risk of developing ovarian cancer due to their age 
(incidence of ovarian cancer begins to increase at this age (Cancer Research UK, 
2013c)). SES was categorised into low (score=0-1), mid (score=2) and high (score=3) 
based on a combined index incorporating education level, car ownership and home 
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ownership. This index was used as it is recommended for a sample including older, 
retired respondents (Wardle et al., 1999). One point is given for owning a home, having 
a car and having any formal education (score range 0-3).  
 
As only 7.1% of respondents were non-White, these ethnicities were grouped together 
and the sample was dichotomised into ‘White’ or ‘non-White’. Respondents were asked 
whether they had known a close family member, close friend or partner with cancer. 
Responses were dichotomised into ‘yes’ (score=1) or ‘no/don’t know’ (score=0) and 
summed to give a score of ‘cancer experience’ (range 0-3). Respondents were also 
asked whether they had experienced cancer themselves (‘no’ or ‘yes’). 
 
6.2.3 Analyses 
Data were analysed using SPSS version 19 (IBM Corporation, 2010). I carried out 
bivariate analyses (using ANOVA, t-tests and correlations) to determine those 
demographic variables which were significantly associated with either risk factor or 
symptom awareness. To select variables for the multivariate models, I first used 
bivariate analyses and analysis of variance (ANOVA) to test for significant associations 
between anticipated time to help-seeking and my hypothesised predictor variables as 
well as demographic factors (reported below). 
 
Demographic variables (SES, ethnicity and age) and variables that were significantly 
associated with anticipated time to help-seeking were entered into two multiple linear 
regressions (using the sample as a whole and the subgroup of women aged ≥45 years) 
to identify significant independent predictors of score on the scale.  
 
6.2.3.1 Weighting  
Small sampling weights were provided by Synovate and were applied to adjust for non-
response bias in terms of government office region, age and occupational status to 
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achieve a population-based sample of women. Weighting had the biggest effect on the 
25-38 age group, but even this effect was very small. Although there were effects of 
weighting observed in the other demographic characteristics, these effects were all 
smaller than 1% (see Table 6.1 for the weighted and unweighted sample 
characteristics). 
 
6.2.3.1 Missing data  
Despite the option to refuse to answer for each of the questions in the Ovarian CAM, 
there were amount small amounts of missing data for some of the variables. The highest 
amount of missing demographic data (3%) were in the homeowner variable (which was 
used to create the SES variable). The other two variables used to create the SES 
variable were also missing small amounts of data (both the education and homeowner 
variables were missing 2% of data). For the time to help-seeking questions, the biggest 
amount of data were observed when women were asked about how long it would take 
them to seek help for passing more urine than usual (4.6%), although all of the 
questions were missing small amounts of data. There were no missing data for any of 
the closed symptom or risk factor questions, any of the emotional, service or practical 
barrier questions or age.  
 
As with the missing data observed in Chapter Five, where a case was missing data, I 
excluded that case from any analyses in which the missing value would have been 
required. Again, given the small amount of missing data it is unlikely that this would have 
affected my findings. 
 
6.2.3.2 Parametric Assumptions 
Data were tested for normality and homogeneity of variance. As the skewness and 
kurtosis of the outcome variable (number of symptoms participants anticipated waiting 
longer for) were both within normal distribution ranges (-1 – 1+), linear regressions were 
appropriate here. 
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6.3 Results 
6.3.1 Participant Characteristics 
The sample consisted of 1000 women. The mean (M) age of the women who 
participated was 47 years (range=16-91, SD=18.56). Most respondents were White 
(93%) and around half had a high SES (54%). Although, as in Chapter Five, non-White 
women were under-presented here, compared to the female population in England and 
Wales (7.1% versus 12%, respectively) (Office for National Statistics, 2014b), the 
proportion of women with a high SES was similar to the levels of British people who fall 
into the higher ABC1 category according to the NRS social grading system (56%) (Ipsos 
MediaCT, 2009; National Readership Survey, 2007). As with the data in Chapter Five, 
the differences observed between the sample here and the British population are likely 
to be a result of the application of weights to the whole survey sample, and not just 
those that completed the Ovarian CAM module. 
 
Almost two-thirds of the women (63%) in the sample overall had known someone close 
with any type of cancer, but few (5%) had experienced cancer themselves. The 
subgroup of women aged ≥45 years (n=510) had a mean age of 62 years (range 45-91). 
Again, most were White (97%) and high SES (60%). Nearly three quarters (72%) had 
known someone with cancer, and 8% had had cancer themselves. See Table 6.1 for 
participant characteristics. 
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Table 6.1 Sample Characteristics (Weighted/Unweighted n=1000) 
  Unweighted   Weighted 
  N (%*)   N (%*) 
Age           
     16-24 154 (15.4)   150 (15.0) 
     25-39 231 (23.1)   244 (24.4) 
     40-59 320 (32.0)   312 (31.2) 
     60 + 295 (29.5)   294 (29.4) 
Age Groups           
     ≥45 515 (51.5)   510 (51.0) 
     <45 485 (48.5)   490 (49.0) 
Ethnicity           
     White 928 (92.8)   928 (92.8) 
     Non-white 71 (7.1)   71 (7.1) 
Socioeconomic status           
      High 513 (51.3)   515 (51.5) 
      Mid 325 (32.5)   324 (32.4) 
      Low 108 (10.8)   108 (10.8) 
Close experiences of cancer         
     Someone close 633 (63.3)   632 (63.2) 
     Personal experience 49 (4.9)   49 (4.9) 
* where %<100%, this is due to missing data 
 
 
6.3.2 Symptom Awareness 
Symptom recall was low, with 58% (n=582/1000) of the whole sample and 54% 
(n=275/510) of the subgroup of women aged ≥45 years unable to recall any of the 10 
symptoms listed in Table 6.2 (M=0.6/10 for the whole sample, SD=0.8 and M=0.6/10, 
SD=0.9 in the older subgroup). ‘Pain in the abdomen’ was the most commonly recalled 
symptom in both the sample overall and in the subgroup (24% and 26% respectively). 
‘Feeling full’ was the least recalled overall (<1%) and in the subgroup it was ‘difficulty 
eating on most days’ (<1%). Recognition scores were much higher with almost all (99%) 
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able to identify at least one of the 10 symptoms in the overall sample (M=6.3/10, 
SD=2.2) and in the subgroup (M=6.1/10, SD=2.2). Recognition was lowest for ‘difficulty 
eating’ (25% in the overall sample; 21% in the subgroup) and highest for ‘pain in pelvis’ 
(87% in the overall sample; 84% in the subgroup) (Table 6.2). 
 
White women were able to recognise significantly more symptoms than non-White 
women (M=6.35/10, SD=2.16 versus M=5.65/10, SD=2.35, p<0.01). Women from a 
higher SES knew significantly more symptoms when unprompted (M=0.69/10, SD=0.63) 
than women from a mid-level SES (M=0.43/10, SD=0.71) and women from a low SES 
(M=0.42/10, SD=0.64) (F(2, 943)=13.14, p<0.001). There were no other significant 
demographic differences in symptom awareness. 
 
Table 6.2. Recalled and recognised ovarian cancer symptoms 
  
Overall sample Subgroup* 
(n=1000) (n=510) 
Recalled Recognised Recalled Recognised 
n (%) n (%) n (%) n (%) 
Persistent pain in abdomen 238 (24) 837 (84) 132 (26) 409 (80) 
Persistent pain in pelvis 96 (10) 867 (87) 55 (11) 431 (84) 
Persistent bloating 91 (9) 683 (68) 57 (11) 329 (65) 
Extreme fatigue 35 (4) 703 (70) 17 (3) 359 (70) 
Increased abdominal size 28 (3) 790 (79) 19 (4) 393 (77) 
Back pain 28 (3) 706 (71) 21 (4) 368 (72) 
Changes in bowel habit 24 (2) 569 (57) 16 (3) 280 (55) 
Passing more urine than usual 9 (<1) 450 (45) 4 (<1) 205 (40) 
Feeling full persistently 6 (<1) 450 (45) 5 (1) 253 (50) 
Difficulty eating on most days 8 (<1) 247 (25) 3 (<1) 105 (21) 
*Subgroup of women aged ≥45 years 
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6.3.3 Risk factor Awareness 
Risk factor recall was lower than symptom recall both in the overall sample and in the 
subgroup of women aged ≥45 years, with 80% (n=796/1000) of the whole sample and 
84% (n=427/510) of the subgroup of women aged ≥45 years unable to recall any of the 
12 risk factors listed in Table 6.3 (M=0.2/12 for the whole sample, SD=0.5 and 
M=0.2/12, SD=0.4 in the older subgroup). Recall was highest for the risk factor ‘having a 
close relative with ovarian cancer’ both in the overall sample and in the subgroup (15% 
and 14% respectively), closely followed by ‘being a smoker’ (recalled by 14% of the 
whole sample and 10% of the subgroup). Women were least aware of the risk factor 
‘having endometriosis’ in both the overall sample and the subgroup, with no women 
recalling this risk factor in both. 
 
As with knowledge of symptoms, awareness of risk factors was considerably higher 
when women were prompted. Almost 100% (97%, n=970/1000) of the total sample and 
96% (n=489/510) of the subgroup of women recognised at least one of the risk factors 
listed in the Ovarian CAM measure. On average, women recognised just under half of 
the risk factors (M=5.1/12, SD=2.5 in the overall sample and M=4.8/12, SD=2.5 in the 
subgroup). Recognition was lowest for ‘going through the menopause’ (16% in the 
overall sample; 14% in the subgroup) and ‘using talc on genitals’ (16% in the overall 
sample; 19% in the subgroup). In both the overall sample and the subgroup, women 
most commonly recognised ‘having a close relative with ovarian cancer’ (77% and 69% 
respectively).  
 
Women from a higher SES knew significantly more risk factors (M=0.29/12, SD=0.55) 
than women from a mid SES (M=0.19/12, SD=44, p<0.05), when unprompted. There 
were no other significant demographic differences in risk factor awareness.  
 
157 
 
Table 6.3. Recalled and recognised ovarian cancer risk factors 
  
Overall sample Subgroup* 
(n=1000) (n=510) 
Recalled Recognised Recalled Recognised 
n (%) n (%) n (%) n (%) 
Having a close relative with ovarian 
cancer 
154 (15) 771 (77) 70 (14) 3560 (69) 
Being a smoker 141 (14) 661 (66) 52 (10) 320 (63) 
Being overweight 37 (4) 551 (55) 16 (3) 279 (55) 
Not having children 22 (2) 197 (20) 11 (2) 96 (19) 
History of breast cancer 12 (1) 529 (53) 2 (<1) 265 (52) 
Using HRT 8 (<1) 384 (38) 4 (<1) 183 (36) 
Having ovarian cysts 5 (<1) 666 (67) 0 (0) 317 (62) 
Using talc on genitals 2 (<1) 159 (16) 2 (<1) 97 (19) 
Being over 50 3 (<1) 366 (37) 2 (<1) 185 (36) 
Having IVF 6 (<1) 156 (16) 5 (<1) 69 (14) 
Gone through the menopause 3 (<1) 287 (29) 1 (<1) 142 (28) 
Having endometriosis 0 (0) 338 (34) 0 (0) 163 (32) 
*Subgroup of women aged ≥45 years 
  
6.3.4 Barriers 
Respondents endorsed few barriers to help-seeking (M=2.2/10, SD=2.2 for the sample 
overall; M=1.6/10, SD=1.8 for the subgroup). A quarter of the overall sample (26%) 
anticipated no barriers, whilst the figure was higher (34%) for women aged ≥45. The 
most endorsed barrier was worry about what the GP might find (34% for the sample 
overall; 29% for the subgroup) and the least endorsed was difficulty arranging transport 
to the GP (5% for the sample as a whole; 4% for the subgroup) (Table 6.4). 
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Table 6.4.  Endorsement of barriers to seeking medical help for a symptom that might be 
serious 
Barrier 
Overall (n=1000) 
Subgroup** 
(n=510) 
n %* n %* 
Emotional barriers     
    Worry what the GP might find 343 (34) 145 (29) 
    Too scared 209 (21) 77 (15) 
    Too embarrassed 138 (14) 38 (8) 
    No confidence in talking to GP about symptom 127 (13) 37 (7) 
Practical barriers     
    Too busy 296 (30) 102 (20) 
    Too many other things to worry about 267 (27) 116 (23) 
    Difficult to arrange transport to GP 48 (5) 22 (4) 
Service barriers     
    Difficult to make an appointment with GP 315 (32) 135 (27) 
    Wasting GP time 303 (30) 120 (24) 
    GP difficult to talk to 131 (13) 44 (9) 
*Respondents were able to endorse more than one barrier  
** Subgroup of women aged ≥45 years 
 
6.3.5 Anticipated time to help-seeking 
Median anticipated time to help-seeking varied by symptom. Women anticipated waiting 
the longest for extreme fatigue, persistent bloating, back pain, persistently feeling full 
and changes in bowel habit. The shortest anticipated time was for persistent abdominal 
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pain. Patterns were the same for the overall sample and the subgroup (Figure 6.1 shows 
median time to help-seeking by symptom for the sample overall). 
 
 
Figure 6.1 Median anticipated time to help-seeking for symptoms of ovarian cancer 
 
In the sample as a whole, bivariate analyses showed that women from a White ethnic 
background anticipated taking longer to seek help for more symptoms than women from 
a non-White ethnicity (M=3.93, SD=3.28 versus (vs.) M=2.83, SD=2.72, p<0.01). This 
was also true in the subgroup of older women (M=4.00, SD=3.25 vs. M=2.04, SD=1.83, 
p=0.001). Analysis of Variance revealed that there was also significant difference in 
anticipated time to help-seeking (F(2,943)=8.55, p<0.001) between women from 
different SES groups. Post-hoc analysis using the Tukey HSD test showed that women 
from a high SES (M=4.28, SD=3.32) would wait longer for significantly more symptoms 
than women from a mid SES (M=3.49, SD=3.12) or a low SES (M=3.20, SD=3.21). 
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There were also significant differences between SES groups in the subgroup of women 
aged ≥45 years (F(2,462)=11.04, p<0.001). The post-hoc analyses showed the same 
pattern, with women from a high SES anticipating waiting longer for more symptoms 
(M=4.53, SD=3.30) than women from a mid SES (M=3.41, SD=3.00) or a low SES 
(M=2.65, SD=2.99). 
 
Finally, there was a significant correlation between number of symptoms women 
anticipated waiting longer for and both number of service barriers (r(998)=.14, p<0.001) 
and practical barriers (r(998)=.20, p<0.001) in the sample as a whole, and between the 
number of service barriers (r(508)=.21, p<0.001), practical barriers (r(508)=.21, p<0.001) 
and emotional barriers (r(508)=.11, p<0.05) in the subgroup of women aged ≥45 years. 
Symptom knowledge (recalled or recognised), risk factor knowledge (recalled or 
recognised) and cancer experience (either personal or experience with someone close) 
showed no association with time to help-seeking in either the sample as a whole or in 
the subgroup. 
 
The regression model for the sample overall explained 6% of variance in scores on the 
scale of anticipated time to help-seeking (Adj R2=.06, F(5,940)=13.53, p<.001). 
Endorsing more practical and service barriers and having a higher SES were significant 
predictors of a higher score on the scale (i.e. longer anticipated time to help-seeking for 
more symptoms). The standardised beta was largest for practical barriers (beta=.16, 
p<.001) and slightly smaller for SES (beta=.12, p<.001) and service barriers (beta=.10, 
p<.01), suggesting that perceiving more practical barriers to help-seeking has the 
strongest influence on anticipated time to help-seeking.  
 
The regression model for the subgroup explained 11% of the variance in scores on the 
scale of anticipated time to help-seeking (Adj R2=.11, F(6,458)=10.56, p<.001). 
Endorsing more practical and service barriers, having a higher SES and being of a 
White ethnicity all significantly predicted a higher score. The standardised beta was 
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largest for SES (beta=.22, p<.001) and smaller for service barriers (beta=.17, p=.001), 
practical barriers (beta=.13, p<.01) and ethnicity (beta=.12, p<.01), suggesting that, in 
the subgroup of women aged ≥45 years, SES has the strongest influence on anticipated 
time to help-seeking. See Table 6.5 for both regressions. 
 
Table 6.5. Multiple linear regression analyses showing predictors of longer time to help-
seeking 
  Overall sample (n=946)*   Subgroup (n=504)* 
  Beta† S.E. p   Beta† S.E. p 
Constant - - .014   - - .529 
Age .06 .03 .064   .01 .05 .802 
Ethnicity .07 .04 .075   .12 .04 .008 
SES  .12 .05 <.0001   .22 .05 .0001 
Practical Barriers .16 .04 <.0001   .13 .05 .008 
Service Barriers .10 .05 .005   .17 .05 .001 
Emotional Barriers - - -   .04 .05 .413 
†
Standardised *Sample sizes are smaller due to missing data 
Overall sample Adj R
2
=.06, p<.001, Subgroup Adj R
2
=.11, p<.001. 
Note: Ethnicity is a categorical variable, coded as Non-White=0, White=1 and SES is an ordinal 
variable, coded as Low =0, Mid=1 and High=2. 
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6.4 Discussion 
To my knowledge, this study was the first to systematically measure anticipated time to 
help-seeking for ovarian cancer symptoms and to identify variables associated with a 
longer time to help-seeking specifically for this cancer in a UK sample. In Chapter One I 
discussed the importance of early detection of ovarian cancer, which may be achieved 
through prompt help-seeking.  
This is also the first study that has attempted to measure awareness of a 
comprehensive list of ovarian cancer symptoms and risk factors in a UK population and 
to identify those that are more, versus less, well-known. Given the evidence discussed 
in Chapter Three, which showed that misattribution of symptoms and non-recognition of 
symptom seriousness may play a part in a longer time to help-seeking, it is important to 
determine the current levels of awareness in order to identify areas for improvement in 
knowledge. Further, the influence of perceived risk (which may result from awareness of 
risk factors) can be explained by many of the models described in Chapter Two, and 
there is evidence for the effects of this within the literature on help-seeking for female 
cancers (Freidman et al., 2006). As such, it is important to also explore awareness of 
risk factors in order to identify areas for improvement. 
 
Ovarian cancer symptom recall was very low (overall M=0.6/10; subgroup M=0.6/10), 
whereas recognition was considerably higher, reflecting previous findings using recall 
and recognition to measure gynaecological cancer symptom awareness, including the 
findings reported within Chapter Five and findings within other cancer groups (Robb et 
al., 2009; Simon, Juszczyk, et al., 2012; Waller et al., 2009). Nevertheless, on average 
women were still only able to recognise just over half of the symptoms when prompted 
(overall M=6.3/10; subgroup M=6.1/10), a figure that does not seem to have improved 
considerably in the following years (Brain et al., 2014). 
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These findings suggest a need for interventions to increase awareness of symptoms of 
ovarian cancer. Moreover, as symptoms for ovarian cancer can be non-specific 
(Department of Health, 2009; National Institute for Health and Clinical Excellence 
(NICE), 2005) it might be pertinent for any interventions designed to increase awareness 
to focus on the characteristics of the symptoms experienced as well as their presence. 
For example, there is evidence that symptoms such as abdominal pain, pelvic pain, 
bloating, constipation, and increased abdominal size are significantly more severe and 
frequent in women with ovarian cancer than in women in a general clinic population 
(Goff, Mandel, Melancon, & Muntz, 2004). 
 
Symptoms for which the lowest recognition was observed were frequent urination 
(overall=45%; subgroup=40%), feeling full (overall=45%; subgroup=40%) and difficulty 
eating (overall=25%; subgroup=21%). Research suggests that these symptoms (as well 
as abdominal and pelvic pain) are present in earlier stage ovarian cancers (Goff et al., 
2007; Hamilton et al., 2009; Lataifeh, Marsden, Robertson, Gebski, & Hacker, 2005; 
Olson et al., 2001) (although more recent evidence suggests that the specificity of these 
symptoms may be lower than originally thought (Lim et al., 2012)). Consequently 
consideration of these symptoms as potential ovarian cancer symptoms could aid earlier 
diagnoses. That awareness was lowest for these symptoms, then, is concerning. On 
average a GP will only see one case of ovarian cancer every five years (NHS Choices, 
2012b; Office for National Statistics, 1999), which may reduce the likelihood of GP 
consideration of ovarian cancer in a patient presenting with such symptoms. However, if 
awareness were higher in women overall, this could increase the chances of the patient 
herself considering ovarian cancer, and therefore being able to highlight this to her GP 
upon presentation. 
 
Overall risk factor awareness was also not very high in this sample, again with recall 
being much lower than recognition; even when prompted, women were able to identify 
less than half of the risk factors for ovarian cancer (M=5.1, SD=2.5 in the overall sample 
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and M=4.8, SD=2.5 in the subgroup). It was promising, however, that over two thirds of 
the overall sample and the subgroup of women recognised the relationship between 
having had a close relative with ovarian cancer and risk of developing the disease, and 
that, although a much lower proportion of women were aware of this risk factor when 
unprompted (14% and 15% in the overall sample and subgroup respectively), it was the 
most recalled risk factor. Given the evidence that around 10% of ovarian cancer cases 
may be attributable to an inherited genetic susceptibility to the disease (through the 
inherited BRCA1 and BRCA2 genes) (Claus, Schildkraut, Thompson, & Risch, 1996) , it 
is important that women are aware of this risk factor. The genetic, inherited risk of these 
genes in relation to breast cancer has been highlighted in the media recently, with a 
number of celebrities (notably, American film actress Angelina Jolie and UK pop star, 
Michelle Heaton) opting to have mastectomies due to this risk. This has no doubt raised 
awareness of the risk for breast cancer, however, it seems there may be more work to 
be done in raising awareness of the risk for ovarian cancer, although around half of the 
women here did recognise the association between breast and ovarian cancer. 
 
More than half the women here also recognised the risks associated with being a 
smoker, being overweight and having ovarian cysts. Again, however, recall was 
considerably lower for these risk factors. Both smoking and weight are modifiable 
factors, and just under 10% of ovarian cancers have been argued to be attributable to 
tobacco (Parkin et al., 2011), whilst increasing weight has been shown to increase the 
relative risk by 1.14 for each 10 unit increase in BMI (Reeves et al., 2007). These risk 
factors are also applicable to most other cancers (Parkin et al., 2011). Increasing 
awareness of these risk factors, then may encourage women to make healthier lifestyle 
choices to reduce their risk of developing any cancer. 
 
In contrast to my hypothesis, I found no association between symptom awareness and 
anticipated time to help-seeking. This finding does not necessarily mean that symptom 
awareness has no influence on time to help-seeking, however. Symptom awareness 
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may influence attribution or appraisal behaviour (which has been shown to be related to 
time to help-seeking (Macleod et al., 2009)), rather than having a direct relationship with 
time to help-seeking. This is evident within the MPT, described in Chapter Two. Within 
this model, an individual will appraise the change they have detected within their body. It 
is this appraisal process and the success of any self-management techniques 
undertaken which determines whether the individual decides to seek medical attention. 
Although an awareness of cancer symptoms likely plays a part in this appraisal process, 
it is perhaps insufficient to determine help-seeking behaviour in isolation. The 
complexities of this relationship should be explored further to aid understanding of help-
seeking behaviour for ovarian cancer symptoms. 
 
It was promising that women anticipated seeking help quickest for persistent abdominal 
pain as this is one of the three most important symptoms highlighted to health 
professionals in the DoH’s Key Messages on ovarian cancer (Department of Health, 
2009), and has been found in up to 49% of early stage (I/II) invasive epithelial ovarian 
cancer cases (Rossing et al., 2010) (90% of ovarian cancers are this type (Cancer 
Research UK, 2012c)). Previous research exploring symptom presentation in primary 
care found that abdominal pain was one of the most common symptoms reported (Goff 
et al., 2004). Further, women with abdominal pain are encouraged to seek help promptly 
for this symptom (Smith and Anderson, 1985). This finding, taken together with the 
results shown here, suggests that women may feel comfortable presenting with 
abdominal pain and consequently may not anticipate a reason to wait before seeking 
help for this symptom. 
 
Both women in the sample overall and the subgroup at increased risk (those aged ≥45 
years) anticipated waiting the longest for extreme fatigue, persistent bloating, back pain, 
persistently feeling full and changes in bowel habit. All of these symptoms are 
mentioned in the DoH’s Key Messages (Department of Health, 2009), which highlight 
persistent bloating and persistently feeling full as two of the three most important 
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symptoms. Abdominal bloating and loss of appetite (represented here as persistently 
feeling full) have been found to have Positive Predictive Values (PPVs) for ovarian 
cancer of 0.3% and 0.6% respectively. When paired, these two symptoms have a PPV 
of 3.3%, second only to the pairing of loss of appetite and abdominal distension 
(PPV>5%) (Hamilton et al., 2009). Although these PPVs are not high (possibly owing to 
a high frequency of these symptoms in the general population (Agréus, Svärdsudd, 
Nyrén, & Tibblin, 1994; Pitts et al., 2011)), bloating or feeling full have been found to be 
present in over 44% of early stage disease (Rossing et al., 2010). 
 
Further, Olson and colleagues (Olson et al., 2001) found that 71% of ovarian cancer 
patients reported experiencing bloating and/or fullness in the six to twelve months prior 
to diagnosis; similar results to those reported by Goff et al. three years later (Goff et al., 
2004). Consequently, if a patient presents with both symptoms, it may help a GP to 
more accurately either diagnose or refer (particularly if the patient is aged ≥45 years, 
given that these symptoms are more likely to be associated with ovarian cancer with 
increasing age (Cancer Research UK, 2013c)). Encouraging earlier help-seeking for 
these two symptoms specifically, particularly in older women, may impact on diagnoses 
of less advanced disease. 
 
The amount of variance explained by the regression models was relatively small, 
suggesting that there are other factors that are important in anticipated time to help-
seeking. However I did identify some important predictor variables. In the overall sample 
and in the subgroup, more perceived practical barriers predicted a higher score on the 
scale of anticipated time to help-seeking (indicating a longer time to help-seeking for 
more symptoms), supporting previous research exploring help-seeking for ‘generic’ 
cancer symptoms (Simon, Waller, Robb, & Wardle, 2010). In contrast to the findings in 
the latter research, I also found that endorsing more perceived service barriers was a 
significant predictor of a higher score on the scale of anticipated time to help-seeking, 
whereas endorsing more emotional barriers was not. This finding may be due to the low 
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awareness that these symptoms could be indicative of ovarian cancer, leading women 
to assume that these symptoms were not significant enough to merit the difficulty of 
arranging a doctor’s appointment. Further, previous findings in the literature discussed in 
Chapter Three has been inconclusive about the effects of one of the emotional barriers, 
‘fear’. The complex relationship between fear and help-seeking may have influenced the 
findings relating to emotional barriers here. Future research might explore this emotional 
barrier separately. 
 
An interesting finding was that women from lower SES and non-White ethnic groups 
anticipated seeking help earlier for more symptoms of ovarian cancer than those from 
higher SES and White ethnic backgrounds. This finding reflects earlier research 
(Adamson, Ben-Shlomo, Chaturvedi, & Donovan, 2003; Robb et al., 2009) and there is 
evidence that these relationships between ethnicity and SES and                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
help-seeking also apply to actual help-seeking behaviour (Morris et al., 2005). However, 
women from lower SES and non-White ethnic backgrounds are more frequently 
diagnosed with later stage cancer compared to those from higher SES and White 
backgrounds (Downing et al., 2007; Morris et al., 2010; Schwartz et al., 2003).  
 
The disparity in primary care help-seeking and stage of diagnosis between White and 
non-White ethnicities may be a result of GP time to referral and diagnosis (Morris et al., 
2005), which in turn may be a product of the lower ovarian cancer incidence rates 
observed in Asian and Black ethnicities when compared to the White ethnic group 
(National Cancer Intelligence Network & Cancer Research UK, 2009). Ovarian cancer 
cases are rare in primary care (NHS Choices, 2012b; Office for National Statistics, 
1999); if few of those cases are in women of non-White ethnicities, this may lead to a 
much reduced possibility that a GP will even consider an ovarian cancer diagnosis in 
these women even if they present promptly with symptoms. In contrast, however, no 
such difference has been observed in incidence for ovarian cancer between SES groups 
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(National Cancer Intelligence Network, 2009). Consequently, the disparity in SES 
groups warrants further investigation. 
 
6.4.1 Strengths and limitations 
As with Chapter Five, this study was strengthened by the use of a validated tool to 
measure awareness and anticipated help-seeking behaviours. If this tool is utilised in 
future research, it will allow researchers to identify shifts or differences in patterns of 
help-seeking by accurately comparing these data with other time periods or other 
countries. Although the sample was not population representative, data were collected 
from a range of women from different age and demographic groups, and consequently, 
it is likely that the relationships found in the results in the present study would apply to 
the UK population. 
 
A potential limitation of this study is the measurement of help-seeking intention for a 
hypothetical symptom as opposed to actual help-seeking behaviour for an existing 
symptom (the limitations of which I have discussed earlier). A second limitation is that 
questions were asked within the context of ovarian cancer and it is likely that women 
anticipated faster help-seeking than would occur in a real life situation where the 
symptom might not be appraised as a warning sign of cancer. For example, the longest 
median anticipated time to help-seeking was two weeks. However, I limited the impact of 
this issue by looking at median time to help-seeking for each symptom and thus 
explored the relative speed of help-seeking behaviour for each symptom, than the time 
period itself. Further, DoH guidelines for patients (NHS Choices, 2012b) do not give 
advice on how long women should wait before seeking medical help for symptoms 
potentially indicative of ovarian cancer. Although the DoH (Department of Health, 2009) 
and NICE (NICE, 2011) guidelines mention persistency as a key feature for health 
professionals to look for, for a number of symptoms (such as pelvic or abdominal pain, 
abdominal distension and difficulty eating or feeling full quickly), they do not define 
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‘persistency’, therefore making it difficult to say how long women should wait before 
seeking help for these symptoms. 
 
A further limitation applicable to this study was the lack of data relating to the frequency, 
severity or novelty of hypothetical symptoms. As such, I was unable to explore the 
impact of these variables on intention to seek help. Doing so would have been 
interesting, as symptoms that are frequent, severe and novel are more likely to indicate 
ovarian cancer (Department of Health, 2009; Goff et al., 2007, 2004; Macleod et al., 
2009; NICE, 2011). Finally, coding of the open recall items was carried out by Synovate 
researchers, and as some symptoms could potentially be viewed as being similar (for 
example ‘persistent bloating’ and ‘increased abdominal size’), it is possible that there 
was some coding error. This may have resulted in the estimates of knowledge found 
here being too conservative. 
 
Quota sampling was used because it is an efficient and practical method of collecting 
data. However, this method limits the generalisability of the findings. Despite this, the 
study was well-powered and novel and it provides an indication of the factors which may 
influence time to help-seeking, as well as an idea of the relative levels of awareness of 
different ovarian cancer symptoms in a UK female population. 
 
6.4.2 Conclusions 
This study suggests that there is low awareness of ovarian cancer symptoms in this 
population and variation in anticipated help-seeking behaviour for these symptoms. 
Women anticipated waiting longest for persistent bloating and persistently feeling full, 
symptoms which are both associated with ovarian cancer, and have been found in just 
under half of early stage cases.  
Although barriers may be important in predicting help-seeking, there may be more 
important variables involved that were not measured here, or the complexity of the 
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relationship between individual barriers and help-seeking may need to be understood 
further. Consequently, there is a need for more in-depth, exploratory research to identify 
these factors. 
In the next chapter, I have explored responses to symptoms potentially indicative of a 
gynaecological cancer, including ovarian cancer in women who are currently 
experiencing these symptoms. Building on one of the limitations in the present study, I 
also explored responses to symptoms which are frequent and/or severe.  
  
171 
 
CHAPTER SEVEN - EXPERIENCE OF SYMPTOMS INDICATIVE OF 
GYNAECOLOGICAL CANCERS IN UK WOMEN (STUDY 312) 
 
7.1. Introduction 
7.1. Background 
In Chapter Three I discussed the work undertaken by Cooper et al. (2013), who 
explored women’s responses to symptoms across all five of the gynaecological cancers. 
Notably, there were some symptomatic women who had waited years to seek medical 
help or had never done so. One of the main limitations of this study was the lack of a 
complete distinction between women who had hypothesised having a symptom and 
those who actually did. Given the differences in hypothetical and actual help-seeking, it 
may be the case that some of the relationships found were not as applicable in real life. 
It is likely that in the UK, as in the US, there are also many more women who are 
experiencing symptoms who do not currently seek help from their GP. Although these 
symptoms are unlikely to be cancer, encouraging help-seeking could not only increase 
earlier cancer diagnoses, but also aid detection of other potentially treatable conditions.  
 
To my knowledge, there have been no assessments of the population prevalence of 
symptoms encompassing all gynaecological cancers, nor responses to these symptoms 
in women experiencing them in a UK sample. In the studies described in Chapters Five 
and Six, it was made explicit to participants that they were being asked about symptoms 
of ovarian and cervical cancer. This is also true of previous research exploring symptom 
awareness and anticipated help-seeking for cancer symptoms in general (Robb et al., 
2009), and research on awareness of specific cancer types (for example, Forbes et al., 
2011).  
 
  
                                                          
12
 A version of this chapter has been published elsewhere and can be found in Appendix 5 (Low, Simon, 
Waller, Wardle, & Menon, 2013) 
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7.1.1 ‘Symptom’ versus bodily change’ 
Symptoms do not necessarily begin as ‘symptoms’ (i.e. associated with illness or 
disease (Cathcart, Wilson, & May, 2012)), rather as sensations or changes within our 
bodies that may come to be interpreted as such. Hay (2008) offers a clear distinction 
between a ‘sensation’ and a ‘symptom’, describing the former as “felt experience” and 
the latter as a “constructed and socially informed cognitive interpretation that indexes”. 
As discussed, in Chapter Two, this is also the stance that the most recent models 
attempting to explain help-seeking (‘Andersen’s Model’ and the MPT) take; both assume 
that a bodily change is first experienced, before illness is inferred. 
 
However, only those bodily sensations or changes that are attended to may be 
subjected to an interpretive process, and not all sensations are attended to. As 
mentioned previously, bodily sensations are constantly being processed, although the 
vast majority are not processed consciously (Pennebaker, 1982). Even those sensations 
that are processed consciously may be dismissed as part of ‘the everyday’. For 
example, Halkowski (2006) describes ‘the patients’ problem’; i.e. how a person, upon 
experiencing a new sensation or change in their body, may consider whether it is just 
part of the normal, everyday sensations and changes that come with having a body, or 
whether it is a threat to health.  
 
In 2012, Cathcart et al. published the findings of a qualitative study exploring the 
transition from bodily sensation to symptom in catarrh sufferers. They concluded that, at 
the time of help-seeking, a person is not at the beginning of their ‘symptom story’. To 
describe the process of how a sensation becomes a symptom, they devised a ‘symptom 
evolution pathway for physiological body sensations’ (Figure 7.1, below). 
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Figure 7.1 Symptom evolution pathway for physiological body sensations (Cathcart et 
al., 2012) 
 
Zone one describes the existence of a bodily sensation, before a person has become 
consciously aware of it. Zone two describes the period when a person becomes aware 
of their bodily sensation because there has been, or there is a perception that there has 
been, a change. Cathcart described the change from Zone one to Zone two as being 
caused by an awareness of the bodily sensation, which had previously been present 
(Zone one), but inconspicuously so. In his catarrh patients, these changes were 
qualitative (change in the consistency of the mucus), quantitative (change in flow rate) 
and temporal (an increase in the length of time the sensation has persisted). 
 
The transition from Zone two to Zone Three (when the sensation becomes a symptom, 
but one has decided that help is not yet required) occurs when a more sinister, deeper 
meaning is attributed to the changed bodily sensation, which then is perceived to be a 
social inconvenience, frustrating and/or a threat to well-being. Finally, a symptom will be 
deemed to require a response, which Cathcart et al. argue may be passive or active, 
negative or positive and mild, moderate or strong, allowing for individual differences in 
symptom response and external influences. Cathcart et al. conclude that once an 
individual has acknowledged a bodily sensation and deemed it to be in need of action, 
the sensation has become a symptom. 
174 
 
Given the above, it is important when exploring help-seeking (either hypothetical or real) 
not to frame a symptom or symptoms in the context of illness, by using the term 
‘symptom’. In doing so, the individual is moved along the pathway of interpretation of a 
bodily sensation as a symptom. The idea that a symptom does not begin as such is also 
reflected in the MPT (Walter et al., 2012) on page 57. The model (which is discussed in 
more detail in Chapter Two) describes the detection of a ‘bodily change’ and the 
subsequent evaluation that occurs to determine a) whether the change is indeed a 
symptom (i.e. indicative of illness or disease) and, if so, b) does it require medical 
attention.   
 
In attempting to explore and understand how a bodily change or sensation comes to be 
perceived as a symptom (if indeed it does), it is necessary to avoid the term ‘symptom’. 
If we consider the pathways described here, it is clear that by using the term, ‘symptom’, 
a research participant will be ‘moved forward’ in the pathway from bodily sensation to 
symptom, to symptom requiring medical attention. It then becomes impossible to explore 
what influences may have led to that occurrence naturally. 
 
7.1.2 Frequency and Severity of symptoms 
In Chapter Six, I noted that a limitation of the Ovarian CAM was the lack of exploration 
of the impact of frequency and/or severity of the symptoms explored and whether asking 
women about a frequent or severe symptom may have affected the findings in relation to 
anticipated time to help-seeking. It is important to explore this, as there is evidence that 
symptoms which are frequent, severe and novel are more likely to indicate ovarian 
cancer (Department of Health, 2009; Goff et al., 2007, 2004; Macleod et al., 2009; NICE, 
2011). Further, generically, it is advised that, for some symptoms, frequency or severity 
may indicate an increased chance of cancer (Cancer Research UK, 2009). However, to 
my knowledge, there is no published research that has explored the relationship 
between frequency and severity of symptoms and help-seeking behaviour for symptoms 
of gynaecological cancers. 
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7.1.3 The current study 
This is the first study to assess the prevalence of symptoms potentially indicative of a 
gynaecological cancer, the frequency and severity of symptoms, and current help-
seeking behaviour in response to symptoms. Therefore no specific hypotheses were 
made for this study. 
 
7.2. Methods 
7.2.1 Recruitment 
As part of their omnibus survey (which included modules from different contributors, on 
a range of non-health topics) I commissioned the market research agency, TNS Global13 
(London) to approach 2173 women (aged ≥16 years) using stratified random location 
sampling. Women were invited to complete my survey module using Computer Assisted 
Personal Interviewing (CAPI) in the presence of trained interviewers in their own homes, 
in July 2011. Before deciding whether to participate, potential respondents were given 
written information about the study due to the sensitive nature of the questions (see 
appendix 6). The information explained that the survey contained questions about bodily 
changes experienced in the last three months, including changes in the reproductive 
system. It made clear that the module was anonymous and confidential and that 
respondents who decided to take part were free to withdraw at any time. The interview 
was conducted in English and therefore any women who were not fluent in English were 
excluded. The study was approved by the UCL Research Ethics Committee (ref: 
1122/005, see appendix 7). 
 
7.2.2 Measures 
7.2.2.1 Participant characteristics 
Respondents were classed as higher or lower SES (A, B, C1 vs. C2, D, E categories) 
using the National Readership Survey social grading system (National Readership 
                                                          
13
 www.tns-ri.co.uk 
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Survey, 2007, described in detail in Chapter Five) as is the convention in the literature 
(for example, Waller et al., 2009). Further, by dichotomising the sample in this way, I 
was able to analyse data from participants in manual and non-manual occupations 
separately. Ethnicity was dichotomised into ‘White’ or ‘non-White’, with White, non-
British women included in the ‘White’ category. It was a requirement of participation that 
women must possess a level of English adequate to understand the survey. I collected 
data on exact age at the time of completing the survey, and dichotomised age at 45 
years, because 85% of all new cases of gynaecological cancers in the UK are in women 
aged ≥45 years (Cancer Research UK, 2012g, 2013b, 2013c, 2013d, 2013e). 
 
7.2.2.2 Symptom reporting 
Women were presented with a list of 13 symptoms (see Table 7.2 in the ‘Results’ 
section for the full list) potentially indicative of a gynaecological cancer (sourced from 
NHS Choices (NHS Choices, 2013c)), and asked, “In the past three months, have you 
experienced any of the following [symptoms]? (please answer each item with ‘yes’, or 
‘no’. If you are not sure, or if the item does not apply to you, answer ‘no’)”. A three month 
reporting time-frame was selected as some symptoms could only be detected following 
at least two menstrual cycles (for example inter-menstrual bleeding). In the analyses, it 
was not possible to stratify symptoms by gynaecological cancer type as many of the 
symptoms of these five gynaecological cancers overlap.  
 
7.2.2.3 Symptom frequency and severity 
Respondents reporting a symptom were asked, “Please tell us (as far as you remember) 
how often you experienced [symptom] in the past three months”. Response options 
included, ‘Once’, ‘twice’ (both recoded as ‘infrequent’) ‘several times’ and ‘all the time’ 
(both recoded as ‘frequent’).  They were then asked: “Using the 5-point scale below, 
please tell us how bad the [endorsed symptom] was on the worst day you had it”. If it 
was as bad as you could imagine it could be, score 5. If it was not bad at all, score 1. 
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Please remember you can score any number from 1 to 5”. Reponses were recoded into 
‘not severe’ (scores 1-3) or ‘severe’ (score 4 or 5). The frequency and severity questions 
were repeated for each symptom the respondent reported. For some analyses, I divided 
respondents into two groups: i) with a symptom that was severe (score 4 or 5), frequent 
(‘several times’ or ‘all the time’) or both, and ii) with a symptom that was neither frequent 
nor severe (see Figure 7.2). These questions were similar to those used in other studies 
exploring frequency and severity of symptoms potentially indicative of a cancer (for 
example, Goff et al., 2004). 
 
Figure 7.2 Participant groups by frequency and severity of symptoms 
  Not severe Severe Infrequent Frequent 
Not severe - - Group I Group II 
Severe - - Group II Group II 
Infrequent Group I Group II - - 
Frequent Group II Group II - - 
 
 
7.2.2.4 Help-seeking 
To measure help-seeking, I asked, “Please tell us from the following what, if anything, 
you did about your [symptom]”. Response options were: seeking advice from a 
pharmacist (chemist); a practice nurse; a GP; going to A&E (the hospital emergency 
department); asking for advice from a friend/relative; looking for advice on the internet; 
asking/looking for advice somewhere else; using an own remedy/treating it themselves; 
and waiting to see if it went away/got worse. For each response option, respondents 
answered ‘Yes’ or ‘No’. Women were only asked about help-seeking for one randomly 
computer system-selected symptom, referred to here as the ‘index symptom’. The study 
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was designed in this way to avoid the survey becoming so time-consuming that it would 
be off-putting to participants. A copy of the full survey can be seen in Appendix 6. 
 
7.2.3 Analyses 
Data were analysed using SPSS version 18 (IBM Corporation, 2009). To assess 
demographic differences between survey responders and non-responders, I used t-tests 
and χ2 tests. I used χ2 tests to identify significant demographic differences in symptom 
reporting and group differences in help-seeking behaviour. I did not perform any 
regression analyses on the help-seeking data in this study as the small group sizes 
would mean that these analyses would likely be underpowered (Field, 2009). 
 
7.2.3.1 Weighting  
Weights for the data were provided by TNS. Data were weighted through an interlocking 
matrix by region (North/Midlands/South), age (16-24; 25-44; 45-64; ≥65 years) and 
social grade (ABC1/C2/DE) to achieve a nationally representative sample of women in 
the UK. Weighting had the biggest effect on SES (48% fell into the ABC1 group in the 
unweighted data, whereas 60% did in the weighted data) and on symptom reporting, 
with 55% reporting at least one symptom in the unweighted data, compared to 44% in 
the weighted sample. The differences observed are likely to have been a result of a 
weighting applied to all of the participants who completed the whole survey, and not just 
those who completed my module. See Table 7.1 for a comparison of the weighted and 
unweighted data. 
 
7.2.3.2 Missing data 
There were no missing data in the demographic, symptom reporting (including 
frequency and severity) or help-seeking data in those women who had a symptom and 
had agreed to participate in the survey module.  
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7.2.3.3 Parametric assumptions 
As in the previous data chapters, data were tested for normality and homogeneity of 
variance to be certain that any significant results were down to genuine group 
differences in means. I also repeated these tests with the demographic data here. As 
the variables were outside of normal distribution ranges (-1 – 1+) when testing 
skewness and kurtosis, non-parametric χ2 tests were used. 
 
7.3. Results 
7.3.1 Sample characteristics 
Of the 2173 women who took part in the overall TNS omnibus survey, 911 (42%) 
completed my survey module. Although this is not a true response rate (as TNS do not 
record how many addresses they attempt to recruit from), it at least provides an 
indication of a response rate to my survey. Respondents were aged 16-98, with a mean 
age of 45 years, SD=17.09). When age was dichotomised, 442 women were aged ≥45 
years and 469 were aged <45 years. Most women were White (93%) and had a high 
SES (60%). Only a very small number of women (7%) reported minority ethnicities, so 
they were grouped together and the sample was categorised as ‘White’ or ‘non-White’, 
as discussed in the methods section. Responders to the symptom survey module were 
significantly younger, had a higher SES, were more likely to have a White ethnicity and 
were more likely to be married or living as a couple than those who refused to complete 
the module (see Table 7.2). 
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Table 7.1 Sample Characteristics (Weighted/Unweighted n=911/ n=882) 
  Unweighted   Weighted 
  
N (%*)   N (%*) 
Age (mean (SD)) 
45 (17.2)   45 (17.1) 
            
Socioeconomic status 
    
      
     ABC1 (higher) 424 (48)   543 (60) 
     C2DE (lower) 459 (52)   368 (40) 
            
Ethnicity 
          
     White 823 (93)   848 (93) 
     Non-white 59 (7)   62 (7) 
            
Marital Status 
          
     Single 219 (25)   204 (22) 
     Married/living as a couple 502 (57)   558 (61) 
     Widowed/divorced/separated 161 (18)   149 (16) 
            
Reported Symptoms 
          
     At least one 
395 (55)   398 (44) 
     None 
488 (45)   513 (56) 
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Table 7.2. Socio-demographic characteristics of responders and non-responders to the 
symptom module (weighted data, overall n=2173) 
  
Responders Non-respondersa 
x2 (df) (n=911) (n=1262) 
n %  n %  
Age (mean (SD), t-test) 45 (17) 49 (20) 5.61** 
              
Socioeconomic status           
  ABC1 (higher) 543 (60) 674 (53)   
  C2DE (lower) 368 (40) 588 (47) 8.25 (1)* 
              
Ethnicity           
  White 848 (93) 1097 (88)   
  Non-white 62 (7) 154 (12) 17.69 (1)** 
              
Marital status           
  Single 204 (22) 294 (23)   
  Widowed/divorced/separated 149 (16) 283 (22)   
  Married/living as a couple 558 (61) 676 (54) 15.10 (2)** 
              
Reported symptoms           
  At least one 398 (44) - - - 
  None 513 (56) - - - 
*Significant at the .01 level, **significant at the .001 level 
a
These women took part in the omnibus survey but opted out of the symptom module 
 
 
7.3.2 Symptom reporting 
Just under half the respondents (44%, 398/911) reported at least one of the 13 
symptoms in the survey (M=1.2, range=0-9), with ‘pain in the abdomen, lower back or 
pelvis’ (19%, n=173), ‘increased abdominal size’ (17%, n=154) and ‘increased need to 
go to the toilet’ (15%, n=138) being the most common (Table 7.3). The median number 
of symptoms endorsed was 0 (56%, n=513), with 11% reporting one symptom (n=103), 
12% reporting two symptoms (n=108) and 21% reporting three symptoms or more 
(n=187). The highest number of symptoms experienced was nine, reported by five 
women (0.5%). Of those women who reported a symptom (n=398), the majority had 
between one and three (72.4%, n=288). Overall, women were more likely to report a 
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symptom indicative of a gynaecological cancer if they were younger (50% of those 
under 45 vs. 37% of those aged 45 and over, χ2 (1,910)=14.87, p<0.001), lower SES 
(49% vs. 40% in the higher SES group, χ2 (1,911)=7.58, p<0.01) and non-White (58% 
vs. 43% in White participants, χ2(1,910)=5.64, p<0.05).  
 
7.3.3 Frequency and severity of symptoms  
Overall, 35% (n=317/911) of respondents reported a symptom that was frequent and/or 
severe, and 9% (78/911) had a symptom that was neither frequent nor severe. Less 
than a third (132/442, 30%) of women aged ≥45 reported a frequent and/or severe 
symptom; 14% of the total sample (n=132/911) (Table 7.4). Individual symptom 
endorsements by age and frequency and/or severity of symptom are reported in Table 
7.3. 
 
As stated above, women were only asked about their response to one index symptom in 
order to keep the survey to reasonable length. As the symptoms were randomly 
selected, it is possible that women may have been asked about a mild, infrequent 
symptom, when they also had a frequent, severe symptom, which they may have 
responded differently to. To assess how many women this applied to, I calculated the 
proportion of women who had an index symptom which was mild and infrequent and the 
proportion of these women who also had a non-index symptom that was frequent and/or 
severe. These calculations showed that just 7% of the total sample (n=911) had a mild 
or infrequent index symptom, as well as a frequent and/or severe non-index symptom. 
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Table 7.3 Gynaecological symptoms reported by all respondents (n=911), and by age and frequency and severity 
Symptoms endorsed 
Whole sample 
(n=911) 
<45 years (n=469) ≥45 years (n=442) 
Frequent 
and/or severe 
Not frequent 
or severe 
Frequent 
and/or 
severe 
Not 
frequent 
or severe 
N (%)* n (%)* N (%)* n (%)* n (%)* 
Pain in abdomen/lower back/pelvis 173 (19) 81 (17) 27 (6) 55 (12) 10 (2) 
Increased abdominal size 154 (17) 62 (13) 26 (6) 45 (10) 21 (5) 
Increased need to go to the toilet 138 (15) 60 (13) 13 (3) 51 (12) 13 (3) 
Increased wind or constipation 121 (13) 42 (9) 15 (3) 46 (10) 17 (4) 
Difficulty eating/feeling full quickly 116 (13) 53 (11) 14 (3) 40 (9) 7 (2) 
Heavier/longer periods 107 (12) 52 (11) 24 (5) 23 (5) 7 (2) 
Pain/discomfort during sex 83 (9) 39 (8) 26 (6) 11 (3) 5 (1) 
Itching, pain or soreness of vulva 64 (7) 24 (5) 17 (4) 18 (4) 4 (<1) 
Bleeding between periods 49 (5) 17 (4) 20 (4) 7 (2) 4 (<1) 
Discharge that smells unpleasant or is blood stained 44 (5) 22 (5) 15 (3) 7 (2) 1 (<1) 
Bleeding during/after sex 31 (3) 10 (2) 13 (3) 1 (<1) 6 (1) 
Growth/lump/sore/ulcer on skin of vulva 26 (3) 5 (1) 11 (2) 1 (<1) 8 (2) 
Bleeding after menopause 10 (1) 1 (<1) 3 (<1) 0 (0) 6 (<1) 
*Respondents were able to select more than one symptom, hence the total percentage will exceed 100%.         
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Table 7.4. Symptoms reported by age group (n=911) 
  
Total 
sample 
(n=911) 
Women 
aged <45 
(n=469) 
Women 
aged ≥45 
(n=442) 
  N (%) N (%) n (%) 
Did not report symptoms 513 (56) 235 (50) 278 (63) 
Reported at least one symptom 398 (44) 234 (50) 164 (37) 
    At least one frequent and/or severe symptom  317 (35) 186 (40) 132 (30) 
    No frequent or severe symptoms 78 (9) 46 (10) 32 (7) 
 
 
7.3.4 Help-seeking behaviour 
Respondents were asked about help-seeking for a single index symptom. The selection 
rate for each symptom (expressed as the number of times the symptom was selected as 
a proportion of the number of times that symptom was endorsed) was fairly similar 
across symptoms (see Table 7.5), and consequently, all endorsed symptoms were 
equally likely to be endorsed as the index symptom. Just over a third (36%, 142/398) of 
respondents who reported a symptom had seen a health care professional (HCP) 
(pharmacist, GP, practice nurse, A&E) about their index symptom, with most (30%, 
120/398) having seen a GP. Of the subset of women aged 15-29 (n=111/398, 28%), 
21% reported having seen a GP for their index symptom. In symptomatic women, the 
most common response to the index symptom was to monitor it (54%, 216/398) and the 
least common response was to go to A&E (6%, 24/398). In the sample as a whole, 16% 
(n=142/911) of women had seen a HCP about at least one of the symptoms under 
investigation and 13% had seen a GP (n=120/911). 
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Table 7.5. Chance of selection as an index symptom for all symptoms 
Symptoms endorsed 
(n=398) 
Chance of selection over 
number of endorsements 
N (%)* 
Pain in abdomen/lower back/pelvis 64/173 (37) 
Increased abdominal size 63/154 (41) 
Increased need to go to the toilet 46/138 (33) 
Increased wind or constipation 44/121 (36) 
Difficulty eating/feeling full quickly 49/116 (42) 
Heavier/longer periods 34/107 (32) 
Pain/discomfort during sex 23/83 (28) 
Itching, pain or soreness of vulva 23/64 (36) 
Bleeding between periods 17/49 (35) 
Discharge that smells unpleasant or is blood stained 9/44 (20) 
Bleeding during/after sex 13/31 (42) 
Growth/lump/sore/ulcer on skin of vulva 11/26 (42) 
Bleeding after menopause 2/10 (20) 
*Respondents were able to select more than one symptom, hence the total percentage will 
exceed 100%. 
 
 
Of the older (≥45 years) symptomatic women, 37% (n=60/164) had seen a HCP and 
33% (54/164) had seen a GP. The most common response to a symptom was to 
monitor it (49%, 81/164) and the least common response was to visit the A&E 
department (2%, 4/164). Older women were significantly less likely to have asked a 
friend or relative for advice (14% vs. 28%, χ2 (1,399)=11.36, p=0.001) or to have gone to 
A&E (2% vs. 9%, χ2 (1,398)=6.47, p<0.05) than younger women. The behaviour 
patterns remained the same for women with a frequent and severe symptom, although 
more women had sought medical help, with 42% having seen a HCP (135/317). 
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Table 7.6. Help-seeking for one index symptom among respondents who reported a 
symptom by risk group (n=397) 
Response to symptom 
Higher risk 
women 
(n=132) 
Lower risk 
women 
(n=265) x
2 
(df) 
N (%) n (%) 
Monitored symptom 69 (53) 147 (55) 0.28 (1) 
Used own remedy/self-treatment 59 (45) 104 (39) 1.08 (1) 
Sought help from GP 50 (38) 71 (27) 5.11 (1)* 
Sought help from internet 32 (25) 79 (30) 1.26 (1) 
Sought help from friend or relative 21 (16) 67 (25) 4.34 (1)* 
Sought help from pharmacist 21 (16) 33 (12) 0.90 (1) 
Sought help from practice nurse 18 (14) 35 (13) 0.02 (1) 
Sought help from somewhere else 14 (11) 30 (11) 0.05 (1) 
Sought help from A&E 4 (3) 20 (8) 3.17 (1) 
Higher risk = women aged ≥45 years with a frequent and/or severe symptom. Lower 
risk = women aged <45 years and women with no frequent or severe symptoms. 
*Significant at the .05 level 
*Respondents were able to select more than one response, so total % sometimes exceeds 
100%. 
 
 
Among the older women (≥45 years) with an index symptom that was frequent and/or 
severe (i.e. the most high-risk group), 43% (n=56/132) had seen a HCP and 38% 
(n=50/132) had seen a GP. These women were most likely to have monitored their 
symptom (53%, 69/132) and least likely to have visited A&E (3%, 4/132). Older women 
with frequent and/or severe symptoms were significantly more likely to have seen a GP 
(38% vs. 27%, χ2 (1,397)=5.11, p<0.05), but significantly less likely to have asked a 
friend or relative for advice (16% vs. 25%, χ2 (1,396)=4.34, p<0.05) than women who did 
not fall into this group (see Table 7.6). 
 
7.4. Discussion 
Just under half (44%) the women in my sample reported a symptom that may indicate a 
gynaecological cancer, and for a third (35%), the symptom was frequent and/or severe. 
The rates of GP consultation for potential gynaecological cancer symptoms found here 
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(13% of the women in the total sample, n=120/911) are somewhat lower than have been 
found in in a previous study exploring primary care consultation rates for gynaecological 
symptoms (Stapley & Hamilton, 2011) (20%). However, Stapley and Hamilton only 
explored consultation rates in women aged 15-29, and when I explored consultation 
rates in a sub-sample of the participants in my study aged 16-29, I found similar rates 
(21%). 
 
Interestingly, previous research exploring intention to seek help for some of these 
symptoms in a UK population found that 65-89% of women said that they would go to 
their GP within two weeks if they had one of these symptoms (Target Ovarian Cancer, 
2013). This again highlights the differences in exploring hypothetical symptoms and 
intention to seek help and actual responses to real symptoms. The current survey 
suggests that, although just under half of British women may currently have a symptom 
potentially indicative of a gynaecological cancer (n=398/911, 44%), only around a third 
of these (n=120/398, 30%) have sought advice from a GP. This percentage is 
considerably lower than the percentage of women who said that they would seek help 
promptly for similar symptoms. This suggests that actual help-seeking may be much 
lower than anticipated help-seeking and adds weight to evidence that intention may not 
be translated into behaviour (Sheeran, 2002), as discussed as a limitation of the TPB, in 
Chapter Two. 
 
This disparity between intention and behaviour in help-seeking may be due to the 
influences on help-seeking behaviour in response to an actual symptom (Andersen et 
al., 2009) that participants may not consider in a hypothetical situation. For example, in 
Chapter Three, I explored the influences on intention to seek help and actual help-
seeking for gynaecological and breast cancers. Although there were some similarities, 
not all of the influences on intention to seek help were applicable in a real life situation 
(see Chapter Three). 
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The findings described here suggest that many more women in the UK have symptoms 
potentially indicative of a gynaecological cancer than seek help for them. Any successful 
intervention which encourages women with these symptoms to seek help at primary 
care level could lead to a considerably increased pressure on the primary care system, 
and there is evidence that GPs may be concerned about the impact of such 
interventions (Evans et al., 2014). However, evidence from other campaigns aimed at 
increasing awareness of cancer symptoms and encouraging prompt help-seeking have 
demonstrated that the increased work load may be manageable. For example, a report 
published in 2011 explored the impact on primary care presentations for lung cancer in 
the Midlands area of the UK, following a campaign in the local area to promote 
awareness and early diagnosis of lung cancer. The report reveals that, although 
presentations for a cough that has lasted for three weeks or more increased by 23%, 
this equated to less than three additional presentations per practice, per week (Mayden, 
2012). Further, in Evans et al.'s (2014) study, a quarter of the GPs had already 
implemented systems to encourage women to seek help promptly for potential 
symptoms of a gynaecological cancer, suggesting that the impact may be smaller still, 
as it may only apply to those practices who have not yet done so. 
 
Moreover, it may not be appropriate to encourage all women with these symptoms to 
seek help immediately; for some women it may be advisable to monitor the symptom in 
the first instance. It is likely that the majority of symptomatic women in the current 
sample did not have a gynaecological cancer, based on incidence rates for these 
cancers in the UK population. In the highest risk age groups for cervical cancer (30-34 
and 35-39) only one case in every 5650 and 6173 women respectively would be 
expected. In the highest risk age groups for uterine, ovarian, vulval and vaginal cancers 
(70-74, 80-84, 85+ and 85+ respectively) one would only expect to see one case in 
every 1101, 1437, 4082 and 23,810 women in the UK respectively (Office for National 
Statistics, 2012b). These incidence rates mean that, statistically, I would expect to find 
less than one case of a gynaecological cancer in this sample of 911 women. 
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Encouraging all of the women in the current sample to seek help then may not be 
appropriate, and an alternative course of action may be to target higher risk groups in 
any intervention aimed at encouraging women with symptoms to seek help. However, 
encouraging all women with a symptom they report as frequent and/or severe to seek 
medical help (whether this symptom indicates cancer or a more benign condition) is 
likely to be of benefit to the patient in terms of receiving treatment and ameliorating 
discomfort. 
 
Just over a third of the women in this study (35%) reported a symptom potentially 
indicative of a gynaecological cancer that was frequent and/or severe. As some of the 
symptoms explored here are more likely to indicate a gynaecological cancer if they have 
such characteristics (Goff et al., 2004; Olson et al., 2001), women with these types of 
symptoms may be at higher risk of a gynaecological cancer. Furthermore, younger 
women were more likely to report a symptom, whereas most symptoms are more likely 
to be indicative of cancer in older women (Cancer Research UK, 2012g, 2013e; Office 
for National Statistics, 2012b). For example, abdominal distension, loss of appetite, 
abdominal pain and urinary frequency all have higher positive predictive values (PPVs) 
for ovarian cancer in women aged ≥55, compared to younger women (Rossing et al., 
2010). 
 
If interventions are not only targeted at women with a frequent and/or severe symptom, 
but also at those who are older, the increase in consultations could be minimised. For 
example, my data showed that only 14% of the women surveyed (n=132/911) were both 
older (≥45 years) and had a frequent and/or severe symptom, but 5% (n=50/911) had 
already seen a GP, so around 9% (82/911) of the total sample could be characterised as 
needing to see their GP urgently. Targeting interventions in this way should ensure that 
consultations occurring as a result of encouraging earlier help-seeking would be more 
likely to lead to a cancer diagnosis. In terms of trying to increase earlier stage diagnoses 
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of gynaecological cancers, this relatively modest increase in consultations as a result of 
any successful intervention could potentially be worthwhile. 
 
7.4.1 Limitations 
Over half (58%) the women who completed the overall omnibus survey did not agree to 
complete the questions; which raises the issue of whether the results reflect the true 
prevalence of possible gynaecological cancer symptoms in the population. However, the 
final sample was broadly representative of the British female population in terms of 
ethnicity and SES (Ipsos MediaCT, 2009; Population, Ethnicity, Religion and Migration 
(PERM), 2009), despite demographic differences between respondents and non-
respondents. Feedback from the interviewers indicated that the reason women gave for 
refusing or withdrawing was often being embarrassed by the survey content, despite the 
assured anonymity and the ability to self-complete the survey, suggesting that the data 
may not be missing at random. It would be difficult to overcome this limitation in any self-
report survey with similar content. 
 
Because it is not clear whether embarrassment would be more or less common in 
women with symptoms, I am unable to speculate about the direction of any possible 
bias. However, to estimate the impact of the missing data on my findings, I extrapolated 
the number of women with at least one symptom from my sample (n=911) to a sample 
including my sample and the non-responders (n=2173) using the demographic 
information I had for the non-responders (age, SES and ethnicity). This showed that the 
number of women that I would expect to report at least one symptom, (based on the 
demographic structure of the sample including the non-responders) ranged from 43% to 
45%; very similar to the findings in the final sample (44%, n=398/911). Of course, these 
estimations do not take into account alternative reasons for non-response, such as 
having a symptom and feeling too embarrassed to talk about it. 
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Due to the small numbers of women endorsing each symptom, I analysed all the 
symptoms together, rather than individually or by cancer type. This meant that I did not 
report findings on help-seeking for individual symptoms or by gynaecological cancer. 
However, any frequent or severe symptom would be of concern, and it was therefore 
important to explore help-seeking responses to all symptoms combined. 
 
The exploration of help-seeking for only one randomly selected index symptom was 
necessary to reduce the overall length of the survey, but may have meant that help-
seeking was explored for a symptom that was neither frequent nor severe, when that 
participant may also have had a symptom that was either frequent, severe or both. 
However, I determined that this only applied to a very small proportion of the total 
sample. 
 
I felt that it was important to explore the help-seeking behaviour for all symptom types, 
including the seemingly less serious symptoms, as this helps to provide a picture of 
whether people seek help appropriately. However, I acknowledge that it would have 
been interesting to have had help-seeking data for all of the symptoms endorsed. This 
could be a consideration for future research. 
 
Finally, the survey did not go through any rigorous reliability and validity testing. 
Wherever possible the items drew on previous published work. For example, the 
frequency and severity questions are similar to those used in a previously published 
study exploring ovarian cancer symptoms (Goff et al., 2004). However, future studies 
using similar measurements may benefit from carrying out psychometric testing prior to 
use. 
 
7.4.2 Conclusions 
There is a clear indication that the occurrence of gynaecological symptoms potentially 
indicative of cancer in women in England is substantially higher than recorded in primary 
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care. The findings presented here suggest that the most likely alternative to help-
seeking may be to monitor the symptom. However, it may not be appropriate to 
encourage all women with symptoms to seek help at the primary care level immediately. 
 
Older women were less likely to report a symptom than younger women.  Evidence that 
symptoms are more likely to be indicative of a gynaecological cancer if frequent and/or 
severe and that gynaecological cancers are more common at older ages, suggests that 
targeting interventions towards older women who have a symptom that is frequent or 
severe could promote appropriate help-seeking without increasing consultations with the 
‘worried well’. 
 
The results in the present study are helpful in understanding how many women may 
have a symptom potentially indicative of a gynaecological cancer, and how most women 
may respond to such symptoms. However, the questionnaire design did not allow for an 
in-depth exploration of why the women who may be in most need of medical advice had 
not sought it out. In the next chapter I aim to explore symptom interpretations and 
responses using a qualitative methodology to attempt to understand these processes in 
more depth. 
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CHAPTER EIGHT – WOMEN’S DETECTION OF BODILY CHANGES, INTERPRETATION 
AND RESPONSE TO SYMPTOMS POTENTIALLY INDICATIVE OF A GYNAECOLOGICAL 
CANCER 
 
 
8.1 Introduction 
8.1.1 Background 
In the preceding chapters I established that intention to seek help was high in women 
who anticipated having a symptom of a gynaecological cancer (see Chapter Six), but 
actual help-seeking was lower in women with symptoms that may indicate a 
gynaecological cancer (see Chapter Seven). Further, my findings in the previous 
chapter showed that there are potentially many more women in the population with 
symptoms than are seeking help for them, although only a small percentage of those 
women might be classed as needing to see their GP urgently. I concluded that 
interventions may be most effective if they are focused upon these higher-risk women. 
However, the research in Chapter Seven did not explore how and why women respond 
to bodily changes. An exploration of this kind could help understand why so many 
symptomatic women do not seek help and, as such, be informative in determining the 
content of any intervention. 
 
In both the previous chapter and in Chapter Three, I described a qualitative focus group 
study published in 2013 by Cooper, Polonec, Stewart and Gelb. This study was novel in 
its exploration of both hypothetical and actual help-seeking across all five 
gynaecological cancers, outside of the context of illness or cancer. The majority of 
research in this area has focused on just one gynaecological cancer type, and has 
tended to be retrospective or just hypothetical (see Chapter Three). However, the study 
does have some limitations; the authors did not always clearly differentiate between 
women who had anticipated help-seeking for a hypothetical symptom and those who 
had experienced actual symptoms (nor did the authors provide information about how 
many symptoms were hypothetical and how many were real). This makes it difficult to 
isolate how women with real symptoms felt about their symptom, what they attributed it 
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to and how they responded to it. Moreover, the study was conducted in the US, which 
has a different healthcare system to the UK and perhaps other cultural differences in 
attitudes to help-seeking. Consequently, not all of Cooper et al.'s findings may be 
applicable here. 
 
8.1.3 The Model of Pathways to Treatment 
With appropriate help-seeking for symptoms that may indicate a gynaecological cancer 
at a low level, it is necessary to identify the processes and influences involved in a help-
seeking response. In doing so, it may be possible to identify areas where interventions 
to encourage appropriate help-seeking could be most effective. The use of a model to 
underpin research exploring time to help-seeking has also been recommended by the 
Aarhus Statement (Weller et al., 2012).   
 
The MPT, (Walter et al., 2012, see page 57), which was discussed in detail in Chapter 
Two, is novel amongst help-seeking models as it includes the process of detecting a 
change in one’s body, deciding that the change is a symptom and then deciding upon a 
response to the symptom. As mentioned in Chapter Two, the help-seeking process is 
complex and not necessarily linear. 
 
8.1.4 The present study 
This study was undertaken to further investigate the process of detection of a bodily 
change, interpretation of the bodily change as a symptom, attributions and responses to 
the symptom. I focused the topic guide around the first two intervals (appraisal and help-
seeking) of the MPT (Walter et al., 2012), avoiding the terms ‘cancer’ and ‘symptom’ in 
order to achieve a level of ecological validity, in line with previous research (Cooper et 
al., 2013) and the study described in Chapter Seven. 
 
The present study was novel in its exploration of current symptom and response 
experiences, only in women who were currently or had recently experienced a symptom 
that may indicate a gynaecological cancer using a qualitative methodology. Exploring 
195 
 
current or recent symptom experiences in these women eliminated any recall bias 
associated with retrospective studies. Further, as with Cooper et al.'s (2013) study, there 
was no context of illness or cancer (achieved through avoiding the terms ‘symptom’ and 
‘cancer’), which reduced any reporting bias that may have occurred if participants had 
been aware that I was concerned with potential cancer symptoms. In order to achieve 
the above, I used in-depth interviews to explore symptom experiences and responses to 
symptoms. The rationale for adopting a qualitative methodology in this study is 
explained below. 
 
8.1.5 Qualitative research methods 
The previous chapters within this thesis have explored help-seeking and symptom 
awareness using quantitative methodologies. These methods, which are concerned with 
hypothesis testing through collection and statistical analysis of numerical data (Clark-
Carter, 1999), are useful in determining awareness of symptoms indicative of 
gynaecological cancers and anticipated help-seeking in a large group of women and for 
determining where statistical differences lie. 
 
Conversely, qualitative research is concerned with the study of phenomena in a 
naturalistic setting using an interpretive approach and focusing on the meanings that 
participants assign to these phenomena (Fossey, Harvey, Mcdermott, and Davidson, 
2002). Qualitative data are non-numerical and are usually collected via participant 
observation, interviews, document analyses or focus group. Qualitative research has 
been steadily growing in popularity within health research (Pope and Mays, 2009), as 
the value of such research in terms of understanding the complex area of health beliefs 
or exploring research areas for which there is little knowledge (Pope and Mays, 1995) 
has become more widely recognised.  
 
As discussed, the vast majority of research exploring delay for help-seeking for 
symptoms potentially indicative of female cancers has explored hypothetical symptoms, 
rather than actual experienced symptoms. In Chapter Seven I aimed to explore the level 
196 
 
of symptoms potentially indicative of a gynaecological cancer and responses to these 
symptoms in women with actual symptoms. However, although it is important that we 
have an idea of how many women may be experiencing these symptoms and what the 
most common responses are, the study in the previous chapter did not capture the lived 
experiences of these women. Women’s actual experiences of these symptoms and real 
world responses to them are likely to be complex and potentially influenced by a number 
of different factors; some of which may not have been considered when using 
quantitative research designs. For example, perceived barriers, low awareness or 
knowledge of symptoms and demographic variables are all thought to play a part in 
seeking help for symptoms of cancer, however, I found evidence in Chapter Six that 
help-seeking for symptoms that may be indicative of a gynaecological cancer cannot 
entirely be explained by these variables. 
 
A qualitative methodology allowed me to explore the intricacies of meanings, thoughts 
and feelings that are part of this potentially sensitive experience. Quantitative 
methodologies such as questionnaires and surveys may not be sensitive enough to 
capture this level of detail. This deeper exploration enabled me to develop a much richer 
understanding of how women experience a symptom potentially indicative of a 
gynaecological cancer in the context of their lives, and to truly understand the lived 
experience of these women. 
 
8.1.6 Aims of this chapter 
a) To understand the processes involved in the detection of a bodily change and 
how that change comes to be perceived as a symptom in women with symptoms 
that may indicate a gynaecological cancer 
 
b) To understand the processes involved in deciding to seek help or take alternative 
action in response to a symptom that may indicate a gynaecological cancer 
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c) To explore help-seeking responses to a symptom which may be indicative of a 
gynaecological cancer, outside of the context of cancer 
 
8.2 Methodology 
8.2.1 Study design 
The current study consisted of in-depth telephone and face-to-face interviews with 26 
women aged thirty years and over. The interviews were carried out during June and 
November 2012. The study was approved by the UCL Research Ethics Committee 
(reference: 2734/001, see appendix 8 for the approval letter). 
 
8.2.2 Sampling 
I aimed to use a purposive method of sampling to guide recruitment in the present study 
in order to achieve a demographically diverse sample. The original target sample was 
40 women aged over thirty who had experienced a symptom that may indicate a 
gynaecological cancer in the three months prior to their recruitment. I chose this age cut-
off as women below this age are far less likely to be at risk of a gynaecological cancer 
(Cancer Research UK, 2011, 2012d, 2012e, 2012f, 2013a). As in Chapter Seven, a 
three month cut-off for symptom experience was chosen so that symptoms and 
responses would still be fresh in participants’ minds, but enough time had passed to 
allow a symptom to be detected (for example, heavier or longer periods might only be 
detected after two or more menstrual cycles).  
 
I aimed to recruit women to four different groups, each consisting of 10 participants. 
Group 1 was to include women who reported a frequent symptom(s) and who sought 
help; Group 2 was to include women with a frequent symptom(s) who hadn’t sought 
help; Group 3 was to include women who had an infrequent symptom(s) who had not 
sought help and finally, Group 4 was to include women who had an infrequent 
symptom(s) who had sought help. These groups were selected to enable me to identify 
factors involved in appropriate help-seeking (Groups 1 and 3) and inappropriate help-
seeking (Groups 2 and 4). These groups were based on the results in Chapter Seven, 
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which showed that women with a frequent and/or severe symptom responded differently 
to those with a mild and infrequent symptom. I did not ask about severity in the 
screening questionnaire as, although both frequency and severity are important (for 
example, Goff et al., 2004; Olson et al., 2001), I wanted to avoid a lengthy screening 
questionnaire in case participants decided that they did not want to be interviewed or 
they were ineligible, which would make their data redundant. I did, however, explore 
both frequency and severity in-depth in the interviews (described below). I aimed to 
recruit women from a range of ethnic and socioeconomic backgrounds (using education, 
home ownership and car ownership as markers), and also asked women whether they 
were registered with a GP or not, as I wanted to interview only women who would have 
the option of seeing a GP. 
 
8.2.3 Recruitment 
To achieve my purposive sample, I developed a screening questionnaire. The screening 
questionnaire (appendix 9) asked women for demographic information (age, ethnicity, 
education, car ownership and housing tenure), which symptoms they had experienced in 
the prior three months (they were provided with a list of symptoms, all of which could 
indicate a gynaecological cancer, which was the same list of symptoms that was used in 
Chapter Seven), how often they had experienced each symptom reported (once or 
twice, several times or all the time) and whether they had sought help or not. I used 
several methods to recruit women to my study in order to increase the chances of filling 
each of the quotas that I had set (discussed above). These methods are described 
below. 
 
8.2.3.1 Online recruitment 
An electronic version of the screening questionnaire was developed to be used online, 
via the website Surveymonkey14. An advertisement explaining the study, along with the 
link to the screening questionnaire was published on a number of websites in June 
                                                          
14
 www.surveymonkey.com 
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2012, including the National Federation of Women’s Institutes online edition 
newsletter15, Hillingdon Women’s Centre16, Harringayonline17, Mumsnet18 and 
Streetlife.com19. Further, information regarding the study and the link to the screening 
questionnaire were emailed to all employees at Santander in the Bluewater shopping 
centre in Kent and Citywire Financial Publishers, based in Vauxhall, London via the 
branch manager and the online producer respectively. The online advertisement and 
text used in the emails can be seen in appendices 10 and 11. 
 
8.2.3.2 Offline recruitment 
In addition to the online advertisements directing women to the web-based version of 
the screening questionnaire, I also created posters advertising the study, with removable 
tabs. The web address for the screening questionnaire was printed on these removable 
tabs, so that interested women were able to take the tabs home and access the 
screening questionnaire at a convenient time. These posters were placed in various 
locations around London, including the Job Centre in Angel, Regent’s Park Library, the 
West London Community Association, Hopscotch Asian Women’s Centre, Curves Gym 
in Bromley and the HPod centre. 
 
Potential participants were asked to complete the online screening questionnaire, and 
were told that they would be asked questions about their current health. At the end of 
the questionnaire, participants were asked whether they would like to be contacted 
about an interview, which would involve discussing their recent health in more detail. 
They were informed that they would be reimbursed for their time and any expenses 
incurred to attend an interview. If women indicated that they would be interested and 
                                                          
15
 www.thewi.org.uk/become-a-member/structure-of-the-wi/england/nottinghamshire/news/federation-
newsletter 
16
 www.hillingdonwomenscentre.org.uk 
17
 www.harringayonline.com/ 
18
 www.mumsnet.com 
19
 www.streetlife.com 
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met the quotas discussed above, they were asked for their contact details and to specify 
a convenient time at which to contact them. I called or emailed these women to confirm 
interest and arranged a time for interview, if relevant. Women were offered either a 
telephone or face-to-face interview at UCL premises (1-19 Torrington Place, London), 
depending upon their preference. 
 
8.2.4 Interview topic guide 
The interview topic guide was underpinned by the MPT (Walter et al., 2012, page 57), 
as discussed above. I developed a semi-structured topic guide that allowed women to 
deviate from the structure and discuss their experiences, which may be outside of the 
context of the MPT. I structured the guide so that women were first asked about what 
bodily changes they had experienced, then about their responses to these changes and 
finally whether they had any other conditions or illnesses or were worried about or felt at 
risk of any. The topic guide was structured in this way to avoid mentioning illness until 
after the participant had discussed their own attributions and responses to the bodily 
change. Once a first draft had been written, this was then reviewed by one of the 
researchers involved in the development of the MPT (Dr. Suzanne Scott), and feedback 
was provided. I amended the interview topic guide following feedback and a final draft 
was drawn up (see appendix 12). 
 
8.3.5 Analysis 
All interviews were recorded using an electronic recorder. An external company (Devon 
Transcription20) transcribed 23 of the 26 interviews verbatim. To ensure that I was fully 
immersed in the data, I interviewed all participants, coded all of the resulting transcripts 
and transcribed 10% of the transcripts (three interviews). Once transcription was 
finished, I also read and re-read the transcriptions of the interviews. 
                                                          
20
 http://www.devontranscription.co.uk 
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I analysed the interviews using framework analysis; a widely used method of qualitative 
analysis which uses a matrix to allow classification and organisation of data according to 
overarching and sub-themes (Ritchie & Spencer, 1994)). This analysis was aided by the 
NVivo software package (version 10, a software package designed to aid qualitative 
data analysis) (QSR International Pty Ltd., 2012). The transcripts were uploaded into the 
software in preparation for coding. 
 
To code the interviews, following my initial reading and re-reading, I identified potential 
themes, and developed an initial thematic framework within which these initial themes 
were placed. Once the initial framework had been developed, I tested it against a subset 
of transcripts. As this was an initial framework, a number of additional themes emerged 
following my initial testing, and the framework was adapted accordingly. 
 
Using the initial, revised framework, I carried out an initial coding of all of the transcripts. 
This involved selecting parts of the text within the transcripts and assigning codes to 
them. More than one code could be assigned to the same piece of text if applicable. 
This initial coding was at a very detailed level, to allow me to identify all of the relevant 
information.  During coding of the later interviews, some codes emerged that had not 
been noted in earlier interviews. In order to ensure that all interviews were coded with all 
of the identified codes, all interviews were recoded after the initial coding was 
completed. 
 
After this second round of coding, I identified 10 main themes (appendix 13), all of which 
had sub-themes. Once an initial coding frame had been identified, a second researcher 
(MS) coded two un-coded transcripts (OL0121 and OL43) using the themes already 
                                                          
21
 Initially, I had aimed to recruit some women online and some women through visiting some of the 
locations described in the recruitment section (section 8.2.3). As such, I had anticipated that some 
women may complete paper-based versions of the screening questionnaire (see Appendix 9) (and would 
have an ID prefix of ‘PB’) and some women would compete an online version of the screening 
questionnaire (and would have an ID prefix of ‘OL’). However, all of the women were recruited online, 
and as such, all had the prefix ‘OL’. 
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identified. Once this was completed, the coding for the two transcripts by MS and myself 
were compared in NVivo using Kappa, which revealed a range of agreement between 
82.97% and 99.97%. Although this methodology of coding validation could be argued to 
simply show how well the second coder has learned the coding frame developed by the 
first coder, I attempted to overcome this limitation by asking MS to identify any additional 
codes that she felt did not fall within the coding frame I had developed. MS did identify 
20 additional codes, however, upon further discussion with MS, it was agreed that all of 
these codes would actually come under the existing coding frame, and so no novel 
codes were added. 
 
This framework was refined a total of eight times. Many of the themes, while interesting, 
were not relevant to the specific area of interest; they did not add to my understanding of 
the processes involved in the detection of a bodily change and how a bodily change 
comes to be perceived as a symptom in the group of women under investigation, nor did 
they aid understanding of the processes involved in deciding to seek help or take 
alternative action in response to a symptom that may indicate a gynaecological cancer. 
As these themes were not useful within the context of this research study, they were not 
included in the analyses reported here. Further, during the refinement process, it 
became clear that some of the overarching themes and sub-themes were similar; as 
such, these were merged. 
 
During the refinement process, advice was sought from two other researchers (JW and 
GB). Once no more themes could be merged and I was left with themes that were all 
relevant to the focus of the research, I created the final framework. Within this 
framework, three broad themes were identified: ‘detection and interpretation of bodily 
changes’, ‘symptom attributions’, and ‘responses to symptoms’. Within these broad 
themes, a number of sub-themes were identified, which can be seen in Figure 8.1. 
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Following identification of the final thematic framework, I began analysing relationships 
and links between themes, which enabled me to look for explanations of the variations in 
responses to symptoms across the women in my sample. To do this, I initially read 
through all the quotes that were coded within each theme. This process allowed me to 
identify where links between themes may lie, and allowed me to immerse myself in each 
theme. Once I had identified where relationships between themes may lie, I used the 
query function within NVivo to explore those relationships in more depth. The query 
function allows quotes which lie across one or more themes to be identified, which in 
turn can reveal how one or more themes may influence another. For example, I was 
able to explore the relationship between a number of different variables (such as family 
history of illness and experiences of, or advice from, others) and responses to 
symptoms (such as the decision to self-manage, learn to live with their symptoms, 
ignore the symptom or decide that nothing can be done). This process allowed a deeper 
level of analysis. 
 
8.3 Results 
8.3.1 Sample of women for interview 
As described above, I aimed to recruit 40 women, which comprised four groups of ten 
women representing inappropriate and appropriate help-seeking. I also aimed to 
achieve a sample of women from a range of socioeconomic and ethnic backgrounds. 
This sampling method was designed to capture the experiences of a range of women 
and experiences.  
 
The final sample consisted of 26 women. Although over 120 women responded to the 
screening questionnaire (n=123), the majority (n=97) of respondents fitted a quota that 
was already filled (most women who responded were educated to a mid- or high-level, 
(i.e. ‘A’ Level or Scottish Highers and above and were White British) or were ineligible 
(for example they did not have one of the symptoms of interest or did not give their 
consent to be contacted for interview). All of the women interviewed were registered with 
a GP. Please see Table 8.1 for demographic information relating to the women who 
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responded to the screening questionnaire (including both those who were interviewed 
and those who were not). Upon recruitment, I found that it was not possible to achieve 
the distinct ‘symptom frequency’ groups I had aimed to, as almost all (n=22, 85%) of the 
eligible women interviewed (n=26) had more than one symptom.  
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Table 8.1 Demographic information of women who were interviewed (n=26) and 
those who responded to the screening questionnaire, but were not interviewed 
(n=44*).  
  
Women 
interviewed 
 Women not 
interviewed 
  n %** N %** 
Age group         
      30-39 9 35 18 19 
      40-49 6 23 13 13 
      50-59 5 19 6 6 
      60-69 6 23 7 7 
Ethnicity         
      White British 22 85 33 34 
      White Other 4 15 7 7 
      Non-White 0 0 4 4 
Education level         
      Degree or higher degree 16 61 25 26 
      Higher education qualification below degree level 2 8 7 7 
      A-levels or Highers 2 8 3 3 
      ONC/BTEC 2 8 0 0 
      O Level or GCSE equivalent 3 11 8 8 
      No formal qualifications 0 0 0 0 
      Other 1 4 1 1 
Car ownership         
      None 7 27 12 12 
      One or more 19 73 32 33 
Home ownership         
      Own outright 7 27 12 12 
      Own with mortgage 12 46 16 17 
      Rent from Local Authority/Housing Association 2 8 3 3 
      Rent privately 4 15 12 12 
      Other (e.g. living with family/friends/squatting) 1 4 1 1 
Symptoms reported***         
      Pain in abdomen/lower back/pelvis 14 54 11 11 
      Increased abdominal size 12 46 21 22 
      Increased need to empty bladder more often/urgently 13 50 18 19 
      Increased wind or constipation 12 46 19 20 
      Difficulty eating/feeling full quickly 6 23 8 8 
      Heavier/longer periods 11 42 12 12 
      Changes in bowel habit 10 38 11 11 
      Pain/discomfort during sex 7 27 17 18 
      Itching, pain or soreness of vulva 7 27 21 22 
      Bleeding between periods 6 23 9 9 
      Discharge that smells unpleasant or is blood stained 7 27 7 7 
      Bleeding during/after sex 6 23 7 7 
      Growth/lump/sore/ulcer on skin of vulva 7 27 7 7 
      Bleeding after menopause† 0 0 0 0 
*53 women responded to the questionnaire, but declined to divulge any demographic 
information either because they were ineligible, and as such were not asked to provide this 
information or they declined to be contacted for interview and did not want their information 
recorded. Therefore no data for these women are provided here. 
**Most participants had more than one symptom and consequently the % for symptoms will 
be >100% 
***Symptom data were taken from the interviews for those women who participated, as this 
was the most up-to-date information at the time. Symptom data for women who responded to 
the screening questionnaire, but who were not interviewed were taken from the screening 
questionnaire. 
†Despite inclusion in the survey, none of the women interviewed reported this symptom. 
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For women with more than one symptom, the frequency of each symptom often varied, 
as did the response to the symptom, meaning that each woman would fit into more than 
one, if not all groups, depending upon the symptom under discussion. Instead, I 
explored frequency itself as a variable that may influence the process of detecting a 
bodily change, attribution, and the response. This is discussed in the thematic 
framework below. 
 
Further, although I aimed to recruit women from a variety of socioeconomic 
backgrounds using car and home ownership and education as markers, I was unable to 
recruit any eligible women with no formal qualifications. However, I did recruit women 
with a range of housing situations, including some women who owned their houses 
outright and some who were renting from their local authority, and women who either 
had one or more cars or none at all. Consequently this indicates that there was some 
variation in the SES of the women interviewed. Similarly, I was unable to recruit any 
women who were not from a White ethnic background. Although four of the women who 
responded to the survey were not White (see Table 8.1), none consented to being 
contacted for an interview. 
 
None of the women interviewed reported post-menopausal bleeding, although five 
women reported being post-menopausal during the interview process. Many women 
reported more than one symptom in the screening questionnaire although specific 
symptoms reported sometimes varied from the screening questionnaire to those 
reported in the interview (possibly due to the time passing between completing the 
questionnaire and completing the interview). Despite this, a range of symptom 
experiences were achieved, with at least six participants reporting each symptom, bar 
post-menopausal bleeding (see Table 8.1). 
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8.3.2 Thematic framework 
8.3.2.1 Theme One: ‘Detection and interpretation of bodily changes’ 
The sub-themes discussed below fit within the ‘detection of bodily change(s)’ event in 
the MPT (Walter et al., 2012) and act to help understand how women detect changes 
within their bodies and how they interpret those changes. 
 
8.3.2.1.1 Prompts to detection and interpretation 
This sub-theme comprises women’s experiences of perceiving a change in their bodies, 
including how that might occur, how they interpret these changes and influences on the 
detection of a bodily change. This broad theme in particular was difficult to draw out, as 
the act of asking women whether they had experienced the bodily changes within the 
study led to some women noticing a change for the first time, when they may not have 
otherwise noticed it. However, there was evidence that bodily changes may remain 
outside of conscious detection until attention is drawn to them by another person in real 
life situations as well. For example, one woman mentioned that she had only noticed the 
change in her body after her sister mentioned that she had also been experiencing the 
same change.  
“I think, well, my sister said that she noticed that and I, kind of, thought, oh, actually, so 
have I.” (OL10, unpleasant smelling vaginal discharge, age 39, White British, High 
SES) 
 
 
8.3.2.1.2 Bodily change fits into part of normal bodily functioning or ‘the expected’ 
For other women, although they appeared to be aware of the change in their bodies on 
some level, they did not pay it much attention as, for them, it fitted into their normal life 
or their expectations of what was normal.  
“It’s not something I have particularly paid attention to; it’s just one of those things that, 
you know, are there.” (OL31, increased abdominal size, age 62, White British, High 
SES) 
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Figure 8.1 Final thematic framework for analysis  
 
 
 
 
8.3.2.1.3 Detection is overridden by other symptoms or distractions 
A few of the women interviewed mentioned that they had not paid attention to a bodily 
change or had not noticed it because they either were distracted by other things 
happening in their lives or by another, more severe symptom. 
“I had a really catastrophic back injury, so I was in so much pain in general anyway, I 
mean … you can't tell?” (OL01, pain during sex, age 50, White British, Mid SES)  
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8.3.2.1.4 Frequency, persistency or impact of bodily change 
For some women, although they had detected their bodily change when it was 
happening, its behaviour, (for example frequency, persistency or having a minimal 
impact on their life), meant that they did not pay any attention to it, or their detection did 
not go further than a brief awareness. 
“To be honest, I have not particularly noticed. I mean, it’s just not something I have 
thought about, really. They are not things you dwell on unless it’s really, really affecting 
your life, do you?” (OL31, changes in bowel habit, age 62, White British, High SES) 
 
8.3.2.2 Theme Two: ‘Symptom attributions’ 
8.3.2.2.1 Concurrent or past known medical condition, surgery or injury 
Most women, across symptoms, attributed their symptom to an existing or past 
condition, illness, disease, surgery or injury. These attributions suggest that women will 
attempt to ‘fit’ arising symptoms to existing illness heuristics, or explain them within that 
context; at least in the first instance.  
 “I probably blame the fibroids … These things are, kind of, crowding me out, I can’t 
eat, I can’t hold my urine, I can’t do anything, I’m heavy, I’m bloated. So I guess the 
fibroids are what I would, kind of, blame logically first” (OL04, heavier or longer periods 
than normal, increased abdominal size, discomfort in the abdomen, increased need to 
empty bladder more often or urgently and difficulty eating, age 46, White British, High 
SES) 
 
For some women, fitting their symptom to an existing condition required them to make 
assumptions. For example, one woman mentioned that she had sensitive skin on the 
outside of her body, and consequently reasoned that she would have sensitive skin 
elsewhere on her body, including the skin in her vaginal wall, which could have led to 
vaginal bleeding during sex. The woman added further weight to her attribution when 
she later explained that she often bled from her nose when irritating it (for example, by 
blowing it). 
“I think skin sensitivity, I honestly do. I feel that this is minor bleeding on the inside of 
the vagina. I … have excessively sensitive skin on the outside and also in my nose and 
I know that sounds weird but it seems to me that if you're kind of sensitive on the 
outside, why might you not be on the inside?” 
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“You know, if I blow my nose here, it will bleed. I mean, I often get blood there. Not nose 
bleeds, but just blood. It's, so going back to vaginal bleeding, you can see why it's not 
something that would disturb me unduly.”  (OL01, bleeding during sex, age 50, White 
British, Mid SES) 
 
 
8.3.2.2.2 Part of ‘the everyday’, ageing, or part of being a woman 
A number of women attributed their symptoms to something that is part of who they are, 
or ‘how their body works’. For some women, the pattern of the bodily change or 
symptom acted to confirm their attribution. If the bodily change acted in a way that fitted 
with how they expected their body to work, or with their idea of their own natural 
rhythms, or even with simply being female, women were able to attribute the changes in 
the body to something expected or normal for them. 
 
“that’s probably, again, linked to my periods because it’s worse at certain times of the 
month ... I’ve just always thought that maybe it’s, kind of, diet and, kind of, linked with 
my periods. A lot of my friends … complain a bit as well so I just, kind of, think that it’s 
something that’s fairly common ... It was just, kind of, one of those things that you just 
think, well, that’s part of being a woman, really. (OL02, abdominal bloating, age 46, 
White British, High SES) 
 
 
However, if that view was challenged by experience or new information, attributions 
could change. For example, one woman described believing that her vaginal discharge 
was normal until her sister mentioned that she had sought medical attention and been 
given treatment for the same symptom. This new information caused her to reassess 
her own attribution. 
 
“I just … ignored it … thinking it was normal and then she said, “Oh, I’ve gone to the 
doctor and got a medicine for this,” and I, kind of, thought, well if you’ve got a medicine 
for that, does that mean it’s not normal? Whereas before I think I’d just assumed it was 
normal”. (OL10, vaginal discharge that smells unpleasant, age 39, White British, High 
SES) 
 
Another common attribution was for women to put the changes in their bodies or their 
symptom down to ageing or to part of the ageing process, such as the menopause. 
Given that over 40% of the women interviewed were at an age where they would be 
expected to be peri-menopausal, menopausal or post-menopausal (the average age for 
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menopause is 52 in the UK, (NHS Choices, 2013d), it is not surprising that the 
menopause was one of the attributions women made here, and it is quite probable that 
this attribution was correct. For some women, that they were going through a big change 
in their bodies anyway, made it difficult for them to isolate their symptom, in much the 
same way as women who had another symptom found it difficult, as discussed above. 
 
“I'm right in the process of kind of menopausing … periods are getting less and less 
and less and less. So I think they're sort of departing. They may even have gone by 
now, I may actually have had the last one. So it's a very.. it's actually really difficult to 
discern kind of what's bleeding and what's period residue.”  (OL01, bleeding after sex, 
age 50, White British, Mid SES) 
 
 
8.3.2.2.3 Hereditary or genetic 
Another common attribution for symptoms was that they were caused by something 
that was a hereditary or genetic condition. This attribution was often accompanied by 
an explanation that there was a family history of this condition. 
 
“I think it's hereditary, you see, because my mother had this problem as well” (OL01, 
Increased need to empty bladder, age 50, White British, Mid SES) 
 
 
For some women, although they did not disclose that a diagnosis had ever been made 
medically, the symptom had been experienced by many women within their family and 
subsequently a sophisticated explanation had been developed. For example, one 
woman who reported pelvic pain around the time of her period disclosed that dizygotic 
twins ran in her family. In this context, she believed that the pain was caused by the 
release of two eggs during ovulation. This attribution was then further cemented by 
information from her grandmother. 
 
“my nan reckons that eggs are released from both sides or a double egg comes from 
one side every other month … She says that’s why twins run in the family … everybody 
was really surprised when I was pregnant that I … didn’t have twins because … I had 
got those pains … That’s why I have been told that I get those pains, because I get a 
bad pain on my left-hand side every other month.” (OL26, pelvic pain, age 34, White 
British, Mid SES) 
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Some women argued that, although the symptom had never been attributed to a 
specific medical cause, this was not a problem as their family members who had the 
same symptom had lived with it without any complications. 
 
“Just like my mum and my auntie, we are all a bit of a likeness that way. My auntie is 
not known as Windy Wendy for no good reason ... But it’s also one of those things that 
… because members of your family have experienced the same sort of problem as 
they have got older and it hasn’t meant anything, you know, there’s been no problem 
associated with it, you think, oh I’m just getting older and it’s a family thing and I don’t 
worry about it.” (OL33, Increased wind, age 60, White British, Mid SES) 
 
 
8.3.2.2.4 Contraception or medication 
For many women, their symptom occurred alongside taking medication or being on 
contraception (including the contraceptive pill or the coil). They therefore attributed their 
symptom to that issue.  
“I guess I have experienced … heavier periods and bleeding between periods in the 
last three months, more than what I would consider to be normal for me. And I have 
definitely attributed both of those things to the fact that I have been doing fertility 
treatment and having exciting fake hormones.” (OL07, heavier or longer periods than 
normal and bleeding between periods, age 33, White other, Mid SES) 
 
 
One explanation for this attribution may have been that these women applied 
parsimony; the taking of medication or being on contraception was a change in their life 
that they could easily attribute the change in their bodies to. One woman even talked 
about how the symptoms she experienced were obviously caused by the medication or 
contraception. 
 
“I have a contraceptive implant which can cause irregular bleeding and I have had it 
since April. It never caused me any trouble and suddenly all this. So that could be one 
of the reasons. That would be the obvious reason.” (OL37, heavier or longer periods 
than normal, age 30, White Other, Low SES) 
 
In these cases a number of women had already been warned that their symptom may 
be a side effect of the medication they were taking. Therefore, when they did 
experience that symptom, it was logical for them to attribute it to the medication. 
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“I suppose the word on the street really was that if you have a normal coil put in … the 
non-hormonal one, that there is a tendency for your periods to be heavier and so I just 
assumed that that was.” (OL16, heavier or longer periods than normal, age 41, White 
British, Low SES) 
 
 
8.3.2.2.5 Don’t know or nothing 
Not all women had made an attribution for their symptom, and there were a number of 
reasons for this. For many women, the symptom seemed to resolve itself, which led 
them to believe that it had not been indicative of anything serious. These women also 
expressed a lack of concern about their symptoms (for example, see OL06’s quote 
below, in section 8.3.2.2.6), which may have influenced their lack of attribution. 
 
“So I just thought to myself I’ll give it a couple of weeks, it doesn’t feel as though it’s 
anything… it feels literally just under the skin. So I thought I’d give it a couple of weeks 
or so and see if it went, and it did. So that was it really, nothing particularly exciting.” 
(OL06, lump on vulva, age 34, White British, Mid SES) 
 
Other women appeared to have just questioned why their symptom was happening, 
without coming to a conclusion. They had considered reasons for the symptom, but, as 
the reasons did not fit with their idea of how their body worked, they could not decide 
upon an attribution. For example, one woman talked about how the bloating and 
abdominal pain she was experiencing did not fit with what she may have otherwise 
attributed her symptom to (her menstrual cycle), because it did not happen when she 
might have expected it to.  
 
“My stomach was completely bloated and I was just, like, not due to get my period right 
then, so that didn’t make any sense and anyway it wasn’t the right, kind of, cramping. I 
was constipated and I was just, like, why is this happening? I still haven’t worked it out, 
no.” (OL07, Increased wind, constipation, increased abdominal size and abdominal 
pain, age 33, White British, Mid SES) 
 
For some women, the perceived normality or low impact of the symptom meant that they 
had not considered what might have caused it. 
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“It happens. Ooh, it’s happened. It’s not offensive, it’s not a particular… it’s just a little 
blow-off of wind. Now, I’ve never sat and thought, is this associated with what I am 
doing, what I’m eating, what I’m drinking. I’ve never really considered it.” (OL33, 
Increased wind, age 60, White British, Mid SES) 
 
8.3.2.2.6 Possibly new illness 
Although I attempted to avoid the context of cancer and illness, some women did 
mention that they had thought about illness, including cancer when they had attempted 
to attribute their symptoms. However, despite the consideration of cancer, women did 
not appear to have been overly concerned or to truly believe that the symptom could 
indicate a cancer. For example, the woman below mentions that perhaps she should 
have seen a doctor, but she wasn’t sure, despite considering stomach cancer. This 
woman appears to dismiss the idea of stomach cancer partly because her symptom 
seems to have improved, leading her to consider other, benign causes, and partly 
because she does not want to see her GP more than she deems is necessary. 
 
“I don’t know, if I have stomach cancer or, I don’t know, anything like that, because 
everything seemed to be getting better and I, kind of, thought it was probably to do with 
the uterus and the fibroids. Whether I should have gone and spoken to the doctor about 
things as well? I don’t know. I don’t like going to the doctor more than I need to.” (OL04, 
increased abdominal size, discomfort in the abdomen, age 46, White British, High SES) 
 
In the example below, the participant has considered cervical cancer, but again, almost 
seems to dismiss this as over-reaction to her symptoms, referring to herself as a 
‘worrywart’. 
 
“I am either going through the menopause or I have got cervical cancer. And then, for 
some reason, I decided that I could possibly have chlamydia, not that that’s got 
anything to do with your periods or the fact that I was at risk of getting it but I’m just, 
erm, a bit of a worrywart, really.” (OL16, heavier or longer periods than normal, age 41, 
White British, Low SES) 
 
 
A lump is often described in the literature as a classic sign of cancer (for example, 
Robb et al., 2009; Smith, Pope, and Botha, 2005), and there is evidence to support the 
idea that this is by far the most well-known symptom (Robb et al., 2009). However, only 
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a couple of the six women22 who reported a lump even considered cancer as a possible 
cause. Most believed that their lump was something benign, such as a cyst, ingrown 
hair or blocked gland. The lack of serious consideration of cancer in these women may 
have been a result of the location of the lump, as illustrated by the woman below. 
 
“I wasn’t particularly concerned about it …  if I find a lump in my breast, then alarm bells 
start ringing and you start going, oh my gosh, I’ve got to see the doctor straight away… 
it maybe fleetingly went through my mind that it would be something that … needed 
investigation, yeah, a bad lump, a cancerous lump or something like that … it’s not 
causing any problems ... it hadn’t made alarm bells ring in my mind so I just want to see 
what happens to it, rather than rushing to the doctor and freaking out.” (OL06, lump on 
vulva, 34, White British, Mid SES). 
 
Believing symptoms were caused by thrush seems to be a common attribution amongst 
women who reported unpleasant smelling vaginal discharge or itching or soreness of the 
vulva. For the woman below, this attribution was made following a conversation with her 
friend, who offered a simple explanation. 
 
“It’s quite funny really. I phoned up my friend and I said, “I’ve got some stuff, I don’t know 
what it is,” and she said, “What is it?” and I told her and she went, “You have got thrush, 
love.” (OL26, unpleasant smelling vaginal discharge, age 34, White British, Mid SES) 
 
 
8.3.2.2.7 Something I have done or I am doing 
A number of women attributed their symptom or bodily change to something they were 
doing, such as drinking alcohol or eating certain foods, or to something that they had 
done, including causing themselves an injury or damage. For example, the woman 
below attributed her increased frequency and urgency to urinate to damage she 
believed that she had caused by holding her urine for long periods of time during a busy 
time at work. Her language suggests that she had to search quite hard for this attribution 
(“if I really, really thought about it”). 
                                                          
22
 In Table 8.1, seven women are reported as having a growth, lump, sore or ulcer on skin of vulva, 
including six women who reported a lump and one woman who reported an ulcer. 
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“I was working on this … project last year and I literally maybe got to pee, maybe, 
maybe once a day as a special treat to myself ... I was working for, like, 60 or 70 hour 
weeks and it was just mental. And if I really, really thought about it, I would probably 
say it was probably that I did some sort of damage during that period … which 
eventually will probably work itself out.” (OL7, Frequent and urgent urination, age 33, 
White Other, Mid SES) 
 
Another woman attributed her bleeding during and after sex to her rigorous sex life. 
 
“The last three months, on one occasion there was bleeding during or after sex but, as I 
said, that’s down to what we are doing.” (OL14, bleeding during or after sex, age 40, 
White British, Mid SES) 
 
 
8.3.2.2.8 Influences on symptom attributions 
The women in this study described a number of ways in which the attributions they 
made for their symptoms were influenced. One of the most common influences on 
attributions was a previous experience of the symptom or of something else (such as a 
surgery or problems in a similar physiological area). For example, the woman below 
describes how the somatic information she received when she had pelvic inflammatory 
disease was similar to that which she was receiving at the point of interview. It was 
therefore easy for her to attribute her current bodily change to a previously experienced 
condition. 
  
“I was pretty convinced it was gynaecological because in the past I had pelvic 
inflammatory disease when I was a lot younger … the feeling that I had reminded me of 
the feeling when I had that many years ago. So that’s what I thought.” (OL06, 
abdominal pain, age 34, White British, Mid SES) 
 
Women also talked about seeking help via what has been described as the ‘lay system 
of care’ (Pescosolido & Boyer, 1999), which includes family, friends and others that an 
individual may come into contact with, such as colleagues. Some women described how 
the experiences of others influenced their appraisals. For example, the woman below 
had suspected that her irregular bleeding was caused by the contraceptive implant she 
had had fitted, and described seeking advice from a friend who also had this 
contraceptive device fitted. 
 
 
217 
 
“I spoke to my friend who had it as well and she said, “Oh, just take [the contraceptive 
implant] out, it will stop.” So it has, hopefully.” (OL37, heavier or longer periods than 
normal, age 30, White other, low SES) 
 
 
Although the ‘lay system of care’ described above describes help sought from social 
connections, I did find evidence that women may use the information they obtain 
through this system of care differently, depending upon whose advice is sought. For 
example, although women talked about incorporating the experiences of others into the 
appraisal of their own symptoms, this was particularly useful when the advice was 
sought from a relative. This type of advice perhaps gives more depth to the appraisal 
and potential consequences of a bodily change or symptom over and above 
experiences of non-relatives because of the shared genes between close relatives. For 
example the woman below talked about the importance of seeking advice from close 
relatives so as to gauge the level of threat to health that her bodily change poses. 
 
“I talked to my mum and my sister about it and my mum said, oh yeah, it's cystitis, 
cystitis. And I said, it's not …  I think it's hereditary … I just tend to think that it's always 
worth asking your mother and your sister about these things because a lot of these 
things are quite similar within families and if they appear to have the same thing and 
they're still alive, why should I not be?” (OL01, Increased need to empty bladder, age 
50, White British, Mid SES) 
 
Another common influence on attributions was how the symptom behaved. For many 
women, the symptom appeared to occur in patterns around their menstrual cycle, or 
around pre-held beliefs of what illness is, which then made it easy for them to attribute 
the symptom to part of that. This attribution then reduced any worry they might have, 
had the symptom behaved differently.  
 
“you know, if I had had it and then it didn’t turn into a period then I’d be worried but, you 
know, I’d, sort of, have it for a day and then my period comes and then it tails off and I 
suppose it’s just the tail end and the beginning, I suppose.” (OL02, blood stained vaginal 
discharge, White British, Mid SES) 
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One woman interviewed talked about how having a lump on her vulva influenced a 
consideration that she may have cancer, because of the association between a lump 
and cancer. However, interestingly, for most of the other women with the same 
symptom, cancer was not a consideration (as described above).  
 
 
“I didn’t believe it was cancer … It’s really weird but that didn’t worry me at all. Whereas 
I think when you do have a little lump, you think, oh is that… [cancer]? Yes, I think 
there’s an element of that… I hope I haven’t got it. I haven’t had it checked. But it’s in 
the back of your mind, of course. Cancer is the thing, whether it’s breast or whatever.”   
(OL28, lump on skin of vulva, age 57, Mid SES) 
 
 
For other women, when the symptom did not behave in a way that they thought it should 
to fit with an attribution, they then considered alternatives. For example, one woman had 
increased wind and constipation, which she usually put down to an intolerance of raw 
onions. However, when an occasion arose where she experienced those symptoms 
when she had not had raw onions, she came up with an alternative attribution. 
 
“nothing else was out of the ordinary; you know, everything else was completely like 
something I would normally eat. So then I just, kind of, thought, well that’s just weird, 
presumably this could just be stress related.” (OL07, increased wind and constipation, 
age 33, White Other, Mid SES) 
 
8.3.2.3 Theme Three: ‘Responses to symptoms’ 
Women reported a number of different responses to their symptoms, including 
monitoring them or waiting to see what happened, seeing a healthcare professional or a 
non-medical professional. 
 
8.3.2.3.1 Saw a healthcare professional  
Almost all of the women interviewed reported having visited at least one healthcare 
professional (HCP) (a GP, a Genitourinary Medicine (GUM) clinic, a pharmacist, an 
osteopath, the hospital accident and emergency (A&E) department, a consultant or a 
specialist) for at least one of the symptoms I asked about. 
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Women identified a number of different issues which influenced their decision to seek 
medical help for their symptom(s). The most common influences on help-seeking were 
related to the behaviour of the symptom itself. Almost all of the women in the study 
stated that they had sought help, or would seek help if their symptom(s) worsened, 
recurred, or changed. For example, women would be prompted to seek help if a new 
symptom appeared alongside the original symptom or if the symptom persisted. 
 
“maybe if it was associated with the sores or if the skin was broken, if it was like there 
was a possibility of infection … or if it was persistent, you know, and lasted for longer. All 
of those things, yeah … if it did actually combine with, you know, more severe, more 
time and maybe other symptoms.” (OL31, vulval soreness, age 62, White British, High 
SES) 
 
One woman, who was only in her late thirties described waiting until her need to 
frequently and urgently urinate were really quite debilitating before she would seek help. 
 
“It would have to go on for a lot longer and be a lot more urgent …  And if I was wetting 
myself or, you know, partially wetting myself then I would be conscious of smelling or 
things like that. I wouldn’t, sort of, suffer in silence but perhaps having to get up every 
hour in the night or … if it’s twice a night then I can put up with it.” (OL10, increased 
need to urinate more frequently and urgently, age 39, White British, High SES). 
 
Another woman had a tipping point of frequency for her symptom; she determined that if 
her symptom occurred a third time, then she would seek help. 
 
“Once the pain has gone, you just tend to think, well, okay, there’s not really any point. If 
I get it again, the third time will definitely be the cut-off and I will go and see if they can 
refer me on.” (OL02, lower back pain, age 46, White British, Mid SES) 
 
 
Other women who had initially decided to self-manage, or would initially consider self-
management, revealed that if their management of the symptom(s) did not work, they 
would then go, or would consider going to their GP. 
 
“I know my own body much better now so if it goes over three days then I would eat lots 
of liquorish, eat some prunes and drink lots of water and if that didn’t work then I would 
probably go to see my GP.” (OL35, constipation, age 64, White British, Low SES) 
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Another, perhaps unsurprising influence on help-seeking was fear, concern or worry 
about what the symptom may indicate. For some women this fear or worry was related 
to an attribution that the symptom was indicative of something serious, which was 
related to an awareness of a family history of illness. 
 
“I had read that if you get bloating and it doesn’t go away, that is usually a sign maybe 
that’s cancer. If it went down, which happens to me, it probably isn’t …There is quite a 
history of cancer in my family … I was frightened so it prompted me… I think I am 
probably like a lot of people who think, oh it will go away, it will be fine, don’t worry, but it 
didn’t and … I got scared.” (OL43, persistent bloating, age 64, White British, Low SES)  
 
 
Another common influence on medical help-seeking was being in pain or discomfort, 
with almost half of the women interviewed mentioning that this would prompt them to 
seek help. The woman below emphasised just how bad the symptom would need to be 
before she would seek help (“If it was painful or really, really bad”). 
 
“it depends how bad it was. If it was painful or really, really bad, then yes, obviously, but 
if it was just a bit of an odour, then, no, I probably would just wait and see.” (OL10, 
vaginal discharge that smells unpleasant, age 39, White British, High SES). 
 
 
A number of women talked about feeling justified in seeking help. This feeling of 
justification came in a number of different forms. For some women, the simple presence 
of the symptom was sufficient justification. One woman reasoned that she would go to 
her GP if her symptom occurred again because, “you are getting that for a reason” 
(OL02, lower back pain, age 46, White British, Mid SES). For others, however, the 
presence of the symptom was not enough to prompt them to seek medical attention, and 
they needed further justification. For example, in the quote above from participant OL43, 
this woman describes how her family history, along with the behaviour of the symptom 
and the fear this caused led her to seek help. This need for further justification is 
possibly linked to a concern that the symptoms weren’t serious enough, and that there 
was a possibility of wasting the doctor’s time. This is illustrated in the quote below. 
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“I felt, silly enough, it justified me going to the GP because I’d had the background. … 
it’s quite old-school thinking - you don’t bother a doctor until you are nearly dying. But 
that justified… yes, there is… it didn’t need justification but that made me think I can go 
now, which is stupid … Yeah, it was stupid that I thought oh now I’ve got that they won’t 
think that I am just… which is stupid.” (OL43, persistent bloating, age 64, White British, 
Low SES)   
 
 
A couple of women talked about initially believing that their symptoms were something 
that every woman experienced. However, after investigating their symptoms online, and 
reading about the experiences of other women, they realised that perhaps their 
symptom wasn’t normal, and consequently they felt justified in seeking medical 
attention. 
 
“I … saw other people’s experiences and that … persuaded me that mine was bad 
enough to actually do something about it and that I wasn’t just making a fuss about 
nothing … I, sort of, realised yes, it probably is quite bad ... that was probably a factor in 
doing something about it as well.” (OL03, heavier or longer periods than normal, age 34, 
White British, Mid SES). 
 
Women perceived a number of different barriers to help-seeking. Two of the most 
common reasons were a lack of worry about the symptom or perceiving the symptom to 
be minor or not serious enough and believing that there was no point, or not enough 
justification (see above) to seek medical attention. Some women believed that there was 
no point in seeking help because they felt that what they were experiencing was just 
something that ‘happens’. 
 
“I guess I have not thought enough to be able to actually go and get it sorted out or, you 
know, speak to anybody about it, I just, kind of, assumed, you know, that might be what 
happens.”  (OL24, bleeding between periods, age 35, White British, High SES). 
 
For one woman, her lack of concern about her symptom led to her feeling that she was 
not bothered enough to seek medical attention. 
 
“I’d say not [severe] enough to bother to do anything about it. “ (OL27, pain and 
discomfort during sex, age 52, White British, high SES) 
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Other common reasons for avoiding seeking help included not prioritising help-seeking 
or putting it off. One woman talked about having help-seeking ‘in the back of her mind’, 
and her language is quite flippant, suggesting a lack of real concern, despite considering 
that she may have either cervical or ovarian cancer. 
 
“I mean in the back of my mind … is, I really must do something about it to make sure I 
haven’t got cervical cancer. And there was a minor ovarian cancer scare for a few days.” 
(OL01, vaginal bleeding after sex, age 50, White British, Mid SES) 
 
Other reasons for putting off seeking medical attention or for putting it off included 
having other illnesses or more urgent health needs, needing or wanting to put others 
first, having a holiday booked, believing that the symptom was a one-off, or judging the 
symptom by previous experiences. For example, one woman had previously 
experienced severe pancreatitis. This previous experience of a very painful and severe 
illness coloured her judgement of later symptoms, whether they were similar or not. 
 
“I have been with the pancreatitis, that was drastic … obviously, that’s immediate. 
Whereas this isn’t quite immediate and I think, actually, that’s a bad thing for me 
because I tend to judge everything by that previous experience, say, well if it’s not like 
that, it’s not as urgent, it’s not as important, which isn’t a good thing … I have been 
blowing it off a bit.” (OL14, heavier or longer periods than normal, age 40, White British, 
Mid SES). 
 
 
A few women described previous bad experiences with a doctor, which then put them off 
considering going in the future. For one woman, her negative experiences with her GP 
led to her decision to seek private medical health care in the future. 
 
“So that’s the end of it, really. I don’t know, I don’t think I will bother going to NHS 
doctors, really, with this again. I’m thinking of going private. Private costs but at least 
they will actually listen to you.” (OL37, bleeding after sex and pain during sex, age 30, 
White other, low SES) 
 
A number of women reported service barriers to seeking help, namely a difficulty in 
getting an appointment, or not having enough time with the GP once an appointment 
was made.  
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“It would have to be easier to get an appointment with the GP. It really is that, that is 
such a bloody drama. And you get you know, thirty seconds with you GP and you're 
allowed to talk about one thing.” (OL01, vaginal bleeding after sex, age 50, White British, 
Mid SES)   
 
Another service barrier that women mentioned in the present study was a concern about 
wasting GP time. For most of these women this seemed to stem from a belief that 
perhaps their symptoms weren’t serious enough, or there wasn’t adequate justification 
to ‘bother the doctor’. 
 
“I would do. I’m sensible. I’m not going to be stupid about it, but, on the other hand, I 
don’t want to bother people because there are people who are really ill.” (OL28, itching, 
pain or soreness of vulva, age 57, Mid SES). 
 
In much the same way that persistency or frequency of a symptom would influence help-
seeking, a lack of persistency or frequency for some women acted as a barrier to help-
seeking, although again, this did seem to be linked with a concern about bothering the 
GP unnecessarily, or wasting their time. 
 
“I think it would have to be more persistent and last for longer for me to think it was 
worthwhile to bother the GP. You always feel apologetic when you see a GP.” (OL31, 
constipation, age 62, White British, High SES) 
 
 
For a number of women, the gender of their GP acted as a barrier to help-seeking. Most 
of these women said that they would prefer a female GP as they would feel 
embarrassed about talking to a male GP about the symptoms in this study. 
 
“I think it would have to become really bad. Because he’s the male GP as well and I 
would feel a bit embarrassed talking to him in a way.” (OL36, increased wind, age 53, 
White British, Mid SES) 
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Finally, one woman talked about a lack of trust as a reason why she would not want to 
go to her GP with intimate female health issues. 
 
“I think there is a real problem with clinics, that there’s nobody… you go into your GP, 
there’s nobody specific who knows who you are, or cares, you are just a number, and I 
know it may be more efficient but I think for female health and particularly things about, 
you know, vagina or sex or this stuff, you need to have somebody that you trust and you 
can go to.” (OL28, Pain/discomfort during sex, Itching, pain or soreness of vulva, 
Growth/lump/sore/ulcer on skin of vulva, age 57, Mid SES). 
 
8.3.2.3.2 Self-manage, monitor, learn to live with or ignore symptoms or nothing 
can be done 
The majority of women interviewed reported having at least one symptom that they 
decided to live with or self-manage, rather than seek medical help, although the reasons 
or justifications they gave for these decisions varied. The language used by some 
women suggested that they viewed their symptoms with a ‘stiff upper lip’, deciding that 
they shouldn’t let it interfere with their lives, even if it was causing them discomfort or 
concern. 
 
“I would say in my mid-40s it started to bother me. I mean, it is a bother but, you know, 
you just put up with it, don’t you?” (OL21, increased wind, age 62, White British, Mid 
SES) 
 
Other women described self-management as a way of ruling things out, or deciding 
whether medical attention was needed. 
 
“I took some motilium and, kind of, moved on with my life and, sort of, figured if it went 
on for any longer then I probably would go and see my GP because that would be 
worrying.” (OL07, increased abdominal size that does not go away (including bloating), 
age 33, White other, Mid SES) 
 
Some of the women who used self-management as a way of ruling things out or 
deciding whether medical attention was needed had an idea about what might have 
caused their symptoms, which appeared to influence their response to it. 
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“I think I’d probably try and sort myself out first with eating and say, right, okay, that’s 
enough of dairy … and then I’d see how it went from there and then if I thought I needed 
to go to my GP, I’d head off there.” (OL27, increased abdominal size, age 52, White 
British, high SES) 
 
For a few women, their decision to put up with their symptom or ignore it seemed to be 
related to the impact it had on their lives. 
 
“it’s not frequent enough, it doesn’t give me any trouble, so, as I say, I’m inclined just to 
ignore it.” (OL33, increased wind, age 60, White British, Mid SES) 
 
One of the most common non-medical self-management techniques that women 
mentioned was to manage their symptoms with food or drink remedies, including 
avoiding certain foods or drinks or introducing others into their diets. Women who 
reported using these self-management techniques mostly reported experiencing 
changes in their bowel habits, including constipation and a persistently increased 
abdominal size, including bloating. This suggests that women believed that their 
symptoms were related to their digestive system, and that they could be resolved by 
altering their eating or drinking habits. For a couple of women, using food or drink 
remedies was preferable to using medication. 
 
“I don’t take laxatives or anything like that. I try to do it through what I eat, through 
roughage. I don’t know whether it’s a lazy gut or whatever because sometimes it can be 
violent.” (OL43, changes in bowel habit, including constipation, age 64, White British, 
Low SES) 
 
 
Although this form of self-management was mostly reported by women who had 
changes in their bowel habits or an increased abdominal size, some women with other 
symptoms also reported using food or drink remedies to manage their symptoms. Three 
women with difficulty eating or feeling full quickly also mentioned attempting to make 
changes to their diets, including reducing their portion sizes, eating a variety of foods 
and eating higher fat foods for energy. 
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“in order to really make sure that I've eaten lots of good solid food that's going to keep 
me strong and keep me moving around, cos I walk and .. I do a lot of stuff. I really do 
rely on fairly kind of high fat stuff.” (OL01, difficulty eating, age 50, White British, Mid 
SES). 
 
Some women mentioned using remedies involving food or drink for symptoms that aren’t 
directly related to the digestive system. For example, one woman mentioned eating 
probiotic yoghurts to combat the unpleasant smelling vaginal discharge that she was 
experiencing, whilst another considered drinking nettle tea to help stop the heavy 
periods she was experiencing, as she believed that this would be effective for her. 
 
“I was considering … nettle tea, it’s a very effective blood-stopping herb… it’s not very 
tasty but I believe if it doesn’t stop I’ll have to start drinking it. But that’s what I 
considered. I didn’t actually have to do it in the end.” (OL37, heavier or longer periods 
than normal, age 30, White other, low SES) 
 
 
Women who were experiencing an increased need to empty their bladders managed 
their symptoms in a number of ways. Some mentioned ensuring that they always went 
to the toilet just before they left their homes. Other management methods included 
avoiding drinking too much or at all before leaving the house or at night. 
 
“I cannot have a drink before I come out. I’ve got an hour … train journey. It’s the 
inconvenience. Because you want to go … I know every toilet in every shop. You are 
gearing where are the loos, that’s the first thing you do and it’s just peeing me off, to be 
quite honest.” (OL43, increased need to empty bladder, age 64, White British, Low SES) 
 
 
Three of the women experiencing pain during sex reported managing their symptom by 
either avoiding penetrative sex, either altogether or during certain times of the month, 
when the pain increased or by using lubricant and ‘taking things slowly’. 
 
“So it’s just managing it and, sort of, finding the time in the month when it’s going to be 
okay. But I appreciate that that will probably get worse and then we’ll have to think about 
other ways of lubrication and stuff. I’m not quite there yet.” (OL02, pain during sex, age 
46, White British, Mid SES). 
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Two women who were experiencing pain in the lower back managed their symptom by 
making changes to their lifestyle or surroundings. For example, one woman mentioned 
that she had been a keen runner, but had read that running was bad for her, so she 
stopped running and found that her back pain improved. Another woman found that 
walking around, rather than lying down was the best way to manage her back pain. 
 
“The best thing I can do when I have got a bad back is… don’t stay in bed, you get up 
and you walk. That was just a natural thing that I felt that I had to do because I think if I’d 
have stayed in bed I would never have got up again.” (OL35, lower back pain, age 64, 
White British, Low SES) 
 
 
Finally, some women reported self-medicating with over the counter medications; again, 
the medications used varied by symptom. One woman reporting constipation mentioned 
that, although she preferred to use non-pharmaceutical methods to manage her 
symptoms, she would also use laxatives when she felt that her symptoms might worsen. 
 
“sometimes I buy a laxative when I feel like I will blow up and I have tried liquorish, 
sometimes different things. So if I change my diet it can help. And I was given loads of 
fibre something, a laxative you make up into a drink by my GP and I really, really don’t 
like it; I’d much rather take a tablet. But I would rather not do anything.” (OL35, 
constipation, age 64, White British, Low SES) 
 
 
Half of the women interviewed said that they would monitor or wait and see what 
happens with at least one of the symptoms they reported. This behaviour either seemed 
to be influenced by a concern over seeking help prematurely, when the symptom may 
resolve itself or not being particularly worried about the symptom, or a hope that the 
symptom would resolve itself and not require medical attention. 
 
“Then I had a little feel, I thought, oh s**t, I’ve got a lump. And then you think [gasps], 
there’s always a moment of [gasps] oh gosh, oh gosh, and then I take a deep breath 
and think, well it will probably go away and if it doesn’t then I’ll do something. That’s my 
psychological, kind of, pattern.” (OL28, lump on vulva, age 57, Mid SES). 
 
Some women again wanted to gather information before seeking medical help, which 
involved monitoring the symptom.  
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“I like the wait and see approach because then, you know, you are gathering more 
data, so to speak, so if it does actually really become a problem, you can go to the GP 
and say, look, this has been going on for x amount of time, this has happened, that’s 
happened, this is happening, I’m not happy there is something wrong. Rather than 
rushing off and going, oh, I’ve Googled it, I’m dying, kind of thing, which is wrong.” 
(OL14, heavier or longer periods than normal, age 46, White British, High SES) 
 
Two women talked about having time limits for how long they would wait and watch their 
symptom for, or limits on how many times the symptom had occurred before they would 
stop monitoring their symptom and seek medical help. 
 
“actually, my behaviour would be that if it was something that I thought, oh my God, it’s 
something really bad, and then to calm down for a bit and think, oh no, it’s not, it’s just 
one of those things. And then just to see how things went and after a week or two if it 
was still going on, to actually go and see the GP.” (OL05, heavier or longer periods than 
normal, itching, pain or soreness of the vulva, changes in bowel habit, age 46, White 
British, Mid SES). 
 
Other women believed that their symptoms were not indicative of anything serious, and 
therefore felt that monitoring them was the best thing to do. 
 
“I wasn’t particularly concerned about it. I mean, I suppose, if I find a lump in my breast, 
then alarm bells start ringing and you start going, oh my gosh, I’ve got to see the doctor 
straight away. So I just thought to myself I’ll give it a couple of weeks, it doesn’t feel as 
though it’s anything.” (OL06, lump on vulva, age 34, White British, Mid SES) 
 
 
8.3.2.3.3 Sought advice or information from lay sources or health websites 
 
Some women opted to seek advice from a source other than a healthcare professional, 
including looking for information online, usually on sites such as NHS Direct23. Other 
women sought advice or information from lay sources, including their friends, family or 
colleagues and online, on non-medical sites, including Mumsnet24. 
 
                                                          
23
 www.nhsdirect.nhs.uk 
24
 www.mumsnet.com 
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A few women saw searching online for information as a precursor to seeing the doctor. 
One woman discussed how this enabled her to try to ‘suss out’ what was going on 
before she saw her GP. Another described being proactive about seeing her doctor, but 
stated that she sought information from the internet and NHS Direct before doing so. 
 
“The first port of call is usually the internet, the second port of call would be NHS Direct, 
the third port of call would be go and see the GP.” (OL30, constipation, age 32, White 
Irish, Low SES) 
 
For other women, however, the internet was used as the sole manner of diagnosis, 
rather than in addition to, or before seeking medical help. Using the information or 
advice they received online, women then self-diagnosed and took action accordingly to 
the diagnosis they had made. 
 
“I tried to stick to the NHS sites actually when I was looking because I thought I could 
trust the advice on those. The one thing that… kept seeming to come up? … 
[Endometriosis] … that’s come up a few times and that slightly concerned me, and that’s 
why I probably felt I best leave that for now because I can think about that another time.”  
(OL24, heavier or longer periods than normal and bleeding between periods, age 35, 
White British, High SES). 
 
 
For one woman, the internet was a place to obtain additional information, alongside that 
given by a doctor. 
 
“Then I went to see the doctor and she said she didn’t think I was peri-menopausal but 
referred me for a scan and then I just Googled what that would all mean and what the 
implications were.” (OL05, heavier or longer periods than normal, age 46, White British, 
Mid SES). 
 
 
Although these women may have felt that the internet was a useful tool when arming 
themselves with information or ruling things out before visiting the GP, some women 
found looking on the internet unhelpful because they felt that they would always be told 
that they were seriously ill. 
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“I do remember Googling these things, and they always come out, you know, with all this 
terrible melodramatic stuff and you think, I'm going to drop dead tomorrow.” (OL01, 
difficulty eating or feeling full quickly, age 50, White British, Mid SES)   
 
Although many women did seek advice on the internet, some also sought advice or 
information from those around them. For some, this then influenced whether they would 
go on to seek medical help or not. 
 
“A friend of mine … is a doctor and I, sort of, said, “Oh, it’s all been a bit horrible,” and 
he was just like, “You are fine,” … I find the thing that if you have a lot of friends who are 
doctors and you do, sort of, say, “I feel a bit ugh,” and they are like, “Yeah?” … What do 
you want me to do about it? ... It gives you a slightly … robust approach to whether or 
not I am actually going to go to the doctor.” (OL07, constipation, increased abdominal 
size and abdominal pain, age 33, White other, Mid SES) 
 
 
8.4 Discussion 
 
8.4.1 Overview of findings 
This study is, to my knowledge, the first to explore how British women attribute changes 
in their bodies potentially indicative of a gynaecological cancer and responses to them in 
women with real symptoms, using a qualitative methodology. Building on the previous 
chapters, I aimed to explore the processes involved in the detection and interpretation of 
bodily changes. I also explored influences on interpretation, attributions and responses 
to symptoms through semi-structured interviewing. 
 
The design of the study was underpinned by reference to the first two intervals 
(‘Appraisal’ and ‘Help-seeking’) of the MPT (Walter et al., 2012, see Figure 2.5 on page 
57), and the events and processes that surround transition from one interval to the 
other. Overall, my findings map broadly onto the MPT, as I found evidence for the 
influence of patient factors in the appraisal process (such as having a previous 
experience of a symptom or something similar) and disease factors (such as having 
preconceptions about what a cancer symptom is) (see Figure 8.2). I did not find 
evidence for the influence of healthcare provider or system factors on appraisal, which is 
unsurprising as women may not have considered seeking help at the appraisal interval. I 
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also identified a number of patient factors which influence help-seeking (such as feeling 
justified or worrying that a symptom might be serious) and some that acted as barriers to 
help-seeking (such as experiencing other, more pressing health issues or social 
conflicts). Being able to see a female was one of the healthcare provider and system 
factors which acted to encourage help-seeking, whereas concern about wasting GP time 
acted as a barrier. Further, I also found evidence for the influence of disease factors, 
such as a worsening, change or recurrence of a symptom which acted to encourage 
help-seeking and having an infrequent or non-severe symptom, which acted as a 
barrier.  
 
I found evidence that women may not always choose to seek medical attention, and will 
sometimes seek advice elsewhere, such as on the internet or through engagement in 
the ‘lay system of care’ (Pescosolido & Boyer, 1999). As such, I added this option to the 
processes within the appraisal interval in Figure 8.2, below. My findings are discussed in 
more detail below, with my discussion broadly organised in relation to the MPT. 
 
Figure 8.2 Mapping of influences on appraisal and help-seeking found in the present 
study onto the MPT 
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8.4.2 Detection of a bodily change 
During the interview process, I found that it was difficult to truly explore the natural 
process of the detection of a bodily change. The action of asking women about their 
bodily changes prompted some women to pay attention to changes that they may not 
have previously or otherwise noticed. I also found evidence in this study (both in the 
artificial interview situation and from real life) that some bodily changes remain in the 
background, outside of explicit detection (and therefore the interpretive and appraisal 
process) until attention is drawn to them. Given that our bodies are constantly 
processing sensations at the most basic level (for example, internal processes) it is 
understandable that not all can, or should, be attended to.  
 
8.4.3 Appraisal  
Once bodily changes have been attended to, they will then be subject to an interpretive 
process, resulting in a belief that the bodily change is either a symptom or threat to 
health, or it is not (Halkowski, 2006; Walter et al., 2012). The majority of ‘delay’ in a 
diagnosis of cancer is attributed to the appraisal stage (for example, Andersen et al., 
1995; de Nooijer et al., 2001; Walter et al., 2012). As such, it is of vital importance that 
we are able to develop a solid understanding of the appraisal process in women with 
bodily changes that may be indicative of a symptom of a gynaecological cancer. 
 
Evidence from the present study suggests that bodily changes may be appraised on 
different levels, and that a lower level (or lack of) processing and interpretive work is 
linked to the context within which the change was experienced or the behaviour of the 
bodily change. If bodily sensations were congruent with what they expected to happen, 
or they were not very different to what may be expected to happen as part of being a 
woman, or of ‘the everyday’ (such as vaginal bleeding), they were not interpreted as 
symptoms. For example, bodily changes that occurred during the menopause (or for one 
woman, the In Vitro Fertilisation process) were easily attributed to that, when a higher 
level of cognitive processing may have occurred outside of that context. Further, I found 
evidence that if a symptom is not in an ‘expected’ location (i.e. the breast), even the 
233 
 
‘classic’ cancer symptom of a lump (for which there is evidence of high levels of 
awareness, (Robb et al., 2009)) can be dismissed as being something benign. This 
process fits with the ‘location’ heuristic, described in the CSM (Leventhal et al., 1980) 
(see Chapter Two, and Table 2.1), which was used in the development of the MPT 
(Walter et al., 2012). 
 
This finding also fits with previous research showing that women with atypical symptoms 
take longer to seek help, suggesting that they are less likely to be appraised as cancer, 
(Ramirez et al., 1999). Further, this can also be explained within the context of the CSM, 
described in Chapter Two. The CSM describes an ‘identity’ domain (i.e. symptoms and 
labels), which may influence the coping response (i.e. whether one seeks help or not), 
as an individual who believes that the symptom is indicative of something serious may 
be more inclined to seek medical attention. Evidence from the breast cancer literature 
shows that an inability to correctly identify a range of symptoms, measured on an 
‘identity scale’ significantly predicts an intention to wait longer before seeking help 
(Grunfeld et al., 2003). 
 
The findings around the influence of the behaviour of a bodily change and the context 
within which it occurs are supported by Pennebaker and Epstein's (1983) research, 
which posits that we hold beliefs about the way in which we expect our bodies to 
function and other research that asserts that symptoms (or bodily changes) will be 
interpreted within an individual’s social (Ajzen, 1985, 1991; Diefenbach & Leventhal, 
1996; Dingwall, 1976; Pescosolido & Boyer, 1999) and cultural context (Andersen et al., 
2010). As many of the symptoms in the study are not occurrences that would be far 
removed from those women might expect as part of their normal lives (for example, 
every woman of child-bearing age will be used to vaginal bleeding as part of their 
monthly periods, and it may be the case that, on occasion, those periods are heavier or 
longer with no sinister cause), this tendency towards an attribution to ‘the everyday’ is 
not surprising. 
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I found evidence that women seek out lay advice within their lay system of care here, 
with women describing seeking advice from friends and family members, as described in 
the IAM (IAM, Dingwall, 1976), discussed in Chapter Two. However, my findings 
suggest that social influence may be more complex than simply seeking advice from 
one’s friends. For example, some of the women in the present study discussed seeking 
advice from family members, but in doing so were also given information about their 
family history that may have explained their symptoms; in turn this may have influenced 
attributions. It may be important for future research to distinguish the difference between 
lay advice from friends and family, as the experiences of close relatives may hold more 
weight than the experiences of friends due to the possibility of an inherited 
predisposition shared with a family member. 
 
8.4.4 Responses to bodily changes and symptoms 
A common response to the symptoms experienced in the present study was to self-
manage or put up with a symptom, rather than to seek medical advice. This was 
consistent with my finding in Chapter Seven that the most common response to a 
symptom was to monitor it, and also consistent with Cooper et al.'s (2013) findings, 
reported earlier. For some women this response was borne out of a decision that they 
did not want the symptom to interfere with their lives, even if it was worrying or causing 
discomfort. That a ‘stiff upper lip’ attitude may influence help-seeking for symptoms of 
cancer has been previously explored (for example, Forbes et al., 2013). However, often 
this stoicism is thought to be a male trait, rather than a female one (for example Barsky, 
Peekna, and Borus, 2001), and has been explored in the literature on male cancers as a 
possible reason for a delay in seeking medical attention (Mason and Strauss, 2004). 
The findings in the present study suggest that this is not an exclusively male trait, and 
perhaps warrants further exploration as an influence on female help-seeking for 
potential cancer symptoms in the literature. 
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For other women here, the decision to put up with or self-manage their symptom was 
the result of a belief that they knew what had caused it. These women wanted to rule out 
benign causes or felt that their symptom did not have a large enough impact on their 
lives; as such, they felt that they could either manage the symptom themselves or put up 
with it (again consistent with the findings reported by Cooper et al. (2013)). However, a 
number of women did mention a ‘tipping point’ at which they could no longer manage or 
put up with their symptom, or at which their initial attribution had been ruled out and they 
would consider seeking medical attention. For some women this tipping point was quite 
concrete and specific. For other women, however, the tipping point wasn’t specific or 
concrete, and was influenced by an increase in persistency, severity or a change in the 
symptom (including the addition of new symptoms). Some of the literature and media 
campaigns encouraging help-seeking for symptoms potentially indicative of cancer 
(including ovarian) do highlight time-points at which one should seek help (NHS 
Choices, 2013a), and it seems that this may be beneficial in encouraging help-seeking 
for symptoms of gynaecological cancers. Further, Leventhal’s CSM (Leventhal et al., 
1980) posits that symptoms which last longer are more likely to be perceived as serious 
than those that last for shorter periods of time (see Table 2.1), which in turn may lead to 
an increased likelihood for seeking medical attention. 
 
Fear of what a symptom might mean (including whether it may indicate a cancer) is 
often cited as a barrier to seeking medical attention (Smith et al, 2005; and Chapter Six). 
My findings in the present study, however, suggest that the relationship between fear 
and help-seeking may be more complex than this. Reflecting my summary of the 
literature on help-seeking for female cancers in Chapter Three, in the present study I 
found evidence that, for some women, when a consideration of cancer was coupled with 
fear, it acted to prompt help-seeking, whereas a consideration of cancer without fear 
(mainly because the consideration was not a serious one) seemed to act as a barrier to 
help-seeking. The discrepancy between my findings here and those in Chapter Six and 
in some of the literature on help-seeking for symptoms of gynaecological cancers (for 
example, Smith and Anderson (1985) may be due to the methods used in these 
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previous studies. For example, in Chapter Six, women were asked about their intended 
response to hypothetical cancer symptoms, and as previously discussed, intention does 
not always predict behaviour. Further, although some of the literature does involve 
patients who have had a diagnosis of cancer, these accounts are retrospective (the 
limitations of this type of literature is discussed earlier in the thesis, see Chapter Three). 
 
A number of the women in the present study described seeking help only when they felt 
justified in doing so. This may be linked to the ‘stiff upper lip’ attitude and a subjective, 
perceived ‘tipping point’. Women may continue to put up with their symptoms, even 
when they are quite severe up until the point that they feel justified in seeking help, 
which may be linked to a worry about wasting the doctor’s time. A couple of women 
mentioned feeling justified because they had heard of other women with similar 
symptoms who had sought help, or perhaps had a diagnosis of illness, or because they 
had a family history of an illness, which added weight to an attribution of illness for their 
current symptoms. In their qualitative synthesis of studies reporting help-seeking for 
symptoms of cancer, Smith et al. (2005) also found that sanctioning of help-seeking 
(sometimes by friends and family members) added legitimacy to the decision to seek 
help, encouraging symptomatic individuals to do so. Taib et al., (2011) described the 
importance of others in the need to be sanctioned as sick or ill in order to interpret 
symptoms of breast cancer as serious. Moreover, there is evidence in the literature that 
marital dissatisfaction and a lack of emotional support may contribute to a longer time to 
help-seeking for symptoms of a gynaecological cancer (Cochran et al., 1986), 
suggesting that a lack of individuals who may help to sanction the decision to seek help 
may reduce the likelihood of doing so. Finally, the effects of sanctioning in seeking 
medical help can be described within the IAM (Dingwall, 1976) and the NEM 
(Pescosolido & Boyer, 1999) (see Chapter Two). The IAM assumes that interpretive 
work will be undertaken not only by the individual, by also by others within their social 
networks, which may lead to a belief that a symptom is normal or abnormal, and 
consequently may lead to help-seeking or not. Within the NEM, again, help-seeking is 
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placed within the context of social networks and influences. The model posits that an 
individual may be encouraged or discouraged from interpreting a bodily change as a 
symptom or help-seeking, depending upon the interactions they have had with others 
within their social network. 
 
Women also mentioned some of the service barriers (including not being able to get an 
appointment with a GP and a concern about wasting the GP’s time) and practical 
barriers (such as not having time to see a GP or having too many other things to worry 
about) explored in Chapter Six and in other literature exploring help-seeking for 
symptoms of cancer (for example, Robb et al. (2009); Waller et al. (2009)).  
  
Unsurprisingly, given the nature of the symptoms explored in the current study, some 
women expressed a preference for a female GP, and suggested that the lack of 
availability of a female GP may contribute to a longer time to help-seeking. One woman 
also mentioned the need for a trust-based relationship with a GP for intimate female 
health problems. 
 
8.4.5 Strengths and Limitations 
This qualitative study was the first to explore the experiences of British women with 
symptoms that may indicate one of the five gynaecological cancers, and to do this 
outside of the context of cancer. The qualitative approach proved to be successful at 
examining influences on attributions and interpretations, as well as responses to 
symptoms on a deeper level than may have been achievable using a quantitative 
methodology. 
 
Two of the main limitations within the present study relate to the sampling and the 
exploration of how women detect a bodily change. I attempted to achieve a diverse 
sample in terms of ethnicity, education and SES by recruiting from a number of different 
companies and agencies. Although there was some variation in housing situations and 
car ownership, my final sample was not as diverse as I had aimed for, as all of the 
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women were from a White ethnic background (although not all were British) and all had 
a formal education. The aim of qualitative research is not to generalise to a larger 
population, and as such does not need to achieve a population representative sample. 
However, my findings in Chapters Five, Six and Seven showed that there were 
differences in symptom and risk factor awareness, anticipated time to help-seeking and 
symptom reporting between different ethnic and SES groups. It may be the case that 
some of the themes identified here may not be applicable to women with a lower SES or 
those from non-White ethnic background. Moreover, had my sample been more 
heterogeneous, additional themes may have emerged, that were not identified here, 
although I did reach data saturation within my relatively homogenous sample. 
Nonetheless, similar research focusing on these groups of women may be beneficial. 
 
Similarly, I initially aimed to purposively sample four groups of women to represent those 
who may have been more likely to have engaged in appropriate help-seeking  and those 
who may have engaged in inappropriate help-seeing. This was not achievable as the 
majority of women had a number of symptoms that may have spanned a number of 
different groups. However, my final sample included women with a range of symptom 
and help-seeking experiences. As such, it is not anticipated that the findings here will 
have been influenced by the lack of these four distinct groups. 
 
8.4.6 Conclusions 
I found evidence here that, once bodily changes have been attended to, they are not 
always subject to the same level of processing. The level at which a bodily change or 
symptom is processed may be influenced by the socio-cultural context within which it is 
experienced. It seems that if a symptom or bodily change is congruent with what is 
expected, or can be attributed to part of the normal bodily processes one experiences, 
individuals will apply a lower level of appraisal.  
 
In particular, it should be noted that women hold a number of expectations about what it 
means to be a woman, such as experiencing vaginal bleeding or going through the 
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menopause. These anticipated processes may not always be very different to symptoms 
that may indicate a gynaecological cancer, which may make it difficult to make an 
attribution outside of these boundaries, and easier for women to normalise or minimise 
their symptoms. 
 
Women in the present study mentioned a concern about wasting GP time and about 
needing to feel justified in seeking help, or reaching a ‘tipping point’. Part of this seemed 
to be influenced by a tendency towards a ‘stiff upper lip’, which may not always be seen 
as a female trait, and a need for their decision to seek help to be sanctioned by others 
either directly or indirectly (through learning of the experiences of others or by learning 
of a potential genetic predisposition to certain conditions). This ‘stiff upper lip’ seems to 
be under-explored in the current literature on help-seeking for symptoms of female 
cancers, and should be considered when developing interventions encouraging women 
to seek help. 
 
Women specifically mentioned a need for trust, and for some, a female GP, when they 
did decide to seek help. This is understandable given the intimacy of the symptoms 
explored in the current study. Having the availability of a female GP may encourage 
help-seeking in this group of women, as well as being able to seek help in an empathetic 
and trusting environment. 
 
Finally, I demonstrated that there are a number of patient, disease and healthcare 
provider and system factors that influence the appraisal and help-seeking interval within 
the MPT. Future studies might test the predictive power of these variables in relation to 
the first two intervals of the MPT. 
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CHAPTER NINE – GENERAL DISCUSSION AND CONCLUSIONS 
 
9.1 Summary of thesis rationale  
The research in this thesis was undertaken in response to an increased effort to improve 
survival rates for cancers in the UK (Department of Health, 2011b; NHS Scotland, 2008; 
Northern Ireland Cancer Network, 2008; Welsh Government, 2012), an effort likely to 
have been driven by evidence in recent years that the survival rates for many cancers 
are falling behind those observed in other European countries (Coleman et al., 2011; De 
Angelis et al., 2014; Sant et al., 2009; Thomson & Forman, 2009). In particular, I 
focused on gynaecological cancers, as this group of cancers poses a significant threat 
to women (see Chapter One), and yet, are under-represented in the early diagnosis and 
help-seeking literature, as demonstrated in Chapter Three. Consequently, 
gynaecological cancers are worthy of a research focus aimed at encouraging prompt 
help-seeking for symptoms. 
 
9.2 Thesis aims and research questions 
The overarching aims of this thesis were to understand current levels of awareness of 
gynaecological cancers and the processes involved in help-seeking behaviour (including 
which variables may be most influential on help-seeking behaviour), and to explore, 
using the MPT, when these variables may be most influential. In Chapter Four, I laid out 
four research questions that I aimed to answer in my thesis. Below I have summarised 
my findings in relation to these questions. 
  
9.2.1 How much do women in the United Kingdom currently know about 
gynaecological cancer symptoms and risk factors? 
In studies one and two (presented in Chapters Five and Six) I explored awareness of 
symptoms and risk factors for cervical and ovarian cancer in women in England using 
the Cervical CAM and the Ovarian CAM, respectively (Simon, Wardle, et al., 2012). 
Although I measured both recalled (unprompted) and recognised (prompted) awareness 
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levels, in Chapter Five I argued that measures of recognition may be more appropriate 
in the area of research under investigation in this thesis. 
 
9.2.1.1 Study one findings  
Study one (presented in Chapter Five) explored awareness of risk factors and 
symptoms of cervical cancer in a population-based sample of 1392 English women. On 
average, there was evidence for a need to increase awareness, as women were only 
able to recognise around half of the risk factors and symptoms presented, even when 
prompted (50% and 55%, respectively).  
 
Knowledge of some risk factors (smoking and infection with chlamydia) appears to have 
improved in recent years, but knowledge of the biggest risk factor, HPV, has largely 
remained the same, compared to previous findings (Philips et al., 2005; Waller et al., 
2004a). Also in line with previous research, my findings suggest that few women are 
aware of the mechanism for the link between sexual activity and cervical cancer (i.e. 
HPV infection), despite the launch of the HPV vaccination and associated publicity. 
 
Women were most aware of the two most common symptoms of cervical cancer 
(unusual vaginal bleeding and persistent, abnormal or unusual vaginal discharge), 
although awareness was still low even for these (29% and 15%, respectively).  
However, these data were collected just prior to the launch of the Department of 
Health’s key messages on cervical cancer in 2010 (NHS Choices, 2011), which includes 
information about risk factors and symptoms. As such, it is possible that awareness may 
now be higher, and future research might measure the impact of these key messages 
using the Cervical CAM for comparison. 
 
9.2.1.1 Study two findings  
Study two (presented in Chapter Six) also demonstrated a low awareness of risk factors 
and symptoms for ovarian cancer in a population-based sample of 1000 English women. 
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On average, women recognised 63% of the ovarian cancer symptoms (reflecting 
findings from a more recent study exploring symptom awareness, Brain et al., 2014). 
Awareness of risk factors was lower, with women recognising less than half of the 
symptoms (43%). 
 
Campaigns focusing on increasing survival rates and reducing incidence of ovarian and 
cervical cancer tend to focus on symptoms and risk factors respectively (for example, 
the NHS ‘Be Clear on Cancer: ovarian cancer’ campaign (NHS Choices, 2013b) and a 
campaign run for the NHS raising awareness of HPV in 2011 (Behance, 2011)). This is 
likely to be a result of the lower survival rates and lack of screening programme for 
ovarian cancer increasing the importance of symptom recognition and prompt medical 
presentation and existence of the cervical screening programme which has reduced 
symptomatic presentation of this disease, as well as the discovery that almost all 
cervical cancers result from HPV infection (Walboomers et al., 1999).  
 
As discussed in Chapter One, there are still nearly 1000 deaths attributable to cervical 
cancer each year (Office for National Statistics, 2012a), and there is evidence that 
attendance in higher risk age groups may be falling (Health & Social Care Information 
Centre, 2012). Further, those who do not attend screening may be diagnosed at a later 
stage (Castanon et al., 2013). These women, may benefit from awareness of the 
symptoms of cervical cancer in order to present to a health care professional in a timely 
manner. This, coupled with the findings from study one suggest that there is a need to 
educate women about the symptoms of cervical cancer, as well as the risk factors. 
 
It is also suggested that women would benefit from efforts to increase awareness of 
ovarian cancer risk factors. The findings in this thesis show that awareness is low, and 
the models of help-seeking described in Chapter Two highlight the importance of an 
awareness of risk for disease. Both the CSM and the IAM can describe how new 
information can increase an individual’s perception of risk for a disease. For example, 
within the CSM, new information (such as that obtained from a media campaign about 
risk factors), can lead to a bodily change that was previously dismissed as not serious, 
243 
 
being reassessed as serious. Within the IAM, symptom interpretation can also be 
influenced by external knowledge, such as an increase in the prevalence of a disease. If 
women are able to identify that they are at risk of ovarian cancer, this may then increase 
the likelihood of prompt help-seeking. 
 
9.2.2 What variables predict time to hypothetical help-seeking for symptoms for 
ovarian cancer? 
In study two, as mentioned above, I also reported data on anticipated time to help-
seeking for symptoms of ovarian cancer. This built on the findings reported in study one, 
exploring not only awareness of risk factors and symptoms, but also whether this and 
other demographic variables might predict time to help-seeking for a gynaecological 
cancer. Further, I also analysed a subgroup of the overall sample, who were at higher 
risk of ovarian cancer due to their age (≥45) (Cancer Research UK, 2013c). 
 
The findings showed that there were a number of predictors of hypothetical time to help-
seeking for ovarian cancer, including endorsing more service and practical barriers, and 
having a higher SES in the overall sample as well as in the subgroup, along with having 
a White ethnicity. These findings are similar to those reported by Brain et al. (2014), who 
also found that being educated to degree level (which may be indicative of a higher 
SES) and endorsing more practical barriers were significantly associated with 
anticipated delay for symptoms of ovarian cancer. However, my full model only 
predicted 6% of the variance in anticipating a longer time to help-seeking in the overall 
sample and 11% in the subgroup, suggesting that there are other variables associated 
with a longer time to help-seeking which were not measured here. 
 
The findings from study two highlight subgroups within the population who may be at 
risk of delaying help-seeking for symptoms indicative of ovarian cancer, and as such 
may allow interventions to be focused on addressing those groups who may be most 
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likely to wait longer before seeking help. In particular, the predictors of time to help-
seeking in women aged ≥45 years may be important, given that these women are more 
at risk of ovarian cancer. Future campaigns or programmes to encourage earlier 
diagnosis for ovarian cancer might focus more on this group of women, 
 
9.2.3 How do women respond both behaviourally and emotionally to symptoms 
which may indicate a gynaecological cancer? 
In study two I explored predictors of hypothetical help-seeking, and identified some 
variables which may predict hypothetical help-seeking. Building on this, in study three, I 
explored responses to symptoms in 911 English women, and broadened my research to 
explore this in all five gynaecological cancers. Further, I wanted to explore whether 
responses to symptoms may be different when outside of the context of cancer, and as 
such I avoided using the term, ‘cancer’ within this study. 
 
As with study two, in order to investigate symptom reporting and help-seeking in women 
who may be at higher risk of developing a gynaecological cancer, I created a sub-
sample of women whose symptoms may have been more likely to indicate a 
gynaecological cancer, as they were both aged ≥45 years and had a symptom which 
was frequent and/or severe (which may be more indicative of a gynaecological cancer, 
for example, Department of Health, 2009; Goff et al., 2007, 2004; Macleod et al., 2009; 
NICE, 2011).  
 
The most common response to a symptom in the overall group and the subgroup to a 
symptom was to monitor it (54% and 53%, respectively). Reassuringly, given their 
higher risk, a higher proportion of the women in the subgroup had seen a healthcare 
professional (HCP) (pharmacist, GP, practice nurse or A&E) than in the overall sample 
(43% versus 36%), with the majority having seen a GP (38% and 30%, respectively). 
The higher risk women were significantly more likely to have seen a GP, but significantly 
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less likely to have asked a friend or relative for advice than women who did not fall into 
this group. This suggests that higher risk women may be more likely to seek medical 
attention, rather than ask their friends or family for advice, whereas women with less 
severe and frequent symptoms are happy to seek advice from the latter. Given the 
increased likelihood that frequent and/or severe symptoms may be indicative of a 
malignancy in older women, these findings suggest that at least 43% of women may be 
acting appropriately, which is reassuring. It still remains, however, that the majority of 
these women are not help-seeking appropriately. My findings also suggest that there are 
many more women in the UK with symptoms than are seeking help for them. 
 
9.2.4 What factors explain the different behavioural and emotional responses 
women may have to an experienced symptom of a gynaecological cancer? 
In study three, I explored responses to symptoms, and identified groups of women in 
which responses such as medical help-seeking or an alternative may be more likely. 
However, I did not explore the processes which may lead to one response or another. 
Although I did explore predictors of anticipated help-seeking in study two, as mentioned 
above, my findings suggested that there are other factors which may be more influential 
on time to help-seeking, which were not measured. 
 
To build on the findings in study three and to explore the factors which influence help-
seeking behaviour in women who have symptoms which may be indicative of a 
gynaecological cancer, in study four I interviewed 26 women about their experiences, 
using a semi-structured interview guide. Again, I avoided the words ‘cancer’ or 
‘symptom’ during the interview. As with study three, study four was also underpinned by 
the MPT. 
 
I found evidence that the level at which women process their bodily changes or 
symptoms is influenced by the socio-cultural context within which bodily changes are 
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experienced; if bodily changes are congruent with what is expected or can be attributed 
to normal bodily processes, they may be subject to a lower level of appraisal. This may 
be particularly important for female cancers, as women hold a number of expectations 
about what it means to be a woman, including experiencing vaginal bleeding as part of 
their regular bodily processes, which may make distinguishing a symptom from these 
difficult.  
 
The non-specific nature of gynaecological cancers symptoms has been noted 
(Department of Health, 2009; National Institute for Health and Clinical Excellence 
(NICE), 2005), and there is evidence that the number of non-specific symptoms 
experienced initially is significantly associated with a longer time taken to appraise 
gynaecological cancer symptoms (Andersen et al., 1995). However, there is also 
evidence that symptoms indicative of a gynaecological cancer may be significantly 
different from those which are benign or part of normal bodily functioning (for example, 
(Hamilton et al., 2009), and that combinations of symptoms may be more likely to be 
indicative of disease (for example, (Goff et al., 2004; Olson et al., 2001). As such, there 
may be an opportunity to educate women about the differences between serious and 
less serious symptoms. 
 
Many women described feeling worried about wasting GP time, a barrier to help-seeking 
for symptoms of cancer which is frequently cited in the literature (for example, Johnson 
et al., 2011), and which was found to influence time to anticipated help-seeking in study 
two. Perhaps linked to this, was a need for help-seeking to be sanctioned, described by 
many women and a ‘stiff upper lip’ attitude to help-seeking. Interestingly, this does not 
seem to be a trait often reported in females (for example Barsky, Peekna, and Borus, 
2001), rather, it is seen as a barrier to help-seeking for male cancers (Mason and 
Strauss, 2004). Women also mentioned a need for trust, which may translate as a 
requirement for access to a female GP when presenting with an intimate symptom. 
Reflecting the findings in study three, which demonstrated a higher level of medical 
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help-seeking for women with a frequent and/or severe symptom, the women here also 
described seeking help if their symptom had occurred a number of times or if it was 
painful. 
 
Overall, study four demonstrated that there are specific patient, healthcare provider and 
system, and disease factors which may influence both the appraisal and the help-
seeking process, including the time taken in both of these intervals of the MPT 
(presented graphically in Chapter Two, page 57). However, although I attempted to 
explore influence on detection of a bodily change, I acknowledge that truly measuring 
how women detect symptoms is difficult, as the act of asking women about these 
symptoms may have caused them to attend to them. 
 
9.3 Contribution to the Literature 
Prior to the research undertaken in this thesis, there had been no literature published 
that had explored symptom awareness for cervical cancer. Although a body of research 
existed that had explored risk factor awareness, hardly any of the previously published 
research had done so in a population-based sample of women. Instead, awareness was 
tested in women who may be likely to have a higher level of awareness, as they were 
recruited via academic institutions or healthcare settings. 
 
Again, prior to the research undertaken here, there was very little literature exploring 
symptom awareness for ovarian cancer, and none that had been conducted in a UK 
population of women. I could only find one study that had explored awareness of risk 
factors for ovarian cancer, despite the clear evidence for a number of factors which 
increase risks for the disease. However, as with the literature exploring cervical cancer 
risk factors, this study was undertaken in a group of women who were likely to have a 
higher level of awareness by virtue of their participation in a trial testing the feasibility of 
ovarian cancer screening. 
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The research undertaken here, then, enables not only current levels of awareness for 
symptoms and risk factors for ovarian and cervical cancer in UK women to be 
understood, it also identifies areas of knowledge that require further investigation. This 
information may be important when designing interventions or campaigns to increase 
awareness, which may in turn reduce the chances of misattribution, non-recognition of 
symptom seriousness and increase awareness of personal risk for these cancers. 
 
The research undertaken in study three was completely novel for a number of reasons. 
Firstly, I found no literature that had attempted to explore the prevalence, frequency and 
severity of symptoms potentially indicative of a gynaecological cancer in the UK, nor 
women’s responses to these symptoms when actually experienced. Further, this study 
explored responses to symptoms outside of the context of cancer, which may have 
consequently reflected real life responses. Understanding how common these 
symptoms are is important when considering future campaigns to encourage help-
seeking, as these data provide an idea of the likely impact of any such campaigns on 
the primary care workload. Moreover, by exploring frequency and severity of symptoms, 
it was possible to explore when help-seeking or not may have been less or more 
appropriate in this population, given the evidence that frequent and/or severe symptoms 
may be more indicative of a gynaecological cancer. 
 
Although one qualitative study had been published exploring responses to 
gynaecological cancer symptoms (Cooper et al., 2013), this was published in the US, 
which has a different healthcare system to the UK. Further, Cooper et al.’s study 
explored both hypothetical and actual responses to symptoms, but did not always 
differentiate between the two, and the study design and analysis was not underpinned 
by any theoretical models. The study described in Chapter Eight was the first to explore 
attributions for and responses to symptoms in UK women with actual symptoms, and to 
map these findings on to a model (the MPT (Walter et al., 2012)), as recommended by 
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the Aarhus statement for improving the design and reporting of studies on early cancer 
diagnosis (Weller et al., 2012). 
 
9.4 Overview   
When considering my research findings presented in this thesis as a whole, it is possible 
to begin to unravel the intricate processes and decisions involved in a response to a 
symptom which may indicate a gynaecological cancer. It is clear that levels of 
awareness of symptoms of gynaecological cancers in UK women are low. There is 
some evidence that symptom awareness may play a part in time to help-seeking, 
although it may not be simply a process of informing women what the symptoms are. My 
qualitative research demonstrates that the appraisal process is complex, and that other 
variables, such as the socio-cultural context in which a symptom is experienced, play a 
role, above and beyond symptom awareness. Further, the non-specific nature of 
symptoms, and in some cases, the similarity to normal processes (Department of 
Health, 2009; National Institute for Health and Clinical Excellence (NICE), 2005) makes 
symptom interpretation difficult, which may lead to a failure to recognise the seriousness 
of the symptom. Educating women about the subtle differences between normal bodily 
function and potential symptoms, and about the increased likelihood of gynaecologic 
malignancy with certain combinations of symptoms may help women to distinguish 
between the two.  
 
Although there may be concerns about the increases in primary care workload following 
awareness campaigns and interventions designed to encourage prompt help-seeking for 
gynaecological cancers (Evans et al., 2014), evidence from other campaigns aiming to 
achieve this in lung cancer have shown that these fears may be unfounded (Mayden, 
2012). Further, if interventions are aimed at those women who are most likely to be at 
risk from developing a gynaecological cancer, these increases may be further 
minimised, as study three showed that this group of women may be very small. 
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The findings presented in this thesis begin to aid our understanding of how women 
appraise symptoms and respond to them, and our understanding of those variables 
which are influential on these processes in women who have experienced symptoms. 
This information may be used to inform interventions aimed at increasing prompt help-
seeking, which ultimately may help to increase earlier stage or lower volume disease, 
which in turn may positively influence survival rates. 
 
9.5 The Model of pathways to Treatment  
The aim of Chapter Three was to discuss and summarise the existing literature on 
factors associated with a prompt time to help-seeking for symptoms of female cancers, 
and to explore how these variables may fit into the MPT (Walter et al., 2012). Although 
the literature exploring factors associated with time to help-seeking for symptoms of 
gynaecological cancers is sparse, I was able to identify a number of factors which may 
influence help-seeking at the appraisal interval, including patient factors and disease 
factors and factors which may influence the help-seeking interval, including patient 
factors, healthcare provider factors and disease factors. 
 
In study four I explored the appraisal and help-seeking intervals of the model, and 
identified a number of different variables which may influence the total time taken to 
seek help from symptom onset. In Figure 8.2, I expanded the MPT to show those 
variables which may be influential in the first two intervals. 
 
I found evidence that expectations associated with being a woman (such as the 
familiarity of vaginal bleeding) may influence the appraisal process, and this would be a 
unique process in the appraisal of female cancer symptoms. Some of the other 
influences may be more likely in women (such as a concern about the GP gender), but 
are not exclusive, and may apply to other cancers. However, it is likely that most of the 
variables I found (such as the frequency or severity of a symptom or expectations of 
what a cancer symptom is) would apply across a number of different cancers. 
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9.6 Strengths and limitations  
The main limitations applicable to studies five and six were related to the exploration of 
hypothetical help-seeking, rather than actual help-seeking. However, retrospective 
research with women diagnosed with cancers also has its limitations, and a prospective 
study (following women who had symptoms to note their responses) would have ethical 
and cost implications, making such a design impossible within the time and funding 
limitations of my PhD. Further, study two placed help-seeking in the context of ovarian 
cancer, which may have influenced the times women reported intending to seek help in. 
In fact, most of the women did report that they would seek help very soon after symptom 
onset. These findings may not therefore reflect real responses to symptoms. In order to 
overcome this limitation, in study three I explored responses to symptoms in women 
who had recent experience of actual symptoms.  
 
It would have been interesting to explore predictors of help-seeking for symptoms of 
cervical cancer, as well as for the other gynaecological cancers. Future work could build 
on this research, exploring levels of awareness for uterine, vaginal and vulval cancers. A 
further limitation applicable to studies one and two was the small amount of variance 
explained within the regression models, suggesting that there were more influential 
variables that were not measured. I attempted to explore what these may be in study 
four. Future research could use this information to explore the influence of these 
variables in a larger sample of women, to determine those that are statistically 
significant predictors of help-seeking behaviour for gynaecological cancers. 
 
In study two, my sample was not population representative, and the use of quota 
sampling may have limited the generalisability of my findings. However, data were 
collected from a range of women from different socio-demographic groups, and 
consequently it is likely that the relationships observed would be the same as those 
observed in a population representative sample. Studies one and two both had a 
proportion of missing data, which is common in these types of surveys. However, the 
amount of missing data was low in both studies (less than 1% for each variable 
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measured in study one and less than 4% for any variable in study two), meaning that it 
was unlikely that my findings would have been different if these data had been included. 
 
I was unable to calculate the response rates in studies one and two, as the companies 
who collected the data used in these studies do not record the number of addresses 
they attempt to recruit from. This is a common limitation associated with outsourced data 
collection. Future researchers might liaise with these companies before data collection 
to see whether the number of individuals approached could be recorded, or could select 
a research agency that does record these data. Alternatively, a proxy measure of 
response rate could be determined when a survey module is part of a larger survey, by 
measuring the number of respondents to the whole survey, and to the individual module, 
as demonstrated in study three. 
 
In study three, only 42% of the women who completed the whole also completed my 
module, which raises questions regarding generalisibility of my findings. Extrapolation of 
the number of women with at least one symptom from my sample to a sample including 
my sample and the non-responders using the demographic information I had for the 
non-responders showed that my findings would have been similar had this group of 
women been included. Further, the sample was broadly representative of the UK 
population in terms of ethnicity and SES, and so this may not have affected my findings 
by a huge degree. 
 
The main strength of study four was the novelty of the research. Study two indicated that 
a large part of what influences women to wait longer before seeking help for a symptom 
of a gynaecological cancer was unexplained. Using a qualitative methodology in study 
four was appropriate, as it allowed novel factors to be identified, and the complexity of 
the help-seeking process for these cancers to be understood at a higher level than was 
previously possible.  
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Sampling issues were also experienced in this study, as I did not achieve the diversity 
within the sample which I had aimed to. However, there was some variation in some of 
the socio-demographic variables, and the aim of qualitative research is not to be 
generalisable. 
 
9.7 Secondary analysis of data within this thesis 
 
The studies presented in Chapters Five and Six were designed prior to the 
commencement of my PhD, and the data were collected in 2009, again, prior to the 
commencement of my PhD. As such, I was not involved in the design of these studies 
nor the data collection process. However, the raw data were made available to me, and I 
undertook data cleaning, recoding, all analyses and interpretation of the findings for 
these two studies within this thesis. I designed the remaining studies presented as part 
of this thesis, with guidance from my supervisors, Dr Jo Waller and Dr Alice Simon and 
from Dr Suzanne Scott. 
 
Although there were some limitations to the design of these studies and the data 
produced (as described above), some of these were only clear after the data had been 
analysed, and in fact, identifying these limitations allowed me to avoid the same 
limitations in the studies that I did design. Designing and collecting data for these 
studies would have taken a considerable amount of time, and the use of these data in 
this thesis meant that I had the time and resources available to build on the findings 
from these studies, and attempt to overcome some of the limitations in my subsequent 
studies. However, as I was not involved in the design and collection of data for these 
studies, it was still necessary for me to become very familiar with both prior to, and 
during analysis, with support from my supervisors, Alice Simon and Jo Waller, who were 
both involved in these studies from conception. Further, the fact that these studies were 
not designed as part of this PhD meant that, while they provided interesting data, they 
were of limited use in exploring the MPT.  
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9.8 Future research suggestions 
9.8.1 The influence of different variables on the appraisal and help-seeking 
intervals of the MPT 
My qualitative work in study four identified a number of factors which may influence the 
appraisal and help-seeking processes. It would be interesting to explore the 
complexities of these relationships in a larger quantitative study, to determine the 
strongest predictors of appraising a symptom as a cancer and medical help-seeking. 
Initially this research may be retrospective, in women who have experienced symptoms, 
or would explore hypothetical help-seeking via a survey, in a larger sample of women. 
 
9.8.2 Development of an intervention to increase awareness of symptoms and risk 
factors and encourage both accurate appraisal and timely help-seeking for 
symptoms potentially indicative of a gynaecological cancer 
Studies one and two demonstrated a need for education on risk factors and symptoms 
for cervical and ovarian cancers, which in turn, may aid accurate appraisal. In particular, 
there may be a need for more information about those symptoms which may be more 
likely to indicate a serious illness. Any intervention aiming to increase awareness of 
these cancers could also be broadened to include the remaining gynaecological 
cancers, in order to ensure that women who may be at higher risk are aware of what 
may be normal and what may not be within their reproductive system, and can act 
accordingly. Study three demonstrated that there may be many more women with 
symptoms than are seeking help. Although it may not always be appropriate to seek 
help immediately for some of these symptoms, there is a clear need for those women 
with higher risk symptoms, who are not seeking help, to be brought into primary care. 
 
Finally, using the results from study four, I extended the MPT to show specific factors 
that may affect appraisal and time to help-seeking, some more likely to occur in women. 
Future campaigns might address these factors when encouraging women to seek 
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medical attention for a symptom potentially indicative of a gynaecological cancer, and 
might target those women who have higher risk symptoms and are less likely to seek 
help promptly. 
 
As described above, the work undertaken within this thesis provides an evidence base 
to support the need for interventions which may improve outcomes for women with 
symptoms of a gynaecological cancer. As such, it would sit within the ‘Development’ 
stage of the complex intervention development-evaluation-implementation process in 
the updated Medical Research Council’s guidance for developing and evaluating 
complex interventions (Craig et al., 2008), which involves identifying the evidence base 
and identifying/developing theory.  
 
9.8.3 Study to identify the true prevalence of symptoms potentially indicative of a 
gynaecological cancer 
The research described in Chapter Seven made an attempt to explore prevalence of 
symptoms potentially indicative of a gynaecological cancer in a UK population. However, 
almost 60% of the women approached did not respond. It would be difficult to overcome 
this limitation, as feedback from the interviewers suggested that women felt too 
embarrassed to answer the questions. Another way of measuring prevalence may be to 
access GP READ codes and measure symptoms which may indicate a gynaecological 
cancer. 
 
9.9 Final comments  
Gynaecological cancers as a group are a significant threat to female health, and for 
most of these cancers, incidence levels are rising, suggesting that the threat may 
increase over time without intervention. Lower one-year survival levels in the UK 
compared to countries with comparable health systems suggest that improvements are 
possible. By increasing prompt help-seeking in symptomatic women, it is believed that 
survival rates can improve, through earlier clinical diagnosis. 
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The research in this thesis demonstrates that symptoms potentially indicative of a 
gynaecological cancer are common, and that differentiating them from those bodily 
processes which are part of being a woman is difficult. I identified a number of factors 
that may encourage help-seeking or act as barriers, and which influence the appraisal 
process, which adds to our understanding of the complexity of the help-seeking process. 
It is clear that there is a strong need for interventions aimed at increasing not only 
awareness, but understanding of the symptoms and risk factors for gynaecological 
cancers, and that those women who are clinically most at risk should be targeted. 
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Are you interested in women’s health research? 
If so, we are looking for women over the age of 30 to complete a five 
minute, confidential online survey about their current health. 
 
The survey is for a research study at University College London about 
women’s health and responses to changes in their bodies. We would like to 
invite some of the women who complete the survey to take part in further, 
paid research. Details of this will be provided during the survey.  
 
If you would like to participate, please enter the following link into your 
internet browser. This will take you straight to the survey.  
https://www.surveymonkey.com/s/BSL8HX8 
Questions? Please contact the researcher:  
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